| Title | Collaboration Type | HHS Participating Agencies | NIH Participating Institutes, Centers, and Offices | Description |
|---|---|---|---|---|
| 2015 Dietary Guidelines Management Team | Other | ACF, CDC, FDA, HRSA, IHS, OS | NIDDK, NCI, OD/DPCPSI/ODP | The Dietary Guidelines Management Team includes federal staff representing the Departments of Health and Human Services and Agriculture throughout the Dietary Guidelines for Americans revision process and supports the Dietary Guidelines Advisory Committee from the planning phase to the final report phase. http://www.health.gov/dietaryguidelines/ |
| 5th Annual NICHD Infant Mortality Awareness 5-Kilometer Run/Walk/Roll | Meeting/ Workshop | OS | NICHD, NIMHD | The Institute welcomed all HHS staff and their families to the 5th Annual Infant Mortality Awareness 5K Run/Walk/Roll. Infant mortality is one of the most important indicators of the health of a nation. According to a National Center for Health Statistics data brief issued in 2013, the United States ranked 27th in the world in infant mortality. Medical research, public health outreach, and social services have helped the overall U.S. infant mortality rate to decline during the 20th century. In spite of this general decline, infant mortality rates for certain populations, including African American, Puerto Rican, and American Indian/Alaskan Native infants remain above the U.S. average of 6.05 per 1,000 live births. This event reaffirms the NIH commitment to conducting and supporting research and outreach that reduces the U.S. infant mortality rate, and the disparate rates that impact communities of color. It also aims to raise awareness about infant mortality, particularly in those communities where the rates are above the U.S. average, by highlighting ongoing efforts from the NICHD and other Institutes, Centers, and Offices to address this public health concern. |
| 8th Annual Conference on the Science of Dissemination and Implementation | Meeting/ Workshop | AHRQ | NHLBI, NCCIH, NCI, NIAAA, NIAID, NIDA, NIDDK, NIMH, NINR | A forum for discussing the science of dissemination and implementation, the 7th annual conference aimed to grow the research base by bridging the gap between evidence, practice, and policy in health and medicine. http://www.academyhealth.org/Events/events.cfm?ItemNumber=13518 |
| A Pilot Study of Urinary Carcinogen Biomarkers in the Golestan Cohort Study | Research Initiative | CDC, FDA | NCI | We are performing a pilot study in the Golestan Cohort to compare exposure to different types of carcinogens (nicotine metabolites, polycyclic aromatic hydrocarbons [PAHs], tobacco-specific nitrosamines [TSNAs], and volatile organic compounds [VOCs]) and creatine in the urine of self-reported cigarette, chewing nass, water pipe, and opium users, and never users of these products. We also will examine the stability of these markers over time by taking advantage of repeated samples that were collected from a subset of participants. Results from the pilot study will then be used to evaluate the potential of future studies and evaluate their design. |
| A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews | Research Initiative | CDC | NCI | A cross-sectional study of 83 airline pilots and 50 university faculty to assess the relation of stable chromosome translocations with cosmic radiation exposure. |
| A Working Group to Consider the Question of Federal Public Health and Medical Resource Allocation | Committee, Work group, Advisory group, or Task Force | OS | CC | Dr. Marion Danis is participating in a working group to consider the question of federal public health and medical resource allocation. The group developed a framework for allocation of federal resources during scarcity after engaging with stakeholders in ethics, disaster preparedness, and emergency management. |
| A5295 Evaluation of Xpert Mycobacterium tuberculosis/rifampin (MTB/RIF) Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis (TB) Suspects | Research Initiative | CDC | NIAID | This initiative will estimate the sensitivity of a single Xpert Mycobacterium tuberculosis/rifampin (MTB/RIF) assay (performed on sputum) in TB suspects with at least one acid fast bacilli (AFB) sputum smear positive result and at least one culture result positive for Mycobacterium tuberculosis. http://globalprojects.ucsf.edu/project/actg-a5295-evaluation-xpert-mtbrif-assay-rapid-identification-tb-and-tb-rifampin-resistance |
| A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial | Research Initiative | CDC | NIAID | NIAID''s AIDS Clinical Trial Group (ACTG) network and CDC''s Tuberculosis Trials Consortium (TBTC) network are collaborating to enroll participants for this study (approximately half in each network). The completed trial will determine if the two proposed regimens can shorten tuberculosis treatment duration. . |
| Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT) | Research Initiative | FDA | NIDA | Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT) is part of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the US Food and Drug Administration (FDA). The mission of the (ACTTION) is to identify, prioritize, sponsor, coordinate, and promote innovative activities with a special interest in optimizing clinical trials that will expedite the discovery and development of improved analgesic, anesthetic, and addiction treatments for the benefit of public health. http://www.acttion.org/news/3_1_12.html |
| Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus | Research Initiative | FDA | NIAMS, NIAID | The National Institutes of Health (NIH), pharmaceutical companies and nonprofit organizations have together created the Accelerating Medicines Partnership (AMP) to develop new models for identifying and validating promising biological targets for new diagnostics and drug development. A major goal is to generate pre-competitive, disease-specific data that will be publicly accessible to the broad biomedical community for further research. The partners have designed a project plan to address relevant challenges for rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) (AMP RA/SLE Program). The goal is to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of autoimmune diseases. This program will involve an enhanced systems-level understanding of gene expression and signaling in target tissues from affected end organs (synovium for RA, kidney and skin for lupus) and blood cells. The initial focus of research will be on RA and lupus, with the flexibility to expand in the future to related autoimmune diseases contingent on scientific feasibility and availability of resources. https://www.niams.nih.gov/grants-funding/funded-research/accelerating-medicines |
| Action for Health in Diabetes (Look AHEAD) | Research Initiative | CDC, IHS | NIDDK, NHLBI | This study is a 16-center, randomized clinical trial investigating the long-term health consequences of weight loss. Enrollment occurred between 2001-2004 with a planned follow-up of up to 13.5 years. The Look AHEAD cohort comprises approximately 5,000 overweight or obese participants with type 2 diabetes, aged 45-76. Participants were randomized to one of two interventions: an intensive lifestyle intervention designed to produce and sustain weight loss over the long term or a diabetes support and education arm. The study intervention was discontinued in Sept. 2012 on the recommendation of the Data and Safety Monitoring Board (DSMB), as there were no differences between the two groups after up to 11 years of follow-up. The study will continue to follow participants for study outcomes. http://www.lookaheadtrial.org |
| Action Plan for Children in Adversity (APCA)/PL 109-95 | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA | NICHD | The Action Plan on Children in Adversity is the first-ever whole-of-government strategic guidance for U.S. Government international assistance for children. The goal of the U.S. Government Action Plan on Children in Adversity is to achieve a world in which all children grow up within protective family care and free from deprivation, exploitation, and danger. The plan is grounded in evidence that shows a promising future belongs to those nations that invest wisely in their children, while failure to do so undermines social and economic progress. Child development is a cornerstone for all development, and it is central to U. S. development and diplomatic efforts. The plan seeks to integrate internationally recognized, evidence-based good practices into all of its international assistance initiatives for the best interests of the child. The Action Plan has three principal objectives and three supporting objectives to promote greater U.S. Government coherence and accountability for whole-of-government assistance to vulnerable children. http://www.childreninadversity.gov/about/how/action-plan |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-up Study (ACCORDION) -- Health Related | Research Initiative | CDC | NHLBI | The Action to Control Cardiovascular Risk in Diabetes (ACCORD) study was primarily composed of three clinical trials that tested treatment approaches to determine the best ways to decrease the high rate of major cardiovascular disease (CVD) events – heart attack, stroke, or death from CVD – among people with type 2 diabetes who are at especially high risk of having a CVD event, like a heart attack or stroke. ACCORDION (the ACCORD Follow-up Study) is a prospective, observational follow-up study of approximately 8000 participants who were treated and followed in the ACCORD Trial. It is designed to further elucidate and clarify the long-term effects of the ACCORD treatment strategy and provide additional data on the long-term relationships among various cardiovascular and diabetic risk factors. ACCORD participants had type 2 diabetes and were at high risk for a CVD event. Those who agree to participate in ACCORDION will continue to be followed through clinic and phone visits for an average of 3.5 years in the period 2011 through 2014. Participants will be seen in 76 clinics across the United States and Canada. The CDC is contributing intellectually and financially to the Health Related Quality of Life and Cost Effectiveness sub-studies of the trial. https://www.accordionstudy.org/public/dspHome.cfm |
| Addiction Technology Transfer Centers (ATTCs) | Resource Development | SAMHSA | NIDA | Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Blending Initiative. NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) joined together to create the Blending Initiative in 2001 to reduce the gap that exists between the publication of research results and impact on treatment delivery. This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. Through this initiative, NIDA and SAMHSA’s Addiction Technology Transfer Centers (ATTCs) disseminate treatment and training products based on results from studies conducted by the National Drug Abuse Clinical Trials Network (CTN) as well as other NIDA-supported research. http://www.drugabuse.gov/blending-initiative |
| Adjuvant Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIAID, NCI | Staff from all National Institute of Allergy and Infectious Diseases (NIAID) Divisions, program staff from the Biomedical Advanced Research and Development Authority (BARDA), and regulatory staff from the Food and Drug Administration (FDA) exchange information about ongoing programs related to novel adjuvants for infectious disease vaccines, identify high priority research areas (and gap areas), and discuss ideas to accelerate progress in adjuvant research through better access to information and resources. |
| Administration of Comprehensive Assessment of Occupationally-Relevant Exposures | Research Initiative | CDC | NIEHS | This task order provides financial support for The National Institute for Occupational Safety and Health (NIOSH) personnel to travel to, attend, and participate in several National Toxicology Program (NTP) meetings held in Research Triangle Park, NC, and Washington, DC. These included Interagency Committee for Chemical Evaluation and Coordination meetings, NTP Technical Report meetings, NTP Board of Scientific Counselors meetings, Report on Carcinogens meetings, NTP Executive Committee Meetings, and ad hoc meetings addressing specific NTP issues. All of these meetings were aimed at investigating, defining, or reporting hazards associated with exposure to environmental chemicals. Many of the exposures are occupational and NIOSH personnel provide expert opinion on chemical exposures linked to cancer, respiratory disease, development and reproductive disorders, neurotoxicity, and immunological toxicity. |
| Adults with Chronic Health Care Needs (ACHCN) Screener Cognitive Testing | Research Initiative | CDC | CC | A screening instrument developed to provide the health services research community with the capacity to estimate the size of and measure the subsequent health care needs and use among individuals with chronic conditions and/or disabilities at the population level is undergoing in-depth cognitive testing by the Questionnaire Design Research Laboratory in NCHS. |
| Advanced Anticonvulsant System Interagency Product Team | Committee, Work group, Advisory group, or Task Force | FDA, OS | NINDS | The Advanced Anticonvulsant System Interagency Product Team is a Department of Defense led effort to facilitate activities, both research and regulatory, related to the FDA approval of midazolam for use in treating nerve agent exposure. |
| Advancing Regulatory Science Through Novel Research and Science-Based Technologies | Research Initiative | FDA | OD/DPCPSI, NCATS, NIDDK, NINDS, OD/DPCPSI/OSC | This regulatory science initiative aims to foster the development, evaluation and availability of new or improved tools, methods, standards, and applied science that support a better understanding and improved evaluation of product safety, quality, effectiveness, and manufacturing throughout the product life cycle. http://nihroadmap.nih.gov/regulatoryscience/ |
| Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | Meeting/ Workshop | AHRQ | OD/DPCPSI/ODP, NHLBI, NIAID, NINDS, NINR, OD/DPCPSI/ORWH | The Office of Disease Prevention coordinates the development of the Pathways to Prevention (P2P) program to host workshops that identify research gaps in a selected scientific area, identify methodological and scientific weaknesses in that scientific area, suggest research needs, and move the field forward through an unbiased, evidence-based assessment of a complex public health issue. Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome was held December 9-10, 2014. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex, multifaceted disorder characterized by extreme fatigue and a host of other symptoms that can worsen after physical or mental activity, but do not improve with rest. The workshop was designed to clarify: 1) How the research on ME/CFS using multiple case definitions has contributed to the state of the current scientific literature on diagnosis, pathophysiology, treatment, cure, and prevention of ME/CFS; 2) How the measurement outcomes (tools and measures) currently used by researchers of ME/CFS are able to distinguish among those patients diagnosed with ME/CFS, including the sensitivity of the tools and measures to identify subsets of patients according to duration, severity, nature of the illness, onset characteristics, and other categorizations; 3) How the research on treatments or therapies shown to be effective in addressing symptoms of ME/CFS will lead to an understanding of the underlying pathology associated with ME/CFS; and 4) How innovative research approaches have provided an understanding of the pathophysiology of ME/CFS, and how this knowledge can be applied to the development of effective and safe treatments. The workshop was sponsored by the Office of Disease Prevention and the Trans-NIH Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research Working Group. During the workshop, invited experts discussed the body of evidence and attendees provided comments during open discussion periods. An independent, multidisciplinary panel prepared a report that identified future research priorities. https://prevention.nih.gov/programs-events/pathways-to-prevention/past-workshops/me-cfs |
| Advancing Understanding of Program Evaluation for the Office of Minority Health (OMH) Preconception Peer Educators Program and the NICHD Safe to Sleep Campaign | Research Initiative | OS | NICHD | The purpose of this agreement is for the Department of Health and Human Services, Office of Minority Health to provide financial support to the NICHD to: (1) conduct a review of relevant program evaluation studies that focus on health communication and outreach programs to increase awareness of health risks and/or modify health-related behaviors; and (2) conduct a literature review of relevant program evaluation studies that focus on health communications, outreach, and peer education or train-the-trainer programs. The long-term goal of this agreement is to coordinate federal efforts to reduce infant mortality and address health disparity reduction by evaluating and assessing the effectiveness of HHS-supported outreach and communication programs. |
| Adverse Event Reporting and Medical Countermeasures | Resource Development | FDA | NLM | NLM is working with the FDA to provide advice on key mobile technologies for targeted adverse event reporting and medical counter measures in emergency settings. The group helped direct the design and development of the mobile app that was co-developed with programmers from Booz Allen Hamilton (BAH), the FDA contractor. BAH was responsible for the Web app that could be encapsulated within Android or iOS frameworks. NLM focused on the iOS framework and developed plugins for encryption, data caching and communications, audio capture, and overall app development. The app can send data to a cloud-based server under the aegis of the FDA. The app was demonstrated to the FDA leadership in June, 2014 and future R&D directions were outlined at the meeting. In addition to the design of the mobile app, NLM advised the FDA team on usability issues and provided guidance on distribution strategies. |
| Advisory Committee for Heritable Disorders in Newborn and Children | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA | NICHD | The Advisory Committee on Heritable Disorders in Newborns and Children was established under the Public Health Service Act, Title XI, § 1109 (42 U.S.C. 300b-10), as amended by the Newborn Screening Saves Lives Reauthorization Act of 2014 (P.L. 113-240). The mission of the Advisory Committee on Heritable Disorders in Newborns and Children is to reduce morbidity and mortality in newborns and children who have, or are at risk for, heritable disorders. The Committee recommends that every newborn screening program include a Uniform Screening Panel that screens for 32 core disorders and 26 secondary disorders. The Committee advises the Secretary, U.S. Department of Health and Human Services on the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and standards. Specifically, the committee provides to the Secretary, the following: Advice and recommendations concerning grants and projects authorized awarded or funded related to screening heritable disorders in newborns and children, technical information to develop Heritable Disorders Program policies and priorities that will enhance the ability of the state and local health agencies to provide screening, counseling and health care services for newborns and children who have or are at risk for heritable disorders, and recommendations, advice and information to enhance, expand or improve the ability of the Secretary to reduce mortality and morbidity from heritable disorders in newborns and children. The committee was chartered on May 7, 2015. http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/ |
| Advisory Committee for Immunization Practices (ACIP) | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID | The Advisory Committee on Immunization Practices (ACIP) is a group of medical and public health experts that develop recommendations on how to use vaccines to control diseases in the United States. The recommendations stand as public health advice that will lead to a reduction in the incidence of vaccine preventable diseases and an increase in the safe use of vaccines and related biological products. |
| Advisory Committee on Organ Transplantation (ACOT) | Committee, Work group, Advisory group, or Task Force | HRSA | NIAID | The Advisory Committee on Organ Transplantation (ACOT) was established to assist the HHS Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, thereby increasing public confidence in the integrity and effectiveness of the transplantation system. http://organdonor.gov/legislation/advisory.html |
| Agency for Toxic Substances and Disease Registry Superfund Research Program (ATSDR-SRP) Seminar Series | Meeting/ Workshop | ATSDR, CDC | NIEHS | To communicate Superfund Research Program (SRP) research findings, provide networking and collaboration opportunities, and discuss needs for future work. http://www.niehs.nih.gov/research/supported/centers/srp/about/partnerships/ats/index.cfm |
| Aging in Place Workgroup | Meeting/ Workshop | ACL, CMS, FDA | NHLBI, NCATS, NCI, NIA, NIBIB, NINDS, NINR | The purpose of the workgroup is to discuss the use and development of technologies for assisting older adults and people with chronic diseases to live independently. http://cra.org/ccc/wp-content/uploads/sites/2/2015/06/CCC-AiP-White-Paper.pdf |
| Aging with Disability | Research Initiative | ACL | NIA | The goal of this collaboration among the National Institute on Aging (NIA), Administration for Community Living (ACL) and National Institute on Disability and Rehabilitation Research (NIDRR) is to explore issues of aging with disability through research, policy analysis, and data development, including joint Funding Opportunity Announcements (FOAs). |
| AHRQ Editorial Board | Committee, Work group, Advisory group, or Task Force | AHRQ | NLM | The AHRQ’s National Guidelines Clearinghouse/National Quality Measures Clearinghouse (NQMC/NGC) Editorial Board is composed of health care professionals with collective expertise in evidence-based quality measures and clinical practice guidelines. This is an expert public-private panel that provides guidance concerning the content and presentation of the related but distinct AHRQ resources, the National Guidelines Clearinghouse and the National Quality Measures Clearinghouse. The Board also serves as a resource for feedback and guidance on developments in health care that inform future work. NLM is a member of this editorial board. http://www.qualitymeasures.ahrq.gov/index.aspx |
| AHRQ Patient Safety Workgroup | Committee, Work group, Advisory group, or Task Force | AHRQ | NLM | AHRQ Patient Safety Network (PSNet) is a national web-based resource featuring the latest news and essential resources on patient safety. The AHRQ Patient Safety Workgroup is an expert public-private panel that provides guidance to AHRQ concerning implementation of legislation related to patient safety reporting and monitoring, including the “AHRQ Patient Safety Common Formats” for reporting patient safety events. NLM serves on this workgroup. https://psnet.ahrq.gov/ |
| AHRQ Registry of Patient Registries (RoPR) | Resource Development | AHRQ | NLM | The Registry of Patient Registries (RoPR) is a database of registry-specific information intended to promote collaboration, reduce redundancy, and improve transparency. ClinicalTrials.gov worked with RoPR to implement a mechanism for patient registries to be registered in ClinicalTrials.gov and additional information provided directly at RoPR. https://patientregistry.ahrq.gov/ |
| AHRQ/CMS/Duke Evidence-based Practice Center (EPC) Comparative Effectiveness Review: Lower Extremity Peripheral Venous Disease, Excluding Acute Deep Vein Thrombosis. | Committee, Work group, Advisory group, or Task Force | AHRQ, CMS | NHLBI | This systematic review will focus on the diagnosis and management of chronic venous disease in outpatient and inpatient settings where care is coordinated by primary care physicians, vascular surgeons, vascular medicine specialists, cardiologists, and/or radiologists. In developing this comprehensive review, the rules of evidence and evaluation of strength of evidence recommended by the Agency for Healthcare Research and Quality (AHRQ)’s Evidence-based Practice Center (EPC) Program in its Methods Guide for Effectiveness and Comparative Effectiveness Reviews (hereafter referred to as the Methods Guide) apply. This review will solicit feedback regarding conduct of the work (such as development of search strategies and identifying outcomes of key importance) from the Task Order Officer (TOO) and the Technical Expert Panel (TEP). The project will follow the methodology recommended by the EPCs for literature search strategies, inclusion/exclusion of studies in review, abstract screening, data abstraction and management, assessment of methodological quality of individual studies, data synthesis, and grading of evidence for each key questions. |
| AIDSinfo | Public Education Campaign | CDC, CMS, HRSA | OD/DPCPSI/OAR, NIAID, NLM | AIDSinfo, a service of the U.S. Department of Health and Human Services (HHS), offers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and the general public. http://aidsinfo.nih.gov/ |
| AIDSinfo/InfoSIDA | Resource Development | CDC, FDA, HRSA | NLM, NIAID, OD/DPCPSI/OAR | These English and Spanish language websites assist in the dissemination of the Public Health Service Treatment Guidelines. https://infosida.nih.gov/ |
| Alaska Native Tumor Registry | Resource Development | CDC, IHS | NCI | In collaboration with CDC, IHS, and NCI, and with technical assistance from the Surveillance, Epidemiology, and End Results Program (SEER), the Alaska Native Tumor Registry collects information on cancer cases among Alaskan Native populations residing in Alaska. http://seer.cancer.gov/registries/alaska.html |
| Alaska Suicide Prevention | Meeting/ Workshop | SAMHSA | NIMH | Each year NIMH, in partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA), hosts a webinar on effective practices in suicide prevention for Alaska Native communities. Suicide is a national concern, with more than 41,000 deaths by suicide occurring in the U.S. each year. Alaska Native and American Indian populations bare a disproportionately high burden from suicide. At the webinar, mental health researchers, representatives from the Tanana chiefs Conference, and academic administrators provide an overview of suicide in Alaska and strategies to promote mental wellness and reduce suicide risk among Alaska Natives. http://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2015/reducing-the-burden-of-suicide-among-american-indian-and-alaska-native-youth.shtml |
| Alcohol Clinical Trial Initiative (ACTIVE) | Committee, Work group, Advisory group, or Task Force | FDA | NIAAA, NIDA | Consortium that includes academia and representatives from the Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA) and the pharmaceutical industry working together to identify and clarify clinical trials methodology to evaluate medications for treating alcohol dependence. http://www.ncbi.nlm.nih.gov/pubmed/21900883 |
| All-Hazards Playbook | Resource Development | OS | NLM | This activity is to develop an interactive tool to help state and local health departments prepare for and respond to disasters in their regions. |
| Alzheimer''s Disease Neuroimaging Initiative | Research Initiative | FDA | NIA, NIBIB | This collaboration is meant to develop biomarkers of Alzheimer’s disease in elderly subjects. A major goal of the study has been to establish and validate MRI and PET images, cerebral spinal fluid, and blood biomarkers as predictors of the disease. http://adni.loni.usc.edu/ |
| America''s Children Forum on Health and Family Statistics | Resource Development | SAMHSA | NIDA | As a member of this collaboration, NIDA contributes data from the, “Monitoring the Future Survey on Illicit Drugs, Alcohol and Tobacco Trends”. http://www.childstats.gov/index.asp |
| American Academy of Pediatrics (AAP) Committee on Drugs | Committee, Work group, Advisory group, or Task Force | FDA | NICHD | The Committee on Drugs reviews all aspects of pediatric pharmacology including drug indications, contraindications, absorption rates, routes of administration, dosing, use precautions, and mode of action as they apply to children. The Committee also advises the Board of Directors in matters related to drug labeling, safety and efficacy for both prescription and over-the-counter drugs; monitors federal legislation related to the drug approval process; and promotes the need for expanded pediatric drug trials. https://www.aap.org/en-us/about-the-aap/Committees-Councils-Sections/pages/Committee-on-Drugs.aspx |
| American Academy of Pediatrics (AAP) Committee on Genetics | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | The Committee on Genetics (COG) studies and makes recommendations to the Board of Directors on recent advances in genetics and provides support to chapters on state legislative issues as they relate to genetics. https://www.aap.org/en-us/about-the-aap/Committees-Councils-Sections/Pages/Committee-on-Genetics.aspx |
| American Academy of Pediatrics (AAP) Committee on Pediatric AIDS | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The Committee on Pediatric AIDS (COPA) provides guidelines and recommendations for the care and treatment of infants, children, and adolescents with HIV and their families through the development of AAP Policy Statements and the provision of guidance and consultation to other policy making bodies as well as to local and federal governances. https://www.aap.org/en-us/about-the-aap/Committees-Councils-Sections/Pages/Committee-On-Pediatric-AIDS.aspx |
| American Academy of Pediatrics (AAP) Council on Injury, Violence and Poison Prevention (COIVPP) | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | The Council on Injury, Violence, and Poison Prevention, was formed on July 1, 2011 with the merging of the former Section and Committee on Injury, Violence, and Poison Prevention. This new leadership body addresses all facets of injury prevention policy, programs, advocacy, and education of general pediatricians, pediatric subspecialists, and families as a unified group. http://www2.aap.org/sections/ipp/ |
| American Academy of Pediatrics (AAP) Disaster Activity Council, Federal Liaison | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NICHD | The American Academy of Pediatrics (AAP) is an organization of more than 64,000 pediatricians committed to the attainment of optimal physical, mental, and social health and well-being for all infants, children, adolescents, and young adults. For more information, see the AAP Fact Sheet. The AAP formed a Work Group on Disasters in 1993 to develop resources on the psychosocial needs of child disaster victims that could be sent to pediatricians if there was a disaster in their community. In 2001, the AAP established a Task Force on Terrorism to manage follow-up efforts regarding the terrorist attacks on September 11, 2001, and issues related to anthrax. The AAP then established a Disaster Preparedness Team that focused on Hurricane Katrina follow-up and clarified the AAP role in reunification, rescue, and recovery. In 2006, the AAP Board of Directors identified disaster preparedness as 1 of 7 priority issues requiring special attention and resources. The AAP appointed the Disaster Preparedness Advisory Council (DPAC) in May 2007 to establish a focused effort within the AAP to 1) Develop and implement a 3-5 year AAP Strategic Plan for Disaster Preparedness; 2) Oversee/support AAP disaster preparedness initiatives while working collaboratively with AAP committees, sections, and councils and key partner organizations; and 3) Strengthen AAP advocacy and policy efforts, which include responding to inquiries as appropriate, identifying opportunities for advocacy such as providing Congressional testimony and offering comments on federal regulations, and mobilizing a Contact Network. In 2010, the AAP conducted an opinion poll on children and disasters. Key issues the AAP is addressing include: •Ensuring that children’s issues are addressed as early as possible in the development of disaster preparedness programs and activities. •Involving pediatric experts in all levels of disaster planning and response (medical home to national levels). •Supporting AAP Chapters and members to integrate pediatric issues into state plans. If you would like a copy of the most recent DPAC meeting minutes, please e-mail DisasterReady@aap.org. The DPAC members recognize that “disaster medicine” is a topic that crosses many other AAP groups. Currently, more than 600 AAP members with an interest, involvement, and/or expertise in disaster preparedness have been identified. These members receive the AAP Children & Disasters newsletter, free disaster-related print materials, and other disaster-related communication through an electronic mailing list. If you would like to be included on this list, e-mail DisasterReady@aap.org. This Web site represents one step to ensure that all pediatricians and other health professionals, parents, caregivers and teachers, policymakers, and communities have the information they need when they need it. This includes a new Web page that highlights progress made in children’s preparedness since Hurricane Katrina. The AAP Tomorrow’s Children Endowment Fund supports this Web site and other disaster preparedness initiatives. We hope that you find it to be a valuable resource! https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/Children-and-Disasters/Pages/Disaster-Preparedness-Advisory-Council.aspx |
| American Association of Pediatrics (AAP) Executive Committee, Section on Perinatal Pediatrics | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The mission of the Section on Perinatal Pediatrics of the American Academy of Pediatrics (AAP) Executive Committee is: to improve the health of the pregnant mother, the unborn fetus and the newly-born child through the sponsorship of programs which encourage the professional growth of the neonatal-perinatal providers, continuously improve clinical care delivery, support continuing and postgraduate education, foster basic, clinical and outcomes research and seek to attain federal and local funding for programs directed towards maternal/child health. The Section on Perinatal Pediatrics (Section) is the home organization for specialists in Neonatal-Perinatal Medicine and also welcomes affiliate members working in related disciplines. At a membership of nearly 3,500, the Section is the largest specialty subgroup of the AAP. The Section’s highest priority is to ensure the optimal health and well-being of babies and mothers and this is accomplished through the Section’s core activities in the realms of advocacy, education, outreach and support of clinicians and researchers. https://www2.aap.org/sections/perinatal/committees.html |
| American Community Survey (ACS) Content Review Working Group | Committee, Work group, Advisory group, or Task Force | OS | NICHD | The American Community Survey (ACS) is an ongoing survey that provides vital information on a yearly basis about our nation and its people. Information from the survey generates data that help determine how more than $400 billion in federal and state funds are distributed each year. Through the ACS, we know more about jobs and occupations, educational attainment, veterans, whether people own or rent their home, and other topics. Public officials, planners, and entrepreneurs use this information to assess the past and plan the future. When you respond to the ACS, you are doing your part to help your community plan hospitals and schools, support school lunch programs, improve emergency services, build bridges, and inform businesses looking to add jobs and expand to new markets, and more. https://www.census.gov/programs-surveys/acs/about.html |
| American Conference for the Treatment of HIV (ACTHIV) | Meeting/ Workshop | CDC, FDA | OD/DPCPSI/OAR | The American Conference for the Treatment of HIV (ACTHIV) is a state-of-the-science conference for frontline health care professionals, in scientific collaboration with multiple federal and independent agencies. The conference is designed for all frontline clinicians providing HIV care for various population groups. http://acthiv.org |
| American Conference for Treatment of HIV (ACTHIV) Steering Committee | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The purpose of this steering committee was to plan for the conference "American Conference for the Treatment of HIV (ACTHIV)”. The 10th annual ACTHIV is a state-of-the-science conference specifically targeted toward US frontline providers of care to persons at risk of, or, with HIV infection. |
| Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks | Committee, Work group, Advisory group, or Task Force | FDA | NINDS, NCATS, NCI, NIAAA, NIDA | The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the US Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health. http://www.acttion.org/ |
| Analysis of Mycotoxins in Dust Samples From a Water Damaged Building | Research Initiative | CDC | NIEHS | These studies are developing methods to quantitate the levels of fungal products in dust samples from water damaged buildings so that biomarkers of effect, such as fungal specific antibodies, can be correlated with biomarkers of exposure. |
| Anti-Infective Drugs Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/default.htm |
| Antimicrobial Resistance Challenge Working Group | Meeting/ Workshop | CDC, FDA, OSG | OD/DPCPSI, NIAID, OD/OIR/OTT, OD/OLPA, OD/OSP | Description of Collaborative Activity: On September 18, 2014, the President issued Executive Order 13676 on Combating Antibiotic-Resistant Bacteria and the and the Antimicrobial Resistance Challenge was called for in the accompanying White House Fact Sheet. The development and use of rapid, point-of-care, and innovative diagnostic tests for identification and characterization of resistant bacteria was a goal identified in the National Strategy for Combating Antibiotic-Resistant Bacteria released in September 2014 and addressed in the National Action Plan for combating Antibiotic-Resistant Bacteria released in March 2015. In conformance with the previous documents, the NIH and BARDA are sponsoring a prize competition, and the FDA and CDC are contributing technical and regulatory expertise to develop the award evaluation process. The aim of the prize competition is to incentivize the development of one or more in vitro diagnostic tests that would be of significant clinical and public health utility to combat the development and spread of antibiotic resistant bacteria. The AMR Challenge Working Group meets bi-weekly. |
| Antiretroviral Pregnancy Registry | Resource Development | CDC, FDA, HRSA | NICHD | This is a registry of use of antiretroviral drugs in pregnancy that is sponsored by various pharmaceutical companies and has a committee of external experts and government staff from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). The registry provides a resource for clinicians and researchers to improve the healthcare quality and patient safety for HIV infected mothers and their infants. http://www.apregistry.com/ |
| Asbestos Workshop | Meeting/ Workshop | CDC | NIEHS | This meeting will include discussion of nomenclature and characterization of asbestos-like materials, giving us the perfect opportunity to establish an interdisciplinary discussion regarding the characteristics of mineral fibers that cause disease. The overall combined conference is planned to take place on September, 2016, at Lister Hill Auditorium in Washington, DC. The working title for the 1.5-day NIOSH workshop is, “Elongate Mineral Fiber Terminology and Characterization”. |
| Asia-Pacific Economic Cooperation (APEC) Cervical Cancer Initiative | Meeting/ Workshop | OS | NCI | NCI/CGH and HHS/OS/OGA have been supporting a collaborative effort to strengthen cervical cancer control through the Asia-Pacific Economic Forum (APEC). Effective cervical cancer control strategies exist all along the cervical cancer control continuum, including primary prevention, screening, treatment, and palliative care. Recent research has demonstrated the effectiveness of lower cost screening techniques, and ongoing research is exploring additional reduced-cost cervical cancer control options. The large number of interventions currently available and on the horizon means that the integration of these approaches into health systems is possible for economies of many different resource levels and can have substantial impact on public health, the workforce, and the broader economy. http://www.cancer.gov/about-nci/organization/cgh/research/apec |
| Assay Guidance Manual (AGM) Workshop | Meeting/ Workshop | FDA | NCATS, NCI, NEI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIMH, NINR | NCATS Assay Guidance Manual, an eBook developed in coordination with an international editorial board and colleagues at Eli Lilly and Company, is a 32-chapter how-to guide for researchers on developing and using assays in high-throughput screening projects. In February 2015, the manual’s editors held an inaugural workshop, "Assay Guidance for High Throughput Screening and Lead Discovery," at the NCATS laboratories in Rockville, Maryland. The goal of the workshop, which was aimed at scientists who are new to the drug discovery community, was to provide a broad introduction and baseline information for developing assay methods. Participants included intramural researchers from many NIH Institutes and Centers and the Food and Drug Administration. Activities included presentations about critical fundamental concepts relevant to researchers with diverse backgrounds and interests, demonstrations and tours, and small group discussions. https://ncats.nih.gov/newsletters/vol04-iss03/mar2015.html#assay |
| Assay Guidance Workshop For High Throughput Screening And Lead Discovery | Meeting/ Workshop | FDA | NCATS, CC, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIMH, NIMHD, NINDS | Researchers from NCATS and the Food and Drug Administration (FDA) hosted the, "Assay Guidance Workshop for High-Throughput Screening and Lead Discovery", in July 2015 at the Harvey W. Wiley Federal Building in College Park, Maryland. The goal of the workshop was to share best practices and advice for robust assay design and development with scientists who are new to the drug discovery community. More than two hundred participants attended the event, including intramural researchers from many NIH Institutes and Centers, the FDA, the National Institute of Standards and Technology, and the Environmental Protection Agency. The workshop included seven lectures by leading drug discovery scientists and editors of the Assay Guidance Manual. A similar workshop will be held at the 2016 annual conference of the Society for Laboratory Automation and Screening in San Diego in January. https://ncats.nih.gov/newsletters/vol04-iss08/aug2015.html#agm |
| Assessment of Occupational Exposure to Coal Tar Pitch Volatiles Containing Polycyclic Aromatic Hydrocarbons (PAHs) in Coal Tar Sealant Applications | Research Initiative | CDC | NIEHS | This study will measure exposure of coal tar sealant applicators to polycyclic aromatic hydrocarbons (PAHs) compounds. |
| Assessment of Occupational Exposure to Flame Retardants | Research Initiative | CDC | NIEHS | To characterize occupational exposure to flame retardants among U.S. workers who are manufacturing or installing flame retardant materials. |
| Asthma Supplement to the National Ambulatory Medical Care Survey (NAMCS) | Health Survey | CDC | NHLBI, NIAID, NICHD, NIEHS | The National Ambulatory Medical Care Survey (NAMCS) Asthma Supplement is a national survey of physician''s opinions about and use of the National Asthma Education and Prevention Program (NAEPP) Guidelines for the Diagnosis and Management of Asthma. The National Institutes of Health and the National Center for Health Statistics collaborate on this activity. http://www.cdc.gov/nchs/ahcd.htm |
| ASTM International F-2529-13--Standard Guide for In-Vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM) | Research Initiative | FDA | NIDCR | Provide a guide based on consensus of viewpoints used to determine the osteoinductive potential of a DBM containing products utilizing the arthymic rodent model. http://www.astm.org/Standards/F2529 |
| Auditory (Hearing) Screening Supplement for Early Childhood Longitudinal Study | Health Survey | CDC | NIDCD | The objective of this Inter-Agency Agreement is to implement a hearing examination protocol in the Early Childhood Longitudinal Study of the Kindergarten Class of 2010–11. This is a large (n=20,000), nationally representative school-based exam and interview survey sponsored by the National Center for Education Statistics (NCES), U.S. Department of Education. The last NCES longitudinal cohort study of school age children began with the 1998 Kindergarten Class. In this earlier cohort, there were no hearing exams (nor vision exams) and the number of young children with hearing loss (reported by parents or teachers) shrank considerably after the initial enrollment of Kindergarteners. In the U.S., the last comprehensive national study of children with hearing exam measures was the 1963–1965 National Health Examination Survey (NHES, i.e., the predecessor of NHANES) for children aged 6 to 11 years. A randomly selected sub-sample of about 4500 children were identified for more frequent follow-up and these children have also been selected for the hearing examination; they are also included in a “selected” (protected) subsample for more intensive tracking in follow-up waves of the survey. Children in the selected subsample will be tracked to new schools when possible if they are later enrolled in (moved to) a school that was not in the original school sample, e.g., when families relocate. In addition to hearing, the ECLS-K: 2010-11 will track several other outcome measures (e.g., general health, social and physical development, achievement scores, and parental and teacher-reported communication problems) associated with educational performance. Hearing will be tested when the children are examined with achievement testing in the school setting. NCES has awarded a contract to WESTAT to conduct the field operations, including selection of sample schools, data collection, and preparation of user-friendly research data files. The contractor will obtain longitudinal measures of hearing sensitivity and middle ear function of Kindergartners during the fall of Second grade (calendar year 2012), spring of Third grade (calendar year 2014), and spring of Fifth grade (calendar year 2016). Hearing thresholds will be recorded from each ear separately. In addition, the contractor will obtain tympanometric traces to assess middle ear function and, also, wideband reflectometry beginning in the spring of Third grade to improve classification of sensorineural versus conductive hearing loss. http://nces.ed.gov/ecls/ |
| Autoimmune Diseases Coordinating Committee (ADCC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | OD/OSP, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR | The purpose of the ADCC is to provide a forum for the coordination of research efforts in autoimmunity and autoimmune diseases among various stakeholders including the NIH, other federal agencies such as the FDA and the CDC, and private organizations with an interest in autoimmune diseases. The ADCC meets twice yearly to discuss a broad range of basic, preclinical and clinical endeavors. http://www.niaid.nih.gov/topics/autoimmune/Pages/coordComm.aspx |
| B-24 Project | Research Initiative | CDC, FDA | NICHD | NICHD has played a lead role in the evolution of the process to include infants/children from birth to 24 months and pregnant women in future (2020 and beyond) iterations of the Dietary Guidelines for Americans; the "B-24 Project." An offshoot of that project was the effort to develop guidelines for nutritional care of preterm infants (the "Pre-B Project"). Both projects have included members of the CDC and FDA on working groups constituted to develop the initial reports that will serve as the basis for the subsequent systematic review and guideline development process. |
| Behavioral Aspects of Prep Counseling HIV Prevention Trials Network (HPTN) Protocol #067: The ADAPT Study (Y01-MH-0315) | Research Initiative | CDC | NIMH, NIAID | This behavioral research study is evaluating whether non-daily medication regimens for HIV Pre-Exposure Prophylaxis (PrEP) may be more acceptable and foster better adherence to treatment. PrEP represents a novel biomedical approach to HIV prevention in which individuals at-risk for HIV take antiretroviral medications to help prevent HIV infection. The HPTN 067 study is conducted through the NIAID-led HIV Prevention Trials Network. An interagency agreement between NIMH and CDC supports the implementation of this international research study at a clinical research site in Bangkok, Thailand. http://www.hptn.org/research_studies/hptn067.asp |
| Behavioral Health Coordinating Council (BHCC) Subcommittee on Marijuana | Committee, Work group, Advisory group, or Task Force | CDC, FDA, SAMHSA | NIDA | Behavioral Health Coordinating Council (BHCC) Subcommittee on Marijuana develops projects with clear goals, provides guidance to achieve steady progress and measurable outcomes, and develop key policy messages on issues related to marijuana http://www.samhsa.gov/about-us/interagency |
| Behavioral Health Coordinating Council (BHCC) Subcommittee On Primary Care And Behavioral Health Integration | Committee, Work group, Advisory group, or Task Force | ACL, AHRQ, CMS, HRSA, IHS, SAMHSA | NIDA, NIAAA, NIMH | Subcommittee of Behavioral Health Coordinating Council (BHCC) that collaborates on primary care and behavioral integration. http://www.samhsa.gov/about-us/interagency |
| Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee | Committee, Work group, Advisory group, or Task Force | FDA | NICHD | The Best Pharmaceuticals for Children Act (BPCA) Data Coordinating Center (DCC) is responsible for managing all aspects of BPCA clinical trials including developing trial design, collecting and analyzing trial data, monitoring data quality, conducting site monitoring, collecting and preparing safety reports, organizing and submitting documentation to the FDA, and managing the Data Monitoring Committee. |
| Best Pharmaceuticals for Children Act Working Group (BPCA) | Committee, Work group, Advisory group, or Task Force | FDA | NICHD | This working group supports the goals of the Best Pharmaceuticals for Children Act (BPCA). The BPCA seeks to improve the level of information—in scientific publications and on the label—about pharmaceuticals used to treat children. The BPCA requires that the NIH identify the drugs of highest priority for study in pediatric populations and publish a list of drugs/needs in pediatric therapeutics. https://bpca.nichd.nih.gov/prioritization/status/Documents/Priority_List_07082014.pdf |
| Big Data to Knowledge (BD2K) | Research Initiative | AHRQ, CMS, FDA, OS | OD/DPCPSI, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ORIP, OD/DPCPSI/ORWH, OD/DPCPSI/OSC, OD/OCPL, OD/OER, OD/OIR, OD/OIR/OTT, OD/OLPA, OD/OM/OB, OD/OSP | The Big Data to Knowledge (BD2K) program aims to facilitate broad use of biomedical big data, develop and disseminate analysis methods and software, enhance training for disciplines relevant for large-scale data analysis, and establish centers of excellence for biomedical big data. In FY 2014, BD2K held discussions with several HHS agencies who have shared interests in Big Data. http://commonfund.nih.gov/bd2k/index |
| Biomarkers Reflecting Inflammation and Nutrition Determinants of Anemia (BRINDA) project | Research Initiative | CDC | NICHD, NIAID | The primary focus of our collaborations stemming from the Iron and Malaria project is now the, Biomarkers Reflecting Inflammation and Nutrition Determinants of Anemia (BRINDA) project. This project involves a meta-analyses of national surveys from 17 countries to examine the relationship between inflammation and biomarker performance/interpretation with specific regard to iron and vitamin A. It also includes an examination of other non-iron determinants of anemia in these low resource settings. As anemia prevalence often serves as a "trigger" for population-based interventions particularly iron supplementation it is critical given current concerns about the safety and efficacy of iron to ensure that such triggers accurately reflect the target problem. CDC has assumed a major role in the conduct of the BRINDA study with technical and financial support of NICHD. |
| Bioresource Development, Validation Tools, and Integrating High-Throughput Screening Technology Standards in Complementary and Alternative Medicine (CAM) Product Use in Children | Research Initiative | CDC, HRSA, SAMHSA | NCCIH, NICHD | Collaborative efforts between the FDA/CBER and the NIH/NCCAM for substantiating health benefit claims for probiotics under Investigational New Drug Applications (INDs) were placed in the framework of U01 Cooperative Agreements that began in 2008. The successful evaluation of the initiative has recently developed into an invitation to develop a Memorandum of Understanding (MoU) to promote resource sharing and exchange of research expertise; development of demonstration project(s); and the initiation of trans-agency research initiatives focused on the integration of advanced molecular technologies that lead to harmonization standards and improved diagnostics for safety and substantiation of the health benefits of probiotic interventions. In 2011, a collaboration with FDA/CFSAN was initiated to expand the validation tool. In 2012, a Materials Transfer Agreement [MTA] was approved and the FDA/CFSAN received the entire data collection to undergo testing employing their novel microarray multi-loci sequence testing system [MLST]. |
| Biosafety Infectious Disease | Training Initiative | CDC | NIEHS | Improve nation capacity to reduce illness and injury as a result of potential exposure to infectious pathogens |
| Board of Scientific Counselors, CDC''s National Center for Injury Prevention and Control | Committee, Work group, Advisory group, or Task Force | CDC | NIA | An NIA representative serves on the Board of Scientific Counselor’s for the Centers for Disease Control and Prevention (CDC) National Center for Injury Prevention and Control. The NIA representative brings expertise in research on older adults. http://www.cdc.gov/injury/ |
| Body Mass and Mortality Relationships | Research Initiative | CDC | NCI | A study of the relationships between categories of body mass and mortality in the U.S. population. http://epi.grants.cancer.gov/bmi/ |
| Brain Attack Coalition | Committee, Work group, Advisory group, or Task Force | CDC | NINDS | The Brain Attack Coalition (BAC) is a group of public and private entities representing medical, scientific, advocacy, and government professionals from across the stroke continuum. The BAC is dedicated to setting direction, advancing knowledge, and communicating best practices to improve our ability to prevent and combat stroke. http://www.brainattackcoalition.org |
| Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG) Special Interest Group | Other | FDA, OSG | NICHD, NCI, NIDDK, OD/DPCPSI/ORWH | In August 2012, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) formed a trans-U.S. Department of Health and Human Services (HHS) scientific interest group, Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG), to provide an intellectual platform for the scientists from HHS agencies interested in breastfeeding and human lactation research activities. http://www.surgeongeneral.gov/library/calls/breastfeeding/calltoactiontosupportbreastfeeding.pdf |
| Burkholderia Interagency Working Group | Committee, Work group, Advisory group, or Task Force | OS | NIAID | This interagency working group coordinates activities related to the Burkholderia research portfolios of NIAID, Biomedical Advanced Research and development Authority (BARDA), and Defense Threat Reduction Agency, and shares data related to the regulatory pathway of existing and novel medical countermeasures against melioidosis and glanders. |
| Cancer and Women''s Health Interagency Agreement | Research Initiative | FDA | NCI | This formal agreement (MoU) establishes the framework and procedures to enhance collaborations and exchange of information between the FDA’s Office of Women’s Health (OWH) and the NCI’s Center to Reduce Cancer Health Disparities (CRCHD). Working together, FDA and NCI seek to increase scientific knowledge and understanding of cancer in women through targeted basic, clinical, bio-behavioral, translational, and community-based participatory research approaches/efforts. FDA and NCI both recognize the need for a unified approach to advancing scientific knowledge related to cancer and women’s health. This harmonized approach will aid in advancing the public health of all women through innovation in cancer research and medical therapies. |
| Cancer Control Plan, Link, Act, Network with Evidence-Based Tools (P.L.A.N.E.T) | Resource Development | AHRQ, CDC, SAMHSA | NCI | Cancer control planners, program staff, and researchers have the same goals: to reduce cancer risk, the number of new cancer cases, and the number of deaths from cancer, as well as enhance the quality of life for cancer survivors. While many share the same goals, all do not have easy access to resources that can facilitate the transfer of evidence-based research findings into practice. This Cancer Control P.L.A.N.E.T. (Plan, Link, Act, Network with Evidence-based Tools) portal provides access to data and resources that can help planners, program staff, and researchers to design, implement and evaluate evidence-based cancer control programs. http://ccplanet.cancer.gov/index.html |
| Cardiovascular Coordination Team | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI | The purpose of the workgroup is to assess the feasibility of conducting an evidence based review to assess the effectiveness of interventions using community health workers for cardiovascular disease prevention. The final review will be included in, “The Community Guide sponsored by the Community Preventive Services Task Force”. |
| CDC Chronic Kidney Disease Surveillance | Health Survey | CDC | NIDDK | NIDDK assists CDC in their surveillance program of chronic kidney disease. http://nccd.cdc.gov/ckd/ |
| CDC Community Guide: Review Various Interventions to Reduce Alcohol-Related Problems | Resource Development | CDC, SAMHSA | NIAAA, NIDA | The Community Guide is a free resource to help people choose the most effective programs and policies to improve health and prevent disease in their communities. http://www.thecommunityguide.org/index.html |
| CDC Elimination of Pediatric HIV in US Stakeholders Group | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | Working group of federal and non-federal individuals to assist the Centers for Disease Control and Prevention (CDC) in developing initiatives to eliminate mother to child HIV transmission in the US. |
| CDC Preventing Chronic Disease: Editorial Board | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | This committee serves as the editorial board for the journal, "Preventing Chronic Disease”. Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. The mission of PCD is to promote the open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. The vision of PCD is to be the premier forum where practitioners and policy makers inform research and researchers help practitioners and policy makers more effectively improve the health of the population. Articles focus on preventing and controlling chronic diseases and conditions, promoting health, and examining the biological, behavioral, physical, and social determinants of health and their impact on quality of life, morbidity, and mortality across the life span. http://www.cdc.gov/pcd/about_the_journal/editorial_board.htm |
| CDC-NIH Lyme Disease Serum Sample Repository | Resource Development | CDC, OS | NIAID | Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the CDC. CDC and NIH both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development. |
| CDC/ National Center for Health Statistics (NCHS) Balance/Dizziness Problems | Health Survey | CDC | NIDCD | The purpose of this agreement is for NIDCD to provide financial support to the National Center for Health Statistics (NCHS) for the inclusion of Balance/Dizziness Supplements for a representative sample of US adults (age 18+ years) and children (age 3–17 years) in the 2016 National Health Interview Survey (NHIS). Previously, NIDCD negotiated an IAA with NCHS for collaboration and funding of the 2008 Adult Balance/Dizziness Supplement and the 2012 Child Balance/Dizziness Supplement to the NHIS. The current fiscal year funds will provide partial support for the renewal of this collaborative effort between NCHS and NIDCD to fund the 2016 Adult and Child Balance/Dizziness Supplements to the NHIS. The new NHIS Supplements will include many of the same questions on Balance/Dizziness included in the earlier 2008 and 2012 studies, although revisions have been made to eliminate some questions in order to include new ones that higher on the current priority list. These questions on the new Balance/Dizziness Supplements will assist NIDCD to make program planning decisions on priorities with respect to the funding of research on the prevention of falls related to dizziness and balance. The results will also be analyzed for use in tracking the Department of Health and Human Services’ (DHHS) objectives in Healthy People 2020. Results from this nationally-representative survey of the U.S. non-institutionalized, civilian population will help NIDCD make budget allocations to subject areas where needs are found to be most critical. http://www.cdc.gov/nchs/nhis.htm |
| CDC/ National Center for Health Statistics (NCHS) National Health Interview Survey (NHIS) - 2014 Hearing Supplement | Health Survey | CDC | NIDCD | NIDCD added a hearing component to the 2014 National Health Interview Survey (NHIS) by sponsoring inclusion of many additional questions on hearing loss and tinnitus. The hearing loss questions on the 2014 National Health Interview Survey (NHIS) will greatly augment the one basic question on hearing difficulty included in the annual core of the NHIS survey by asking additional hearing health questions for both the adult (18+ years) and child. http://www.cdc.gov/nchs/nhis.htm |
| CDC/ National Institute of Occupational Safety and Health (NIOSH) for Audiometric Support for 3 NIDCD-Sponsored, Population-Based Surveys | Health Survey | CDC | NIDCD | The purpose of this agreement is to provide funding for scientific and technical support as well as quality assurance of three large audiometric examination surveys funded by NIDCD. These health surveys are: (i) The National Health and Nutrition Examination Survey (NHANES), (ii) Age, Gene/Environment Susceptibility Study–Reykjavik Study (AGES–RS), and (iii) the Early Childhood Longitudinal Study – Kindergarten Class of 2010/2011 (ECLS–K:2010/2011). http://www.cdc.gov/niosh/ |
| CDC’s Division of Select Agents and Toxins (DSAT) | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID | The workgroup held biweekly meetings to discuss the following: point of regulation of select toxins (Botulinum neurotoxins, Staphylococcal enterotoxins, Abrin, Ricin, Conotoxins, Saxitoxin, Tetrodotoxin, Diacetoxyscirpenol, T-2 toxin), natural environment, toxin exclusion limits, space decontamination, and potential updates to the CDC’s manual “Biosafety in Microbiological and Biomedical Laboratories.” http://www.cdc.gov/phpr/dsat.htm |
| CDC’s Field Epidemiology Training Program (FELP) Cancer Curriculum | Training Initiative | CDC | NCI | CDC and NCI (Center for Global Health and Cancer Prevention Fellowship Program) are collaborating to add a cancer curriculum to CDC’s Field Epidemiology Training Program. https://www.tephinet.org |
| Center for Disease Control (CDC) and Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OAR | The CDC / HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment shall advise the Secretary; the Director, CDC; and the Administrator and Associate Administrator for HIV/AIDS, and HRSA, regarding objectives, strategies, policies, and priorities for HIV and STD/hepatitis prevention and treatment efforts including surveillance of HIV infection, AIDS, STDs/hepatitis, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS and STDs/hepatitis; identification of policy issues related to HIV/STD/hepatitis professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV and STDs/hepatitis; and support to the agencies in their development of responses to emerging health needs related to HIV and other STDs/hepatitis. http://www.cdc.gov/maso/FACM/facmCHACHSPT.htm |
| Centers for Medicare and Medicare Services (CMS)- NIH Data Access Committee | Committee, Work group, Advisory group, or Task Force | CMS | NINR, CC, CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/OSP | Observational studies based, in part, on available Centers for Medical and Medicare Services (CMS) data could generate important knowledge and policy relevant findings. NIH and CMS established a Data Access Committee to identify and pursue short and long term research priorities. Current initiatives include: implementation of an Inter-Agency Agreement wherein NIH directly purchases blanket access to CMS data from CMS, instead of paying grantees to access these data individually (which incurs high indirect cost rates for NIH); and convening quarterly meetings of the CMS-NIH Data Access Committee to discuss data policy and access issues. Future meetings may include presentations by NIH-funded investigators and in-house CMS data analyses. |
| Characterizations of Fungal Exposures | Research Initiative | CDC | NIEHS | These studies address the limitations in traditional methods for assessing fungal exposures by using molecular techniques to identify fungi in dust samples and biological fluids. |
| Characterize Emerging HIV Strains from Blood Donors and Patients | Resource Development | FDA | NIAID | This initiative will characterize emerging HIV strains from blood donors and patients to determine viral tropism based on co-receptor usage strains. It will update the global viral panels to analyze multiple, diverse isolates from different parts of the world. This activity is part of NIAID’s ongoing efforts to develop a well-characterized repository for diagnostics, and drug and vaccine studies. http://eqapol.dhvi.duke.edu/viral-diversity-program |
| Chemical Integrated Program Team (IPT) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NICHD | This workgroup is a Public Health Energy Enterprise. The Chemical Integrated Program Team (IPT) working group provides an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, radiation/nuclear, etc.). The scope of their work includes setting requirements for the stockpiling of Medical Countermeasures (MCMs), MCM delivery, and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting. |
| Chemical, Biologic, Radiologic, Nuclear and Explosive (CBRNE) Branch Subject Matter Advisory Resource Team (SMART) | Committee, Work group, Advisory group, or Task Force | OS | NICHD | The Subject Matter Advisory Resource Team (SMART) works to conduct analysis of response issues or problems in an unencumbered, academic environment to triage potential issues out or provide decision support when indicated. Participation is generally limited to facilitate rapid analysis and fluid discussion. Depending on the natural of any incident (e.g. Chem, Bio, Nuke/Rad, etc.), this list will be augmented and subject specific participants may be added or subtracted. https://aspr.hhs.gov/wg/hhscapabilities/resourcedocs/Chemical%20Biologic%20Radiologic%20Nuclear%20and%20Explosive%20Disaster%20Response%20and%20Recovery%20Resources.pdf |
| CHEMM (Chemical Hazards Emergency Medical Management) | Resource Development | ATSDR, CDC, OS | NLM | This activity is to develop and maintain a comprehensive web resource and mobile app (in conjunction with the Wireless Information System for Emergency Responders [WISER]). Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards via a user-friendly interface. http://chemm.nlm.nih.gov |
| Chronic Fatigue Syndrome Advisory Committee (CFSAC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, OS | NINDS, CSR, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NINR, NLM, OD/DPCPSI/OBSSR | The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS). These include: 1) factors affecting access and care for persons with ME/CFS; 2) the science and definition of ME/CFS; and 3) broader public health, clinical, research and educational issues related to ME/CFS. http://www.hhs.gov/advcomcfs/ |
| Clinical and Translational Research Course for PhD Students | Training Initiative | FDA | CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS | The Clinical and Translational Research Course for Ph.D. Students is a two-week intensive introductory course for graduate students in the basic biomedical sciences who have at least one year of graduate study. The purpose of the course is to demonstrate and highlight the roles of PhD scientists in clinical and translational research, to provide an overview and examples of how basic science and clinical observations lead to translational research, and to increase awareness and access to Ph.D. role models, research resources, and potential career opportunities at the NIH. http://www.cc.nih.gov/training/phdcourse |
| Clinical Decision Support (CDS) Federal Collaboratory and Inventory of Federal Clinical Decision Support Activities | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, HRSA, IHS, OS | NLM, CC | A federal community of interest focused on clinical decision support (CDS), and a compilation of project summaries describing CDS activities that are either funded by the US Federal government, or that are being executed by agencies of the government. CDS encompasses a variety of tools and technologies that are used within electronic clinical information systems to improve the quality, safety, efficiency and effectiveness of patient care. CDS provides clinicians, staff, patients, and other key decision makers with knowledge and person-specific information, intelligently filtered at appropriate times, to enhance health and health care. CDS encompasses computerized alerts and reminders, clinical guidelines, order sets, order entry feedback, patient data reports and dashboards, documentation templates, diagnostic support, and the presentation of contextually relevant reference information within clinical information systems. NLM has submitted to the Collaboratory and Inventory summaries of NLM projects involving Clinical Decision Support. https://www.healthit.gov/policy-researchers-implementers/cds-activities |
| Clinical Intervention to Help Pregnant Women Quit Smoking in the US | Research Initiative | CDC | NICHD | The purpose of this Interdepartmental Delegations Authority (DDA) activity is to support a study to further understanding of an effective clinical intervention to help pregnant women quit smoking in the US. |
| Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID | This working group discusses a range of issues relevant to the development of antiviral drugs for the treatment of influenza. |
| Clinical Islet Transplantation Consortium | Research Initiative | CMS, FDA | NIDDK, NIAID | The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in people with type 1 diabetes. Studies conducted by the CIT Consortium will focus on improving the safety and long-term success of methods for transplanting islets, the insulin-producing cells of the pancreas, in people whose own islets have been destroyed by the autoimmune process that characterizes type 1 diabetes. One clinical trial, in particular, is studying the efficacy of islet transplantation after kidney transplantation. Participants may include Medicare beneficiaries. This study was mandated in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. http://www.citisletstudy.org |
| Clinical Trial Designs for Emerging Infectious Diseases | Meeting/ Workshop | CDC, FDA | NIAID | This workshop will focus on a discussion of lessons learned from Ebola crisis. http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/ucm466153.htm |
| Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup | Committee, Work group, Advisory group, or Task Force | CDC | CC | Dr. Marion Danis is participating as a member of the Medical Countermeasures Work Group to provide clinical algorithms that will assist clinicians to evaluate, triage, diagnose and treat large number of patients presenting with symptoms of anthrax. It will also provide a clinical prioritization schema for the use of medical countermeasures specific to anthrax and outline unique critical care issues that may require special consideration. |
| Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, OS | NLM | NLM is collaborating with OS and HHS Office of the National Coordinator for Health Information Technology (ONC) on developing and disseminating regulatory language related to health information technology, meaningful use, and standards and certification criteria related to electronic health records and messaging. Collaboration includes serving as members of the Content Standards Workgroup, and Semantic Standards Workgroup of the Health IT (HIT) Standards Committee. The HIT Standards Committee is a Federal advisory committee that was created by the Health Information Technology for Economic and Clinical Health (HITECH) Act to provide input to HHS on the policies and technologies needed to improve health and care. http://www.nlm.nih.gov/healthit.html |
| ClinicalTrials.gov | Resource Development | FDA | NLM, CC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD/OSP | ClinicalTrials.gov is an NLM-operated database containing summary protocol and results information from publicly and privately funded clinical research. As of November 2015, the database included protocol information on more than 200,000 studies conducted in over 191 countries, with nearly 19,000 records displaying summary results. NLM originally collaborated with FDA on implementing Section 113 of the Food and Drug Administration Modernization Act. It is currently collaborating with FDA and other parts of NIH to implement the statutory requirements of Section 801 of the Food and Drug Administration Amendments Act of 2007. http://www.clinicaltrials.gov/ |
| Collaboration With Indian Health Service Institutional Review Board (IRB) In Training IRB Interns From Native Communities | Committee, Work group, Advisory group, or Task Force | IHS | CC, NHGRI | The Clinical Center’s Department of Bioethics, in collaboration with NHGRI, piloted an Institutional Review Board (IRB) internship program for Native Americans. As part of the program, Sara Hull collaborated with the IRB of the Indian Health Service. http://www.ihs.gov/Research/index.cfm?module=hrpp_about |
| Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA, HRSA | NIAID | This committee provides scientific direction to the Registry on an ad hoc basis. |
| Committee on Emerging Science for Environmental Health Decisions | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, FDA, OS | NIEHS, NCATS, NCI, NHGRI, NICHD | This National Academy of Science (NAS) Committee facilitates communication among government, industry, environmental groups, and the academic community about scientific advances that may be used in the identification, quantification, and control of environmental impacts on human health. New methods and approaches that can be used to identify and control environmental impacts on human health are explored in regular workshops that provide a public venue for exchanging information and discussing potential implications for environmental health decisions. http://nas-sites.org/emergingscience/ |
| Committee on Fetus and Newborn (COFN) | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The Committee on the Fetus and Newborn (COFN) studies issues and current advances in fetal and neonatal care; makes recommendations regarding neonatal practice; collaborates with the American College of Obstetricians and Gynecologists (ACOG) to consider perinatal issues on which the practices of obstetrics and pediatrics merge; and works cooperatively with ACOG on new editions of Guidelines for Perinatal Care. In 1937, the Academy established the Committee on Neonatal Morbidity and Mortality to collaborate with a similar Committee in the American Pediatric Society. Together, these committees agreed that neonatal mortality and morbidity could be reduced by applying what was already known. The group made a number of recommendations including: collect statistics and develop a standard nomenclature for causes of death, conduct more autopsies to learn about the causes of death, collaborate with obstetricians, and develop standards for protection of newborn infants. In 1938, the committee requested a name change to the Committee on Problems of the Fetus and Newborn Infant and in 1941, the name was changed to its current name, COFN. http://www.aap.org/en-us/about-the-aap/Committees-Councils-Sections/Pages/Committee-on-Fetus-and-Newborn.aspx |
| Committee to Review The National Institute for Occupational Safety and Health (NIOSH) Decisions on Special Exposure Cohorts | Committee, Work group, Advisory group, or Task Force | OS | NCI | NCI was a panel member for administrative review of the National Institute for Occupational Safety and Health (NIOSH) decisions to create special exposure cohorts in response to claimants. |
| Common Data Elements (CDE) for Patient-Centered Outcomes Research | Resource Development | OS | NLM, CC, CIT, NCATS, NCI, NEI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIEHS, NIMH, NINDS, NINR, OD/OER | Led by NLM, a work-group of the Trans-NIH BioMedical Informatics Coordinating Committee (BMIC) and others are working to promote the use of common data elements in research, surveillance, and patient registries to facilitate data sharing and reuse. Work has produced a portal of NIH projects that use Common Data Elements (CDEs) and, with the assistance of funding to develop data infrastructure to promote patient-centered outcomes research (OS Patient-Centered Outcomes Research Trust Fund), will contribute to development of a search, retrieval, and repository mechanism that will support and reflect the standards work of the Standards & Interoperability (S&I) Framework Structured Data Capture Initiative. This project contributes to efforts to develop a repository and search tool for identification of CDEs for Patient-Centered Outcomes Research. http://www.nlm.nih.gov/cde/ |
| Community Guide Screen Time Team | Meeting/ Workshop | CDC | NHLBI | The goal was to review the evidence related to screen time and its effects on obesity and health behaviors of youth. |
| Community Health Worker Initiative | Public Education Campaign | HRSA, IHS | NHLBI | The Community Health Worker (CHW) Initiative supports activities to reduce disparities in cardiovascular risk factors and asthma in African American, Latino, American Indian, and Filipino population groups. The project uses formative research (literature reviews, focus groups, and workshops) to inform the development and implementation of approaches that integrate CHW activities into the broader health workforce to improve cardiovascular health and reduce asthma disparities. http://www.nhlbi.nih.gov/health/pubs/pub_slctpro.htm |
| Comparative Effectiveness Research Coordinating Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CMS, FDA | NINR, CC, CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/OSP | The NIH Comparative Effectiveness Research Coordinating Committee (CER CC) was established in 2008 at the request of the NIH Director. Its members include NIH Institute and Center (IC) Directors and high level senior staff. Its charge is to coordinate ongoing CER initiatives across the agency, develop a long term research vision for CER, implement collaborative initiatives with sister agencies, determine appropriate definitions, policies and guidance relative to CER, administer the CER funds awarded through ARRA, and track the outcomes of those projects. The CER CC has organized meetings with AHRQ, CMS, the VA, FDA, the Office of the National Coordinator for Health Information Technology (ONC), and PCORI, to discuss potential strategic collaborations. NIH invested $597M in CER in FY2012, and estimates funding $581M in FY 2013. |
| Computational Toxicology for NIH Medications Discovery | Research Initiative | FDA | NIDA | Through an inter-agency agreement, the FDA provides structure-activity, relationship-based toxicity predictions for compounds that are under evaluation in the NIDA Addiction Treatment Discovery Program. On a limited basis, other NIH ICs may utilize this resource by working through NIDA. |
| Computer-aided Diagnosis for Radiology Images | Research Initiative | FDA | CC | The collaboration focuses on the improvement of computer-aided diagnosis for radiology images. Specific applications include computer-aided polyp detection for CT colonography, improvements in the conduct and analysis of observer performance experiments using radiology images and the use and development of advanced machine learning and receiver operating characteristics methods with application to computer-aided diagnosis. |
| Conducting Comprehensive Toxicological Assessments | Research Initiative | FDA | NIEHS | The purpose of this Agreement is to conduct, at FDA/NCTR, comprehensive toxicological assessments on FDA priority chemicals/agents nominated to the National Toxicology Program. Studies can include range finding sub-chronic and chronic, compound-specific mechanistic studies, and consideration of the use of alternate test systems. This combination of studies is designed to facilitate the interpretation of study results in support of comprehensive quantitative human health risk assessments. The primary goal of this program is to develop a comprehensive scientific data base that can be utilized to reduce the uncertainty in risk assessment/risk benefit analysis for specific chemicals with high FDA impact. |
| Congenital Heart Public Health Consortium | Resource Development | AHRQ, CDC | NHLBI | The Congenital Heart Public Health Consortium (CHPHC) is a group of organizations uniting resources and efforts in public health activities. The mission of the CHPHC is to prevent congenital heart defects and improve outcomes for affected children and adults. The consortium achieves its mission by providing leadership and a unified voice for public health priorities, expanding opportunities for surveillance and public health research, and informing public policy priorities that benefit public health and affected persons. The CHPHC represents various federal, state, and community organizations, including those representing patient/family, clinical, and research interests. It is pooling expertise and experience and using a public health model to address Congenital Heart Disease (CHD) issues across the lifespan. https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/chphc/Pages/default.aspx |
| Consensus-Based Entity (CBE) Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA | NLM | The Consensus-Based Entity (CBE) Committee is a HHS-wide entity, chaired by ASPE, to provide oversight and input into the execution of ASPE’s legislation-mandated contract with the National Quality Forum (the Consensus-Based Entity) for establishing quality and performance measures. NLM participates as an invited member. |
| Consortium for TB Biomarkers (CTB2) | Resource Development | FDA | NIAID | The Consortium for TB Biomarkers (CTB2) seeks to establish a robust biorepository of well-documented clinical specimens to support the discovery and qualification of biomarkers of TB drug effect, especially surrogate markers for stable cure vs. relapse, and to facilitate development of rapid, reliable TB diagnostics, including tests for drug-susceptibility that would be practical for use in resource poor settings. |
| Contact Lens Safety Campaign | Public Education Campaign | CDC | NEI | The NEI helped CDC disseminate contact lens safety information via social media during its spring break campaign in March. Additionally, NEI added CDC resources to its Pinterest page. |
| Content Standards Workgroup of the Health Information Technology (HIT) Standards Committee | Committee, Work group, Advisory group, or Task Force | OS | NLM | The Content Standards Workgroup of the Health Information Technology (HIT) Standards Committee is part of the Federal Advisory Committee that is charged with making recommendations to ONC on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information. http://www.healthit.gov/facas/health-it-standards-committee/hitsc-workgroups/content-standards-workgroup |
| Council on Emergency Medical Care | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, OS, SAMHSA | NIMH, NCATS, NHLBI, NICHD, NIGMS, NINDS, NLM | The Council on Emergency Medical Care (CEMC) is a coalition comprised of subject-matter experts and policy makers in emergency medical care from organizations across the Federal Government. This entity contributes to the development, advancement, and coordination of federal strategies, policies, and priorities relating to emergency medical care to improve the nation’s emergency care system. |
| Countermeasures Against Chemical Threats (CounterACT) Research Network | Research Initiative | CDC, FDA, OS | NINDS, NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NLM | The CounterACT program is a translational research program supporting basic, translational, and clinical research aimed at the discovery and/or identification of better therapeutic medical countermeasures and/or diagnostic technologies against chemical threat agents, and facilitates their movement through the regulatory process in collaboration with other federal departments and agencies, such as the Biomedical Advanced Research and Development Authority (HHS BARDA). The program includes a comprehensive network of Research Centers of Excellence, individual co-operative research projects, small business innovation research grants, contracts, and interagency agreements with the Department of Defense. Among other activities, NINDS organizes an annual meeting of investigators supported by the program allowing researchers to share information, encourage collaboration, and enable NIH staff to evaluate the group’s progress on themes such as nerve agents, seizure detection technology, cyanide, and sulfur mustard. |
| Country Work in Cancer Research and Cancer Control Planning Strengthening – Kenya | Other | CDC | NCI, FIC, NIAID | Kenya has an estimated population of over 42 million. Cancer ranks third as a cause of death after infectious and cardiovascular diseases. It estimated that over 18,000 Kenyans die of cancer annually. The most common types of cancer in Kenya are cancers of the cervix, breast, esophagus and prostate. The Ministry of Health released a National Cancer Control Strategy (2010-2015) and a National Cervical Cancer Prevention Program Strategic Plan (2012-2015). NCI looks to build upon those efforts in coordination with the many US government and non-governmental partners (NGOs) working in country. US government agencies, including the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Disease (NIAID), the Fogarty International Center (FIC), the Centers for Disease Control (CDC), and the US Agency for International Development (USAID) have a significant presence in Kenya. Between FY2010 and FY2012, there were 121 NIH or CDC awards totaling $160.1M. USAID invested $700 million in Kenya in FY2011. At least 6 NCI-designated cancer centers have activities in Kenya ranging from capacity building for cancer screening and treatment, to studies of cancers associated with chronic infection, including HPV. Notably, Moi University has hosted the Academic Model Providing Access to Healthcare (AMPATH), in partnership with Indiana University (IU), since 2001. The AMPATH-Moi-IU partnership has created the largest clinical research data enterprises in the developing world and includes 18 HIV clinics in western Kenya with 2,000 new patients enrolling per month as of 2012. |
| Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP) | Resource Development | CDC, FDA | NIDDK | From 1963 to 1985, the National Hormone and Pituitary Program (NHPP), funded by the U.S. Department of Health and Human Services (HHS), sent Human Growth Hormone (HGH) made from human pituitary glands to hundreds of doctors across the country. As a part of research studies, doctors used the hormone to treat nearly 7,700 children for failure to grow. In 1985, the HHS learned that three people treated with pituitary HGH died of Creutzfeldt-Jakob Disease (CJD), a rare, incurable brain disease. The HHS immediately stopped distributing the hormone and began a national study to learn more about how pituitary HGH treatment may have caused this problem. http://www.niddk.nih.gov/health-information/health-topics/endocrine/national-hormone-pituitary-program/Pages/national-hormone-pituitary-program-comprehensive-report.aspx |
| Critical Path to Tuberculosis (TB) Drug Regimens (CPTR) Rapid Drug Sensitivity Testing (DST) Consortium | Committee, Work group, Advisory group, or Task Force | CDC | NIAID | The purpose of the Critical Path to Tuberculosis (TB) Drug Regimens (CPTR) Rapid Drug Sensitivity Testing (DST) Consortium is to support and sustain discussion, share information, and to coordinate clinical trials of new TB drug combinations. The overall goal is to rapidly advance new cost-effective therapies while maintaining the highest standards of scientific rigor. The Consortium will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations. |
| DailyMed | Resource Development | FDA | NLM | DailyMed provides high quality information about marketed drugs, including FDA labels (package inserts). The Web site provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts. NLM provides this DailyMed as a public service, free of advertising. http://www.dailymed.nlm.nih.gov |
| Data Access for Grantees | Resource Development | CMS | NIA | NIA developed a Memorandum of Understanding (MoU) to assist grantees with accessing Centers for Medicare & Medicaid Services (CMS) data. It is anticipated that this initiative will create a more user friendly and more cost efficient means for grantees to access CMS data especially the need to access Part D data. Specifically, this MOU gives CMS''s Privacy Board justification to release Part D data to NIA grantees with Data Use Agreements. Researchers pay for data use. This includes activities for remote access data enclave. |
| Demand Reduction Interagency Working Groups | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS, SAMHSA | NIAAA, NIDA | These working groups aim to prevent substance abuse and related negative consequences by implementing a prevention framework to serve as a foundation for collaboration among Federal agencies in the development of joint initiatives that serve States and communities across the Nation. |
| Department of Defense Resuscitation and Transfusion Steering Committee | Committee, Work group, Advisory group, or Task Force | CDC | CC, NHLBI | Oversees DoD research in resuscitation and transfusion. |
| Developing Clinical Vocabulary Standards for Public Health Reporting | Resource Development | CDC | NLM | This collaboration between NLM and CDC is to develop Logical Observation Identifiers Names and Codes (LOINC) codes for use in public health reporting, including tumor registry reporting, and reportable disease reporting. https://phinvads.cdc.gov/vads/SearchVocab.action |
| Development and Use of a Non-human Primate Model of Pertussis Diseases and Transmission | Research Initiative | FDA | NIAID | NIH has been working with the FDA toward development and use of a non-human primate model of pertussis disease and transmission. |
| DHHS Health Care Personnel Influenza Vaccination Interagency Working Group | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee is charged with developing strategies to improve the fraction of healthcare professionals who are vaccinated with the influenza vaccine. http://www.hhs.gov/ash/initiatives/hai/hcpflu.html |
| DHHS Healthcare Infection Control Practices Advisory Committee (HICPAC) | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee serves as the major policy advisory committee in the nation for healthcare epidemiology. |
| DHHS Steering Committee for the Prevention of Healthcare-Associated Infections | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee is charged with developing a national action plan for addressing the important problem of healthcare-associated infections. http://www.hhs.gov/ash/initiatives/hai/actionplan/ |
| Diabetes Mellitus Interagency Coordinating Committee (DMICC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, IHS, OS | NIDDK, CSR, NCATS, NCCIH, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | The DMICC facilitates cooperation, communication, and collaboration on diabetes among these government entities. DMICC meetings, held several times a year, help members identify emerging issues and opportunities and develop ways in which different government components can work together and build upon each other’s expertise and resources. This approach helps ensure that federal diabetes activities are coordinated and not duplicated, as well as stimulates collaborations where appropriate. http://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/diabetes-mellitus-interagency-coordinating-committee/Pages/background.aspx |
| Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS) | Research Initiative | CDC, IHS | NIDDK, NCATS, NCI, NCMHD, NEI, NHLBI, NIA, NICHD | The Diabetes Prevention Program (DPP) showed that lifestyle change or metformin delay the development of type 2 diabetes. The Diabetes Prevention Program Outcomes Study is studying the long term effect of diet and exercise and the diabetes medication, metformin, on the delay of type 2 diabetes in participants of the DPP. https://dppos.bsc.gwu.edu/web/dppos/about |
| Diabetic Eye Disease Information Dissemination | Public Education Campaign | CDC | NEI | CDC''s National Diabetes Education Program is part of the National Eye Health Education Program Partnership. This past year NEHEP and CDC worked CDC''s National Diabetes Education Program is part of the National Eye Health Education Program Partnership. This past year NEHEP and CDC worked outlets and conference calls, and circulated information in phConnect and among each other''s stakeholder groups. |
| Diabetic Retinopathy Clinical Research Network | Research Initiative | OS | NEI, NIDDK | The Diabetic Retinopathy Clinical Research Network (DRCR.net) is a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, diabetic macular edema and associated conditions. The DRCR.net supports the identification, design, and implementation of multicenter clinical research initiatives focused on diabetes-induced retinal disorders. Principal emphasis is placed on clinical trials, but epidemiologic outcomes and other research may be supported as well. The network is funded by the NEI, and co-funded by OS, through NIDDK, with the Special Funding Program for Type 1 Diabetes Research. http://drcrnet.jaeb.org/ViewPage.aspx?PageName=Home |
| Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population | Research Initiative | CMS | CC | Centers for Medicare and Medicaid Services (CMS) and NIH CC Rehabilitation Medicine (RMD) agreed to collaborate in data-sharing for research the results of which may be helpful to improve medical-service quality, utilization, and effectiveness for Medicare and Medicaid beneficiaries. CMS will provide electronic data to NIH CC/RMD who will perform analyses that are agreed to by both parties. |
| Diet-Induced Hypomethylation in Preneoplastic Liver | Research Initiative | FDA | NCI | The Food and Drug Administration (FDA) National Center for Toxicological Research and the National Cancer Institute (NCI) Division of Cancer Prevention, Nutritional Sciences Research Group are collaborating on an Interagency Agreement in which NCI will provide funds to examine the role of epigenetic mechanisms as factors that predetermine individual susceptibility to development of hepatocellular carcinoma and to provide evidence that epigenetic alterations may be used as markers of susceptibility to disease development and correction of those epigenetic abnormalities during hepatocarcinogenesis may be a crucial decisive factor in cancer prevention strategies. |
| Dietary Supplements Ingredient Database (DSID) | Research Initiative | CDC, FDA | OD/DPCPSI/ODP, NCI, NHLBI, NIDDK | This U.S. Department of Agriculture (USDA) based program provides basic information about the nutrient content of selected ingredients in dietary supplements, compared to label-reported ingredient levels. The database provides statistical estimates—based on chemical analysis—of the nutrient content of selected ingredients in dietary supplements, compared with label-reported ingredient levels. Currently the Dietary Supplements Ingredient Database (DSID) provides estimated levels of 18 vitamin and mineral ingredients derived from analytical data for 115 representative unspecified adult multivitamin/multimineral supplements (MVMs). Additional dietary supplement ingredients will be included in future releases of the database. http://dietarysupplementdatabase.usda.nih.gov/ |
| Dietary Supplements Label Database (DSLD) | Resource Development | CDC, FDA | OD/DPCPSI/ODP, NLM | A joint project of Office of Dietary Supplement and National Library of Medicine, now contains over 50,000 labels, with new data accumulating at the rate of 1,000 labels per month. The DSLD will grow to include nearly all of the dietary supplement products in the U.S. All labels are verified yearly to ensure that they remain current. The DSLD provides product information that can be organized and searched by users. The primary users of this database are researchers who use the DSLD to help determine total nutrient intakes from food and supplements in populations they study. Health care providers use it to find the content of products their patients are taking. http://www.dsld.nlm.nih.gov/dsld/ |
| Digital Quantitation of Plasma Cells in Marrow Biopsies | Research Initiative | FDA | CC | Collaboration with M. Choi., W.C. Cheng., and A. Badano., from the Imaging Physics Lab, Division of Imaging and Applied Mathematics Office of Science and Engineering Labs, Center for Devices and Radiological Health, of the Food and Drug Administration (FDA). The project consists of developing software and establish validations for the automated determination of marrow cellularity and enumeration of plasma cells identified by immunohistochemistry (IHC) using a CD138 antibody. This initial effort should serve as proof of principle for a broader plan to utilize IHC-based automated quantitation of different types of cells in bone marrow core biopsies for diagnosis, prognosis and therapy monitoring of marrow disorders. Last winter (Jan-March 2014) we had the fortune to have an engineering student with us who had previous experience developing image analysis software and volunteered to help us moving our project forward. His final product is a working prototype that produces excellent results counting plasma cells in the bone marrow, and we are currently writing a paper for publication presenting the data. |
| Disaster Research Response Project | Research Initiative | ATSDR, CDC, FDA, OS | NIEHS, NLM | The NIH Disaster Research Response (DR2) Project is a pilot project aimed at creating an environmental health disaster research system through platforms of ready-to-go research data collection tools and a network of specially trained research responders. This project was developed and will be administered by the NIEHS and NLM. Elements of the system include epidemiologic questionnaires and clinical protocols, specially trained disaster researchers, environmental health disaster research networks, a reach-back roster of subject matter experts, and a support infrastructure that can be activated and deployed during public health emergencies and declared disasters. This effort will not only serve as a model for enhancing environmental health research responses, but will also provide invaluable lessons and platforms for others interested in advancing timely post-disaster research activities. http://disasterinfo.nlm.nih.gov/ |
| District of Columbia Center for AIDS Research (CFAR), AIDS Prevention Center (APC), and D.C. Department of Health (DOH) Continuum of Care Working Group Meeting | Meeting/ Workshop | CDC | NIAID, NICHD, NIDA, NIMH | The Center for AIDS Research (CFAR), AIDS Prevention Centers (APC), and D.C. Department of Health (DOH) working group meetings provide a forum for networking and collaboration for CFAR, DOH, and NIMH-supported AIDS Prevention Center (APC) investigators, as well as a platform for the presentation of progress and results of the NIH supported HIV Continuum of Care research projects. http://dccfar.gwu.edu/cfar-hiv-continuum-care-working-group-meetings |
| Dominantly Inherited Alzheimer''s Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset of Dominantly Inherited Alzheimer''s Disease | Research Initiative | FDA | NIA | This collaboration aims to set up an international network consisting of a consortium of scientific investigators that will have the responsibility to identify, recruit, evaluate, and follow-up individuals from families with early onset dominantly inherited Alzheimer’s Disease [i.e., families with the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) mutations or duplications or others still to be discovered]. http://www.dian-info.org/ |
| Drug Induced Liver Injury Network (DILIN) | Committee, Work group, Advisory group, or Task Force | FDA | NIDDK | Both a prospective and retrospective database containing cases of drug-induced liver disease, the Drug Induced Liver Injury Network (DILIN) is funded by a cooperative agreement and includes eight clinical centers and a central data coordinating center. One of the goals of the DILIN is to establish a database of well-characterized cases of drug-induced liver injury along with serum, DNA, and tissue samples that will facilitate research on the mechanisms of hepatic injury due to drugs. Cases of liver injury due to herbal medications are also included. The DILIN will develop standardized definitions of drug-induced liver disease and standardization of scoring systems for causality. Three employees of FDA serve as ad hoc members on the committee overseeing the network activities. http://www.dilin.org/ |
| Early Hearing Detection and Intervention | Meeting/ Workshop | CDC | NIDCD | This collaboration focuses on a teleconference sponsored by CDC. http://www.cdc.gov/ncbddd/hearingloss/index.html |
| Early Learning Interagency Policy Board (IPB) | Other | ACF | NICHD, NIDA | The purpose of this workgroup is to collaborate with the Administration for Children and Families (ACF) in order to coordinate efforts in the area of preschool education, including research. |
| East Asia Viral Hepatitis and Liver Cancer Consortium | Other | CDC | NCI, NIAID, NIDDK | The consortium aims to coordinate and share human, financial, and technical resources to effectively and efficiently address research and public health action needs in the prevention and control of viral hepatitis and liver cancer. This is a trans-HHS collaboration working with the World Health Organization Western Pacific Region Office WHO/WPRO and Ministries of Health of several partner countries. |
| Ebola Clinical Research Response in West Africa | Research Initiative | CDC, FDA | NIAID | Research collaborations to respond to Ebola emergency in West Africa |
| Electronic Research Administration (eRA) | Other | AHRQ, CDC, FDA, SAMHSA | NINR, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/OER | The Electronic Research Administration (eRA) provides information technology solutions and support for the full life cycle of grants administration functions for the NIH as well as the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Veterans Health Administration (VHA). eRA offers vital solutions to manage the receipt, processing, review, award and monitoring of over $30 billion in research and non¬research grants awarded annually by NIH and other grantor agencies in support of the collective mission of improving human health. eRA helps NIH meet a vital mission: the support of cutting¬ edge biomedical research via grants to scientists at universities and other research institutions. Over 4,100 NIH staff, 729 partner agency staff, and 171,083 active external users depend on eRA daily. Used by Federal staff and applicants at over 28,400 research institutions worldwide, eRA has helped eliminate the hundreds of millions of pieces of paper previously required to: • Record, review and process over 89,600 applications each year. • Support more than 3,960 review meetings held annually. • Administer more than 61,200 awarded competing and non¬competing grants. • Maintain patent and invention records for 32 Federal agencies (see the iEdison website). • Support thousands of applicant interactions with the Federal Government before and after the grant award, through the eRA online interface. eRA''s focus is on supporting the mission of serviced agencies by providing tools to electronically manage and report on grants in a way that maximizes efficiencies, provides a strong and scalable infrastructure, is responsive to evolving customer needs and employs sound management controls. eRA systems align with Grants.gov (the one¬ stop web portal for finding and applying for federal grants), allowing for full electronic processing of grant applications from application submission through closeout of the grant award and reporting thereafter. eRA operates as a fee for service activity to OPDivs and other federal agencies. http://era.nih.gov/ |
| Emergency Care Research Interagency Program Officer Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NICHD, FIC, NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NIDDK, NIGMS, NIMH, NINDS, NLM | This working group aims to share common challenges in conducting emergency care research, identify innovative solutions amongst the projects in NIH Institutes/Centers portfolios for common problems; discuss performance evaluation of emergency care networks; and discuss models for funding and evaluating data coordinating centers. https://www.nigms.nih.gov/About/Overview/OECR/Pages/NIH_emergencygroup.aspx |
| Emergency Preparedness, Medical Countermeasures | Resource Development | OS | NCI | NCI provides expertise in radiation biology and radiation oncology to help guide the research and development for medical countermeasures for radiation injury and for biomarkers for assessing injury, dose and who needs treatment. http://www.phe.gov/about/barda/Pages/default.aspx |
| Endocrinologic and Metabolic Drugs Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/default.htm |
| Enhancing the National Death Index (NDI) | Resource Development | CDC | NIA, NCI, NHLBI | This agreement will enable the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics to expedite the processing of state death certificate data for annual updates to the National Death Index (NDI). http://www.cdc.gov/nchs/ndi.htm |
| Enterovirus D68 (EV-D68) Mouse Model Development For Acute Flaccid Myelitis | Research Initiative | FDA | NIAID | The purpose of this collaboration is to develop an animal model of Enterovirus D68 to understand disease progression and outcomes such as acute flaccid myelitis. |
| Ethical, Legal and Social Issues (ELSI) Sub-study in the Biospecimen Pre-Analytical Variables (BPV) Project | Research Initiative | OS | NCI, CC | Pre-Analytical Variables (BPV) Ethical Legal and Social Implications (ELSI) Substudy is a study of the ethical, legal and social implications related to the informed consent process for biobanking. The ELSI study is designed to address current issues related to informed consent for biobanking, particularly the issues of consent for broad future research use and return of research results. The objective of the ELSI Substudy is to assess research participant comprehension and concerns related to informed consent and data sharing for biobanking across the diverse patient populations included in the BPV program. The intent of this evaluation is to improve our understanding of the issues that impact donor participation in such programs and to identify factors that may result in decreased rates of donor participation. This study provides a unique and unprecedented opportunity to address these issues in a diverse patient population of actual biospecimen contributors approached for consent using a highly harmonized informed consent document. Each Biospecimen Source Site collecting tumor tissue from surgical procedures is participating in the ELSI study. To date, several hundred interviews with BPV participants have been submitted for analysis. Data collection concluded in May of 2015 and data analysis is in progress. |
| European-US Pediatric Formulations Excipients Committee | Committee, Work group, Advisory group, or Task Force | FDA | NICHD | Multinational academic, industry, and regulatory group convened to determine toxicity of excipients in pediatrics. Accomplishments include developing a database that is tested both in the EU and US. |
| Evaluating Community-Clinical Engagement Models | Meeting/ Workshop | CDC | NHLBI, NCI, NICHD, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | Evaluating Community-Clinical Engagement Models describes the strategies used by community engagement programs and models that enable health care and communities to collaborate to address childhood obesity. This effort is part of the National Collaborative on Childhood Obesity Research, under the NIH Obesity Research Task Force and involves, NIH, CDC, USDA and RWJF. Describes the degree to which current efforts have undergone evaluations, including process measures, metrics, or indicators that have been used; identify the value that a model provides for stakeholders and leaders (e.g., community or employee health impact) and funders (e.g., organization mission); develop an evaluation framework that can be used to motivate program developers, stakeholders, and funders; and provide recommendations to enhance future research and dissemination. |
| Evaluation of Patient Reported Outcomes Following LASIK Surgery | Research Initiative | FDA | NEI | This will be a prospective, questionnaire-based study conducted by the U.S. Navy Refractive Surgery Center San Diego in collaboration with the U.S. Food and Drug Administration’s Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices. The primary purpose is to quantify the satisfaction and health related quality of life of 500 active duty patients over a period of six months following state-of-the-art laser in situ keratomileusis (LASIK). The questionnaire to be used will be a new instrument which, once validated in this study, might be employed in future clinical studies that include civilian refractive surgery centers in the U.S. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/LASIK/ucm190291.htm |
| Evidence-Based Review & Report Program | Resource Development | AHRQ | OD/DPCPSI/ODP, NCCIH | This Congressionally mandated program reviews current scientific evidence on the efficacy and safety of dietary supplements; identifies research needs; and prepares reports of their findings. http://ods.od.nih.gov/Research/Evidence-Based_Review_Program.aspx |
| Extracellular Ribonucleic Acid (RNA) Communication | Research Initiative | FDA | OD/DPCPSI, NCATS, OD/DPCPSI/OSC | Recent advances have indicated that ribonucleic acids (RNAs) can play a role in a variety of complex cellular functions, including newly discovered mechanisms of cell-to-cell communication. RNA can be exported from cells in extracellular vesicles or bound to lipids or proteins, to circulate through the body and affect cells at a distance. However, the actual impact of the extracellular RNAs, or exRNAs, is currently unknown. NIH and FDA intend to collaborate and coordinate efforts towards the preclinical and clinical use of exRNAs to address human health and disease. http://commonfund.nih.gov/Exrna/index |
| Eye Research Collaboration | Other | FDA | NEI | National Eye Institute (NEI) investigator Rachel Caspi is collaborating with Drs. Daniela Verthelyi and Raymond Donnelly of the Food and Drug Administration (FDA) on uveitis research. Uveitis is an autoimmune disease that targets the eye. If left untreated the disease can cause permanent vision loss. Current treatments consist of steroids to suppress the immune system. However, chronic use of these drugs has many side-effects and complications. |
| Family Health History | Health Survey | CDC, HRSA, OS, OSG | NCI, NHGRI, NLM | My Family Health Portrait is the Web-based tool from NHGRI and the U.S. Surgeon General’s Family History Initiative that helps individuals track their family health history. Using any computer, an Internet connection and an up-to-date Web browser, individuals can provide health information to build a drawing of their family tree and a chart of their family health history. Both the chart and the drawing can be printed and shared with family members and an individual’s doctor. http://www.hhs.gov/familyhistory/ |
| Fatherhood Outreach: Implications of Men''s Health and Community Engagement in Pregnancy Outcomes | Meeting/ Workshop | ACF | NICHD | In 2013, NICHD, in collaboration with the Administration for Children and Families, the Maternal & Child Health Bureau of the Health Resources and Services Administration, and the NIH Office of Behavioral and Social Sciences Research held a workshop entitled, “Paternal Involvement in Pregnancy Outcomes to identify research gaps in topics related to fathers’ role in pregnancy outcomes”. This is a follow-up meeting that will focused on community engagement with fathers to support healthy pregnancy outcomes. The objectives of this 2-day workshop were to: •Increase awareness of the role of men’s health in pregnancy outcomes •Identify potential collaborations between researchers and community organizations and innovative strategies for engaging fathers in research to support healthy pregnancy outcomes. This workshop included presentations from both academic researchers and community organization representatives with interests in engaging fathers in research to promote healthy pregnancy outcomes. https://www.nichd.nih.gov/about/meetings/2015/Pages/072915.aspx |
| FDA Blood Product Advisory Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI, CC | The Food and Drug Administration (FDA) Blood Products Advisory Committee advises the FDA regarding issues of blood safety and efficacy. The committee reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood, products derived from blood and serum or biotechnology which are intended for use in the diagnosis, prevention, or treatment of human diseases. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/default.htm |
| FDA Cancer Imaging Program (CIP) Bi-annual Meeting | Meeting/ Workshop | FDA | NCI | This collaboration is a bi-annual meeting to enhance communication between the Cancer Imaging Program (CIP) and the Division of Medical Imaging Products of CDER in the FDA. This allows for a two-way exchange of information and discussion of issues that are important for each side. Topics that have been discussed include CIP''s standardization efforts of medical imaging scanners in NCI Cancer Centers, presentation and discussion of specific new molecular imaging modalities, and discussion of recent FDA decisions regarding new medical imaging innovations. |
| FDA Drug Safety Oversight Board | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | OD/OSP, NCI | The FDA Drug Safety Oversight Board (DSB), created in 2005 and mandated by law in the FDA Amendments Act of 2007, advises the FDA''s Center for Drug Evaluation and Research (CDER) Center Director on the handling and communicating of important and often emerging drug safety issues and regulatory science. The DSB is composed of representatives from two FDA Centers and eight other federal government agencies: the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS), Department of Defense (DOD), Health Resources and Services Administration (HRSA), Indian Health Service (IHS), National Institutes of Health (NIH), and Department of Veterans Affairs (VA). An important role of the DSB is to help FDA assess the impact of their safety decisions on the healthcare systems of its Federal Partners. The Board, with its broad representation from federal healthcare organizations, can provide valuable input and allows FDA to hear other perspectives on drug safety issues. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm082129.htm |
| FDA Medical Countermeasures Initiative (MCMi) Regulatory Science Steering Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | This committee provides guidance to the Medical Countermeasures Initiative (MCMi) stakeholders. |
| FDA Memorandum of Understanding with NHLBI [Docket No. FDA–2008–N–0043] | Committee, Work group, Advisory group, or Task Force | FDA | NHLBI | The group meets quarterly at alternate sites to discuss stem cell research, cell therapy research, and clinical trials related to these areas. Group members are invited to attend the Center for Biologics Evaluation and Research (CBER) or NHLBI working groups and workshops on these topics. http://www.fda.gov/OHRMS/DOCKETS/98fr/E8-25738.htm |
| FDA Pediatric Advisory Committee (PAC) Neonatal Subcommittee | Committee, Work group, Advisory group, or Task Force | FDA | NICHD | This committee addresses the need to expand current pediatric science to include the neonatal population. The committee addresses the challenges and identifies different programmatic strategies for advancing the knowledge necessary to develop neonatal regulatory science. |
| FDA Substance Registry System Public Interface | Resource Development | FDA | NLM | The National Library of Medicine (NLM) and the Food and Drug Administration (FDA) established a collaborative effort to provide an interface for public access to the FDA’s Substance Registration System (SRS). The FDA SRS utilizes an existing NLM database backend architecture to provide public search capability for FDA substances and medicinal products. http://fdasis.nlm.nih.gov/srs/srs.jsp |
| FDA-NCI Every Other Month Meeting | Meeting/ Workshop | FDA | NCI | An every other month meeting to enhance communication between the two agencies, thereby expediting the development of new anti-cancer agents. General topics discussed include patient safety, clinical efficacy, and regulatory pathways to licensure; as well as an understanding of the operations of the sister agencies. |
| FDA-NIH Tobacco Regulatory Science Workgroup | Research Initiative | FDA | NIMH, CSR, FIC, NCI, NEI, NHGRI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NINDS, NINR, NLM, OD/DPCPSI/OBSSR | The FDA-NIH Tobacco Regulatory Science Workgroup is comprised of NIH staff and staff from FDA Center for Tobacco Products. The purpose of the group is to leverage the research experience and capability of NIH to maximize the opportunity available in authorities given in the Family Smoking Prevention and Tobacco Control Act to reduce tobacco related morbidity and mortality. http://prevention.nih.gov/tobacco/default.aspx |
| FDA/NIH Interagency Clinical Outcomes Assessments Working Group Meeting | Committee, Work group, Advisory group, or Task Force | FDA | NIMH, NCCIH, NCI, NHLBI, NIAMS, NINDS | The Federal Drug Administration (FDA) and NIH institute representatives meet periodically to discuss the development of valid patient-oriented treatment outcomes, and relative measurements, for use in clinical trials of therapeutic interventions. |
| Federal Breastfeeding Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OSG | NICHD | The purpose of this workgroup is to develop strategies to implement the Surgeon General’s call to action to support breastfeeding. |
| Federal Collaboration on Health Disparities Research (FCHDR) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, OS, SAMHSA | NIMHD | To engage a wide range of federal agencies in cross-agency research partnerships to promote more coordinated efforts that target health improvement in populations disproportionately affected by disease, injury, and/or disability. http://minorityhealth.hhs.gov/fchdr/ |
| Federal Consortium on the Substance Abusing Offender | Committee, Work group, Advisory group, or Task Force | SAMHSA | NIDA | Coordination of agencies that work with substance abusing offenders. |
| Federal Dietary Reference Intakes Steering Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, OS | NIDDK | This committee serves as an interagency forum to provide oversight on the process used to establish the Dietary Reference Intakes. These values serve as a basis for many federal nutrition programs and policies. |
| Federal Education and Training Interdisciplinary Group (FETIG) National Center for Disaster Medicine and Public Health | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The Federal Education and Training Interagency Group for Public Health and Medical Disaster Preparedness and Response (FETIG) committee provides oversight and guidance to the National Center for Disaster Medicine and Public Health which is a center of the Uniformed Services University of the Health Sciences-the Nation’s only federal sciences university. |
| Federal HIV/AIDS Web Council (AIDS.gov) | Resource Development | CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OAR, NCI, NIAID, NIDA, NLM | AIDS.gov expands visibility of timely and relevant Federal HIV policies, programs, and resources to the American public. Increase use of new media tools by government, minority, and other community partners to extend the reach of HIV programs to communities at greatest risk. Increase knowledge about HIV and access to HIV services for people most at-risk for, or living with, HIV. http://aids.gov/ |
| Federal Interagency Forum on Aging Related Statistics | Resource Development | ACL, AHRQ, CDC, CMS, OS, SAMHSA | NIA | This Interagency Forum was formed with the goal of bringing together Federal agencies that share a common interest in improving aging-related data. The specific goals of the Forum are to improve both the quality and use of data on the aging population. http://www.agingstats.gov/agingstatsdotnet/Main_Site/About/About_Forum.aspx |
| Federal Interagency Health Equity Team (FIHET) | Committee, Work group, Advisory group, or Task Force | ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIMHD, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NINR, OD/DPCPSI/ODP | Federal leadership for the National Partnership for Action to End Health Disparities (NPA) is provided by the Federal Interagency Health Equity Team (FIHET). The FIHET was established to foster communications and activities of the NPA within federal agencies and their partners; and to increase the efficiencies and effectiveness of related policies and programs at the national, state, tribal, and local levels. NIMHD staff serves on the FIHET including two subgroups, Health-In-All Policies working group, and the Data, Research, and Evaluation Subcommittee. http://www.minorityhealth.hhs.gov/npa/ |
| Federal Interagency Health Equity Team (FIHET) - Maternal and Child Health | Other | OS | NICHD | The purpose of this team is to serve on various committees to provide input/recommendations on maternal and child health equity. |
| Federal Interagency Task Force on the Arts and Human Development | Research Initiative | ACF, ACL, SAMHSA | NIA, NCCIH, NICHD, OD/DPCPSI/OBSSR | Beginning in 2011, the National Endowment for the Arts (NEA) has convened a Federal Interagency Task Force on the Arts and Human Development to encourage more and better research on how the arts can help people reach their full potential at all stages of life. Task force members represent multiple units across federal government, including the U.S. Department of Health and Human Services, the National Institutes of Health, the National Science Foundation, and the U.S. Department of Education, among others. To date, the Task Force has met quarterly to share ideas and information about research gaps and opportunities for understanding the arts'' role in improving health and educational outcomes throughout the lifespan. The Task Force has conducted a series of public webinars on compelling research and practices. Additionally, the group has begun a literature review of research on the arts and human development. In November 2012, four Task Force member agencies hosted a first-ever convening at the National Academy of Sciences to review the current state of research on the arts, health, and well-being in older Americans. http://www.nea.gov/national/TaskForce/index.html |
| Federal Interagency Traumatic Brain Injury Research (FITBIR) Working Group | Resource Development | AHRQ, CDC, HRSA, OS, SAMHSA | NINDS, CIT, NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIGMS, NIMH | The charge of the Interagency Committee includes promoting collaboration among federal agencies. A goal of this committee is to develop a national “Roadmap” for Traumatic Brain Injury (TBI). This strategic planning effort will represent the collective expertise of providers, educators, advocates, federal/state/national organizations, and individuals with TBI and their families and will result in a consensus document outlining the critical elements of a successful system of care for TBI service delivery. https://fitbir.nih.gov/ |
| Federal Partners Committee on Women and Trauma | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, SAMHSA | NIDA, NIAID, NIMH, OD/DPCPSI/ORWH | Led by the Department of Labor (DOL) and Substance Abuse and Mental Health Services Administration (SAMHSA), the Women and Trauma workgroup includes more than three dozen federal agencies, departments, and offices one of the largest interagency collaborations in federal government history. http://www.nasmhpd.org/Publications/Women_and_Trauma.aspx |
| Federal Partners in Bullying Prevention, Intervention, and Recovery | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA, IHS, SAMHSA | NIMH, NIAAA, NICHD, NIDA | This workgroup meets to provide a forum through which staff from relevant federal agencies can communicate and exchange ideas concerning how to prevent or stop bullying in schools and communities. http://www.stopbullying.gov/ |
| Federal Partners in Chronic Obstructive Pulmonary Disease (COPD) | Committee, Work group, Advisory group, or Task Force | ACL, CDC, CMS, HRSA, IHS, OSG | NIA, NCI, NHLBI, NIDA, NIEHS | To share information about current activities related to COPD and discuss opportunities for further cooperation and enhanced effectiveness of the federal response to this serious public health problem. http://www.nhlbi.nih.gov/research/reports/2013-copd-workshop |
| Federal Partners Working Group-Administration for Community Living (ACL) | Committee, Work group, Advisory group, or Task Force | ACL | NINR, NIA, NICHD, NIDCR, NIMH, NIMHD, NINDS | This group is made up of representatives from the Administration for Community Living, National Institute on Disability and Rehabilitation Research, National Institute on Aging, National Institute of Nursing Research, and National Center for Medical Rehabilitation Research (NICHD) who are working to identify evidence-based interventions that are ready for dissemination and implementation in community programs and collaboratively support their translation into the community. The group will: work collaboratively to promote dissemination, implementation, and evaluation of promising scientific findings; translate evidence-based interventions to inform policy and improve practice; strengthen the capacity of each respective agency to enhance the health, well-being, and independence of older adults and people with disabilities across the life span, and in various environments. Areas of interest include topics such as: health and wellness; new models of care; community living and participation; and caregiving. |
| Federal RePORTER | Resource Development | ACF, AHRQ, CDC, FDA | OD/OER | STAR METRICS (Science and Technology for America’s Reinvestment Measuring the Effects of Research on Innovation, Competitiveness and Science) is a trans-federal agency consortium that has designed, created, and maintains the Federal RePORTER database. Federal RePORTER is a searchable database of scientific awards from federal agencies and to make this data available to the public. With participation from HHS and non-HHS agencies, this database will allow for portfolio analysis and metrics development across the spectrum of science domains. https://www.starmetrics.nih.gov/ |
| Federal Supply and Demand of Isotopes | Committee, Work group, Advisory group, or Task Force | FDA | NIBIB, NCI | This workgroup was formed as follow-up to the Inaugural Workshop on Isotope Federal Supply and Demand, a workshop now held annually. The workgroup consists of representatives of Federal agencies with the aim of providing a forum for interaction between agencies and departments to communicate about potential shortages of isotopes that are of strategic importance to the nation including the availability of medical isotopes. DOE is charged with the production of isotopes that are not commercially available, and coordinates the informational and production efforts. Dr. Roderic Pettigrew, Director of NIBIB is the NIH point of contact on this topic. The workgroup holds an annual workshop that includes all Federal agencies that use isotopes; the workshop promotes discussion on the use, supply and demand of isotopes in various areas including homeland defense, medicine, agriculture, and basic and applied research. The fourth workshop was held in November 2015. A NIH representative participated as a panel member at a congressional briefing on this topic in December 2014. The event was co-sponsored by the American Chemical Society and Research America! http://science.energy.gov/np/community-resources/workshops/2015-workshop-on-isotope-federal-supply-and-demand/ |
| Federal Working Group on Bone Diseases | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, OS | NIAMS, CSR, NCATS, NCCIH, NCI, NEI, NIA, NIAAA, NICHD, NIDCR, NIDDK, NIEHS, OD/DPCPSI/ORWH | Serves to develop and foster collaborative activities among the government agencies in bone diseases. |
| Federal Working Group on Dietary Supplements (FWGoDS) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA | OD/DPCPSI/ODP, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR | The Federal Working Group on Dietary Supplements (FWGoDS) is comprised of individuals from federal agencies that share information and discuss issues, initiatives, and research related to dietary supplements. The FWGoDS facilitates communication and collaboration between NIH and its federal partners in several ways: co-funding research investigations within the NIH, expanding opportunities for research-investigator training, and strengthening collaborative efforts involving dietary supplement research, education, and communication. The FWGoDS meets twice a year and serves as a means of communication between the Office of Dietary Supplements (ODS) and its federal partners. |
| FedTel: Cross-Federal work group on telehealth | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NIBIB, NLM, OD/DPCPSI/OBSSR | The goal of this work group is to develop a coordinated view of what the Federal government is undertaking in telehealth, in an effort to identify possible collaboration mechanisms and share lessons learned across multiple agencies. Current topics of emphasis include Telehealth and Health Information Technology (HIT); Technology, Innovation and Standards; Public Education of Telehealth; and Access to Health Care. |
| Field Epidemiology Training Program (FETP) Tobacco Control Curriculum Training | Meeting/ Workshop | CDC | NCI | Cancer incidence and mortality are rising rapidly worldwide, particularly in low- and middle-income countries. There is an overwhelming need for countries to adopt and implement cancer control actions. Yet only 1 in 5 low- and middle-income countries have the necessary data to drive policy and reduce the burden and suffering due to cancer. The Global Initiative for Cancer Registry Development (GICR) is a coordinated, multi-partner approach to deliver the required change. It is time to make cancer data count. |
| Filovirus Animal Non-Clinical Group (FANG) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | The Filovirus Animal Non-Clinical Group (FANG) focuses on the advanced development of Filovirus medical countermeasures (MCM), both vaccines and therapeutics. The FANG focuses on the product development tools and other interagency product development issues relevant to FDA approval of filovirus MCM. A standing interagency working group, the Portfolio Advisory Committee, oversees the FANG. The FANG will develop strategies to address broadly applicable and interagency product development issues relevant to licensure of filovirus MCM. The FANG will develop consensus recommendations to facilitate standardization of reagents, methods, and procedures across multiple agencies and laboratories. |
| Fogarty HIV Research Training Program | Training Initiative | CDC | FIC, NIDA | The goal of these HIV research training programs (Fogarty HIV Research Training Program (AITRP) and Fogarty HIV Research Training Program) is to build multi-disciplinary bio-medical, behavioral, and social science research capacity for the prevention, care, and treatment of HIV/AIDS and HIV-related conditions in adults and children in low- and middle- income countries (LMIC). Research training will be provided to scientists at institutions in countries defined by the World Bank criteria as LMIC. In FY15, PEPFAR/CDCCOP funded one supplement to a parent AITRP award in Ukraine through SUNY Medical Center Downstate. Also, research training activities in Uganda continued to be supported in FY 15 through the FY2014 PEPFAR/CDC-COP funded supplement to the Fogarty HIV Research Training award at the University of California, Berkeley. http://www.fic.nih.gov/Programs/Pages/hiv-aids-research-training.aspx |
| Food Safety and Nutrition Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIDDK, NIEHS | The Food Safety and Nutrition Working Group (FSNWG) aims to highlight and promote awareness of an integrated approach to nutrition and food science in academia, and among nutritionists and food scientists; facilitate the alignment of research priorities to address food safety, food quality, and nutrition in single studies; and identify future research areas that can mesh food safety, food quality, and nutrition together. |
| Genetic Studies in the National Birth Defects Prevention Study | Research Initiative | CDC | NHGRI | Collaboration between CDC and NHGRI to carry out DNA sequencing and genotyping on samples collected as part of the National Birth Defects Prevention Study. |
| Genetic, Functional, and Epidemiologic Studies of Chronic Hepatitis C | Research Initiative | FDA | NCI | Interdisciplinary studies to determine the molecular and immunological mechanisms of action of interferon lambda region genetic variants in HCV infection. |
| Genetics in Environmental and Occupational Diseases | Research Initiative | CDC | NIEHS | These studies evaluate unique cohorts of individuals from professions associated with immune-mediated occupational diseases including asthma, respiratory and contact allergy, chronic beryllium disease, rhinitis, and silicosis. Occupational cohorts are being studied for a number of endpoints including the impact of genetic polymorphisms on inflammatory disease development and clinical outcomes, the role that genetic variations play in environmental and workplace related diseases, and the identification of unique immunological biomarkers for disease. |
| Genomic Nursing Science Blueprint: Next Steps | Committee, Work group, Advisory group, or Task Force | HRSA | NINR, NCI, NHGRI | The goal of this initiative is to consider opportunities to facilitate genomic nursing research, to identify researcher resources and gaps, to explore exemplar models to be used as a framework that supports research, and to envision a platform for promotion of genomic nursing research and collaboration. |
| Global Change Research Program (GCRP) Interagency Climate Change and Human Health Group (CCHHG) | Committee, Work group, Advisory group, or Task Force | CDC, OS | NIEHS, FIC | NIEHS co-chairs along with CDC and NOAA the interagency working group under the Global Change Research Program (GCRP) that plans, coordinates and executes many federal science activities on climate change and human health. |
| Global Environmental and Occupational Health (GEOHealth) | Other | CDC | FIC, NCI, NIEHS | FIC, NCI, NIEHS and NIOSH/CDC, Canada’s International Development Research Centre (IDRC), and the Global Alliance for Clean Cookstoves are supporting Global Environmental and Occupational Health (GEOHealth) Hubs, which are regional hubs based at low- or middle-income country (LMIC) institutions focused on collaborative research, data management, training, curriculum development and policy support around high-priority local, national and regional environmental and occupational health threats. The expectation is that GEOHealth Hubs will become the lead resources for environmental and occupational health, attract and retain the best talent in the region, and provide the scientific evidence for policy formulation. Together all regional hubs supported will form the GEOHealth Network, a platform for coordinated environmental and occupational health research and research training activities. In FY15 FIC and its partners issued linked U2R and U01 awards to U.S. and LMIC institutions. All partners contribute funds to the program. http://www.fic.nih.gov/Programs/Pages/environmental-occupational.aspx |
| Global Health Security Advisory Group (GHSAG) | Committee, Work group, Advisory group, or Task Force | CDC, OS | NIAID, NINDS | The Global Health Security Advisory Group (GHSAG) is a committee composed of high-level representatives of the national health authorities for the G-8 block of countries. The GHSAG was formed to develop and implement concrete actions to improve global health security and serve as a network for rapid response to biological, chemical, radio-nuclear terrorism (CBRN) crises. http://www.ghsi.ca/english/index.asp |
| Global Ingredient Archival System (GINAS) | Research Initiative | FDA | NCATS | The Global Ingredient Archival System provides a common identifier for all of the substances used in medicinal products, utilizing a consistent definition of substances globally, including active substances under clinical investigation, consistent with the ISO 11238 standard. |
| Global Initiative for Cancer Registry Development | Other | CDC | NCI | Cancer incidence and mortality are rising rapidly worldwide, particularly in low- and middle-income countries. There is an overwhelming need for countries to adopt and implement cancer control actions. Yet only 1 in 5 low- and middle-income countries have the necessary data to drive policy and reduce the burden and suffering due to cancer. The Global Initiative for Cancer Registry Development (GICR) is a coordinated, multi-partner approach to deliver the required change. It is time to make cancer data count. http://gicr.iarc.fr/ |
| Global Injury Prevention Conference | Meeting/ Workshop | CDC | NICHD, OD/DPCPSI/OSC | Trauma and injury represent two of the leading causes of death and disability in the world, and developing countries, where financial and medical resources are sorely lacking, bear a large proportion of the burden. Physical and emotional trauma and injuries can be unintentional—such as traffic accidents, burns, falls and poisonings—or intentional—resulting from deliberate acts of violence against oneself or others. It can result from environmental causes, such as pollution, water contamination, and poisonings, as well as occupational (industrial accidents and farm injuries) and societal (conflicts, rioting, wars). Residents of low- and middle-income countries as well as vulnerable populations (children, the elderly) are particularly at risk. This meeting gathers international experts on trauma, injury, abuse, and public health to discuss current state-of-the-science on issues related to global trauma and injury and to examine possible opportunities for additional research, coordination, and collaboration. The co-sponsor of this meeting was the Fogarty International Center (FIC), NIH |
| Global Strategic Plan to Prevent Harms Associated with Alcohol Misuse | Meeting/ Workshop | CDC, SAMHSA | NIAAA | NIAAA represented HHS at the World Health Organization coordinating with officials at CDC and SAMHSA to review Global Strategies to Prevent Harms Associated with Alcohol Misuse. |
| Go4Life | Public Education Campaign | ACL, AHRQ, CDC, OS, OSG | NIA, NCCIH, NEI, NHLBI, NIAMS, NIDDK, NIMH, NINDS | Go4Life, is an exercise and physical activity campaign from the National Institute on Aging at the National Institutes of Health (NIH), and is designed to help individuals fit exercise and physical activity into their daily life. Motivating older adults to become physically active for the first time, return to exercise after a break in their routines, or build more exercise and physical activity into weekly routines are the essential elements of Go4Life. Go4Life offers exercises, motivational tips, and free resources to help individuals get ready, start exercising, and keep going. The Go4Life campaign includes an evidence-based exercise guide in both English and Spanish, an exercise video, an interactive website, and a national outreach campaign. http://www.nia.nih.gov/Go4Life |
| Guidance Manual for Assessing Health Impacts of Multiple Chemicals and Other Stressors | Committee, Work group, Advisory group, or Task Force | ATSDR | NIEHS | This manual, Guidance Manual for Assessing Health Impacts of Multiple Chemicals and Other Stressors, is a revision of ATSDR’s 2004 Guidance Manual for the Assessment of Joint Toxic Action of Chemical Mixtures (ATSDR 2004a). The revised manual serves as a supplement to the ATSDR (2005) Public Health Assessment Guidance Manual by describing a recommended process to evaluate the potential public health impacts of exposures to multiple chemicals and other stressors, a frequent occurrence and concern for people living in the vicinity of sites with toxic substances. The revised manual builds on the process described in the 2004 manual and reviews scientific research advancements since 2000 related to assessing health effects from exposures to multiple chemicals and other stressors. |
| Guidelines for Prevention of Perinatal Group B Streptococcal Disease-Neonatal Evaluation | Research Initiative | CDC | NICHD | This Interagency Agreement requires the technical assistance of the National Institute of Child Health and Development (NICHD) Neonatal Research network for development of current guidelines for prevention of group B streptococcal disease calling for a limited neonatal evaluation including blood culture at birth and initiation of empiric antibiotic therapy for all newborns born to mothers with chorioamnionitis. Four publications have resulted from current work. NICHD has an ongoing data collection that began in April 2015 to provide more information regarding early onset sepsis in infants (the infants are all babies at our NRN centers with documented sepsis). |
| Health and Retirement Study (HRS) | Research Initiative | CDC, CMS | NIA | This study follows more than 20,000 men and women over 50, offering insight into the changing lives of the older U.S. population. Launched in 1992, this multidisciplinary, longitudinal study has become known as the Nation’s leading resource for data on the combined health and economic conditions of older Americans. |
| Health Behavior in School-Age Children: NEXT Longitudinal Study 2009-2013 | Health Survey | HRSA | NIAAA, NCI, NHLBI, NICHD | NEXT is a four-year longitudinal assessment of a representative sample of U.S. school children starting at grade 10. The goals of the U.S. NEXT longitudinal study include: to identify the trajectory of adolescent health status and health behaviors from mid-adolescence through the post high school year; to examine individual predictors of the onset of key adolescent risk behaviors and risk indicators during this period; to identify family, school, and social/environmental factors that promote or sustain positive health behaviors; and to identify transition points in health risk and risk behaviors and changes in family, school, and social/environmental precursors to these transitions. http://clinicaltrials.gov/ct2/show/NCT01031160 |
| Health Economics | Research Initiative | AHRQ, CMS | OD/DPCPSI, NIA, NIDA, NIMH | The Health Economics program aims to support theoretical and applied research to understand how innovations in treatments, diagnosis, and preventive strategies can be most effectively deployed to improve health and wellbeing. Research supported by this program will identify factors determining optimal adoption of highly effective health technologies, innovations, and discoveries, so that past and future investments by NIH may have greater public health impact. The Health Economics program is collaborating with AHRQ and CMS to discuss ongoing efforts in this area of research. http://commonfund.nih.gov/Healtheconomics/index |
| Health Literacy Work Group | Other | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | NICHD, NCI, NEI, NHGRI, NHLBI, NIDA, NIDCR, NLM | This Workgroup is comprised of various HHS agencies that work towards meeting the Department’s prevention goals and to accomplish the National Action Plan and the Healthy People 2020 Objective: Improve the health literacy of persons with inadequate or marginal literacy skills. http://www.surgeongeneral.gov/topics/healthliteracy/appxc.htm |
| Health Services and Technology Assessment Text (HSTAT) | Resource Development | AHRQ, CDC, OSG, SAMHSA | NLM | The National Library of Medicine of the National Institutes of Health provides a free, web-based resource of full-text documents that provide information on health-care decision making. http://www.ncbi.nlm.nih.gov/books/NBK16710/ |
| Healthcare Systems (HCS) Research Collaboratory | Research Initiative | AHRQ, CDC, FDA | NINR, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, OD/DPCPSI/OSC | The overall goal of the Common Fund’s Health Care Systems (HCS) Research Collaboratory program is to strengthen the national capacity to implement cost-effective large-scale research studies that engage health care delivery organizations as research partners. The aim of the program is to provide a framework of implementation methods and best practices that will enable the participation of many health care systems in clinical research, not to support a defined health care research network. Research conducted in partnership with health care systems is essential to strengthen the relevance of research results to health practice. http://commonfund.nih.gov/hcscollaboratory/index.aspx |
| HealthMap: Knowledge Management for Emerging Infectious Disease Intelligence | Research Initiative | OS | NLM | Leveraging previous National Library of Medicine (NLM) funded work under the HealthMap project, the HHS Assistant Secretary for Preparedness and Response (ASPR) and OPEO co-funded an administrative supplement to an NLM/NIH grant to provide funding to Harvard University for a pilot project in which Harvard will develop real-time applications to collect, parse, analyze, and display open source data in order to address the national needs of emergency preparedness and response for hurricanes. http://www.healthmap.org |
| Healthy People 2010/2020 Partnership | Other | AHRQ, CDC, CMS, HRSA, IHS, OS | NHLBI, NINDS | The Partnership provides the opportunity for several units of the Federal government to work on activities related to the Heart Disease and Stroke (HDS) components of the Healthy People initiative. In particular, the purpose of the activity is to catalyze progress toward achieving the Healthy People goals through the various phases of prevention, including prevention of the development of risk factors for HDS; detection and treatment of risk factors for HDS; early identification and treatment of HDS especially in the acute phases; and prevention of recurrence and complications of HDS. |
| Healthy People 2020 - Blood Diseases, Disorders, and Safety | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS | NHLBI | The purpose of this agreement is to support development and implementation of survey questions and measures to assess progress made toward the achievement of the Healthy People 2020 national objectives for blood diseases/disorders and safety. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=4 |
| Healthy People 2020 - Disability and Health Objective on Epilepsy Care (DH-6) | Committee, Work group, Advisory group, or Task Force | CDC, OS | NINDS, NICHD | Working group to coordinate Healthy People 2020 objectives on epilepsy care in US adults, based on National Health Interview Survey data. In 2013, the group converted the objective from developmental to measurable status. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=9 |
| Healthy People 2020 - Environmental Health and Respiratory Disease Topic Areas | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, OS | NIEHS, NHLBI | Led workgroups, coordinated meetings, developed goals, reported to DHHS, and collaborated with other Federal agencies. |
| Healthy People 2020 - HHS Disability and Health Workgroup | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The purpose of this workgroup is to discuss the measurement of health and the targets for persons with disabilities. |
| Healthy People 2020 - Kidney Disease | Public Education Campaign | CDC, CMS, FDA, HRSA, OS | NIDDK | The Office of the Secretary of HHS leads the Healthy People 2020 initiative. The lead agency for most data activities is the CDC. However, for the kidney area, most of the information is provided by NIDDK through the US Renal Data System. http://www.healthypeople.gov |
| Healthy People 2020 - Lesbian, Gay, Bisexual, and Transgender (LGBT) Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, OS, SAMHSA | NIMHD | To provide science-based, 10-year national objectives for improving the health of all Americans, and to establish benchmarks and monitor progress over time. http://www.healthypeople.gov/ |
| Healthy People 2020 - Older Adults | Committee, Work group, Advisory group, or Task Force | ACL, AHRQ, CDC, CMS, HRSA | NIA | This Healthy People 2020 topic is designed to develop an understanding of the health and health care needs and implications for older adults. The objectives overall will promote healthy outcomes in this population. The goal of these objectives is to improve the health, function, and quality of life of older adults. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=31 |
| Healthy People 2020 - Respiratory Diseases | Health Survey | CDC | NHLBI, NIAID, NIEHS | The purpose of the collaborative activity is to support development and implementation by the National Health Interview Survey (NHIS) of measures that could be used to assess progress towards achieving Healthy People 2020 respiratory/asthma objectives. The NHLBI and the National Center for Health Statistics collaborate on this activity. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=36 |
| Healthy People 2020 - Sleep Health | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, OSG | NHLBI, NCCIH, NIA, NICHD, NINDS, NINR | This activity supports the development and implementation of survey questions and measures to assess progress on achieving the Healthy People sleep health objectives. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=38 |
| Healthy People 2020 - Social Determinants of Health Working Group | Committee, Work group, Advisory group, or Task Force | CDC, SAMHSA | NIAAA, NCI, NHLBI, NIAMS | The overarching goals for Healthy People 2020 incorporate a focus on social determinants of health as well as on health outcomes and risk factors. The Working Group intends to develop objectives for the social determinants and methods to ensure their integration across all Healthy People 2020 objectives. http://healthypeople.gov/2020/ |
| Healthy People 2020 - Structured Evidence Queries (SEQs) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS, SAMHSA | NLM | NLM is collaborating with ODPHP to develop structured PubMed searches for the HP 2020 objectives. Each PubMed search (a SEQ or "seek") is developed by medical librarians and reviewed by members of the HP 2020 working groups. The canned PubMed searches enable the public health workforce to find evidence-based information related to a specific HP 2020 objective. The SEQs are accessible from the HP 2020 website as well as the PHPartners.org website. http://phpartners.org/hp2020/index.html |
| Healthy People 2020 - Visual Health | Health Survey | AHRQ, CDC | NEI | Healthy People 2020 is a collaboration with NIH, CDC, and AHRQ to survey and measure public health outcomes for a variety of common diseases over the current decade. NEI''s goal for this program is to Improve the visual health of the Nation through prevention, early detection, timely treatment, and rehabilitation. NEI created several objectives that can be found at: https://www.healthypeople.gov/2020/topics-objectives/topic/vision/objec… https://www.healthypeople.gov/ |
| Healthy People 2020 Adolescent Health Work Group | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | This work group addresses the goal of the Healthy People 2000 Adolescent Health which is to improve the healthy development, health, safety, and well-being of adolescents and young adults. |
| Healthy People 2020 Heart Disease and Stroke | Health Survey | CDC, OS | NHLBI, NINDS | The purpose of the collaborative activity is to support the development by the National Health Interview Survey (NHIS) of measures that can be used to assess progress toward achieving Healthy People 2020 Heart Disease, Blood Pressure, and Cholesterol Objectives to improve cardiovascular health and quality of life through prevention, detection, and treatment of risk factors for heart attack and stroke; promote early identification and treatment of heart attacks and strokes; and prevent of repeat cardiovascular events. The NIH, CDC, and the National Center for Health Statistics collaborate on this activity. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=21 |
| Healthy People 2020 Nutrition Working Group | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | The purpose of this committee is to support the objectives of the Healthy People 2020 Nutrition goals. |
| Healthy People 2020 Working Group on Family Planning | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | The purpose of this committee is to support the objectives of the Healthy People 2020''s objectives on Family Planning which is to improve pregnancy planning and spacing, and prevent unintended pregnancy. |
| Healthy People 2020-Dementias, Including Alzheimer''s Disease | Committee, Work group, Advisory group, or Task Force | ACL, AHRQ, CDC, CMS, HRSA | NIA, NIMH, NINDS | This Healthy People 2020 topic will focus on increasing the awareness of the diagnosis of Alzheimer’s disease, and reducing the proportion of preventable hospitalizations in persons with diagnosed Alzheimer’s disease and other dementias. The goal is to reduce the morbidity and costs associated with, and maintain or enhance the quality of life for, persons with dementia, including Alzheimer’s disease. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=7 |
| Healthy Vision Month | Public Education Campaign | CDC | NEI | Each May, the NEI sponsors Healthy Vision Month (HVM) which is a national observance designed to elevate eye health as a priority for Americans. NIH worked with CDC for the 2014 observance to disseminate disease information for CDC''s Vision Initiative website and provided online banners and buttons linking to the HVM site and to the NEI for additional information. http://www.nei.nih.gov/hvm/ |
| Hematopoietic Stem Cell Transplantation Interagency Working Group | Committee, Work group, Advisory group, or Task Force | FDA, HRSA | NCI, CC, NHLBI, NIAID, NIDDK | This working group reviews matters associated with hematopoietic stem cell transplantation. |
| Hemophilia/Hepatitis C Project | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI | The Working Group supports the design and conduct of the Hemophilia/Hep C Project. |
| Hepatitis B Research Network | Research Initiative | CDC | NIDDK | The Hepatitis B Research Network (HBRN) was established in 2008 to advance understanding of disease processes and natural history of chronic hepatitis B, as well as to develop effective approaches to treatment with currently available therapies. The Network brings together clinical centers from throughout the U.S. and Canada. This multi-center Network is enrolling patients in multiple clinical trials in both adults and children with hepatitis B. http://www.hepbnet.org/ |
| HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG) | Research Initiative | AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA | NIDA, NIAID, NIDDK, NIMHD | HHS agencies review the Institute of Medicine (IOM) recommendations and develop a comprehensive strategic viral hepatitis action plan that would: address IOM recommendations for viral hepatitis prevention, care, and treatment; set forth actions to improve viral hepatitis prevention and ensure that infected persons are identified and provided care and treatment; and improve coordination of all activities related to viral hepatitis across HHS and promote collaborations with other government agencies and nongovernmental organizations. http://www.hhs.gov/ash/ohaidp/initiatives/ |
| HHS Adolescent Health Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA | NIDA, NIAAA, NICHD, NIMH | Interagency working group established in January 2010 within the Office of the Assistant Secretary for Health as a forum for HHS agencies to share updates on adolescent health activities and address cross-cutting issues. http://www.hhs.gov/ash/oah/news/e-updates/eupdate_evelyn.html |
| HHS Adult and Adolescent HIV Treatment Guidelines Panel | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NICHD | The purpose of this committee is to support and improve the HIV Treatment Guidelines. |
| HHS Advisory Committee on Blood & Tissue Safety & Availability (ACBTSA) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, OS | NHLBI, CC | This federal advisory committee advises the Secretary of the Department of Health and Human Services and the Assistant Secretary for Health on a number of issues related to blood (and tissue) safety including, public health parameters related to the safety and availability of blood and blood products; broad public health, ethical, and legal issues related to transfusion and transplantation safety; and the effect of various economic factors on blood (and tissue) safety and availability (and infectious disease concerns for organ transplantation). The ACBTSA is a Federal Advisory Committee (i.e., a FACA) seated with industry representatives, physicians/scientists, consumer advocates, and federal ex-officio members from the HHS Agencies, the Department of Defense, and the Department of Veteran''s Affairs. http://www.hhs.gov/ash/bloodsafety/advisorycommittee/ |
| HHS Arctic Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, HRSA, SAMHSA | NIMH, NIDA, NIEHS, NIGMS, NIMHD | The HHS Arctic Working Group was organized in March 2015 by the Office of Global Affairs, Office of the HHS Secretary. The purpose of the Working Group is to (1) ensure coordination of deliverables to the Arctic Executive Steering Committee (AESC), which was established by Executive Order and held its first meeting in February, 2015; (2) provide an opportunity for cross-agency learning and communication regarding activities and projects in Arctic regions; and (3) facilitate future interagency collaborations. |
| HHS ASPR Obstetric-Pediatric and Chemical Integrated Program Teams (IPT) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NICHD | This workgroup is a Public Health Energy Enterprise. The IPT working group provides an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, rad/nuc, etc.). The scope of their work includes setting requirements for the stockpiling of Medical Countermeasures (MCMs), MCM delivery, and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting. |
| HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Behavioral Health Quality Measures | Committee, Work group, Advisory group, or Task Force | CMS, SAMHSA | NIDA | A subcommittee of the HHS Behavioral Health Coordinating Committee is a coordinating body within the U.S. Department of Health and Human Services (HHS) that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. This subcommittee addresses behavioral health quality measures. |
| HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Communications | Committee, Work group, Advisory group, or Task Force | ACL, OS | NIDA, NIMH | A subcommittee of the HHS Behavioral Health Coordinating Committee is a coordinating body within the U.S. Department of Health and Human Services (HHS) that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. This subcommittee of communication professionals collaborates on inter-departmental behavioral health initiatives and promotional efforts. |
| HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Prescription Drug Abuse | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIDA | A subcommittee of the HHS Behavioral Health Coordinating Committee is a coordinating body within the U.S. Department of Health and Human Services (HHS) that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. The National Institute of Drug Abuse (NIDA) Serves as Co-Chair with FDA on this inter-agency subcommittee addressing prescription drug abuse. |
| HHS Biannual Dual Use Research of Concern (DURC) Inventory | Resource Development | CDC, FDA, OS | OD/OSP, CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI | Development of the HHS Biannual Dual Use Research of Concern (DURC) inventory reports, as required by the USG Policy for Oversight of Dual Use Research of Concern. |
| HHS Biomedical Advanced Research and Development Authority (BARDA) Armed Forces-Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Integrated Project Team | Committee, Work group, Advisory group, or Task Force | OS | NIAID | The National Institute of Allergy and Infectious Diseases (NIAID) participates on the HHS BARDA Armed Forces Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Integrated Project Team to collaborate and provide subject matter expertise, advice, and guidance on establishing a quality assurance program at AFRRI for GLP compliance. |
| HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological and Nuclear Threats Integrated Program Team | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | This Interagency Working Group, established under the Biomedical Advanced Research and Development Authority (BARDA), determines overall radiation countermeasures strategy and priorities. The National Institute of Allergy and Infectious Diseases (NIAID) provides subject matter expertise, advice and guidance on medical countermeasure development, requirements, and preparedness/response. |
| HHS Biovigilance Committee | Committee, Work group, Advisory group, or Task Force | CDC | CC, NHLBI | This committee develops systems for reporting adverse events resulting from blood transfusion or donation. |
| HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, OS | NHLBI, CC | The HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC) is chaired by the Assistant Secretary for Health and voting members are the senior-most heads of the relevant Staff divisions and Operating divisions of HHS (e.g., the Director of CDC and NIH, Administrator of CMS, and Commissioner of FDA). The BOTSEC is an internal council chartered to consider significant issues and make decisions that require cross-Agency input, including resources. In important aspect of the BOTSEC is the formation of HHS-wide (i.e., multi-Agency) working groups to explore significant public health items such as re-examining the lifetime blood donor deferral policy for MSM, and the creation of hemovigilance systems to collect and analyze data on adverse events that occur during the blood donation and utilization processes. http://www.hhs.gov/ash/bloodsafety/ |
| HHS Climate Adaptation Strategies | Committee, Work group, Advisory group, or Task Force | CDC, OS | NIEHS | NIEHS has been partnering with the Assistant Secretary for Health (ASH), the Assistant Secretary for Administration (ASA), and more recently the Assistant Secretary for Preparedness and Response (ASPR) and other operating and staff divisions of HHS to respond to White House directives on climate change adaptation at the agency level. This includes production of the HHS Climate Adaptation Plan and the coordination and production of deliverables under the President''s Climate Action Plan. |
| HHS Climate Justice Conference | Meeting/ Workshop | CDC, IHS, OS | NIEHS, NIMHD | NIEHS co-hosted a, "HHS Climate Justice Conference" with the HHS Office of the Assistant Secretary for Health and other supporting organizations. The forum brought together researchers, policy makers, advocates, and implementers working in the fields of climate change and environmental justice. The meeting goal was to inform the implementation of the HHS Environmental Justice Strategy, create and implement meaningful public partnerships, and ensure interagency and intra-agency coordination. http://www.niehs.nih.gov/about/visiting/events/pastmtg/2015/climate/index.cfm |
| HHS Dietary Guidance Review Committee | Committee, Work group, Advisory group, or Task Force | ACF, CDC, FDA, HRSA, IHS, OS | NIDDK | This committee reviews draft nutrition materials developed by all federal agencies and fulfills the legislative mandate (1990 NNMRRA) to ensure that Federal dietary guidance is consistent with the Dietary Guidelines for Americans and is scientifically accurate. http://www.health.gov/dietaryguidelines/2015.asp |
| HHS ED Developmental and Behavioral Screening Working Group | Committee, Work group, Advisory group, or Task Force | ACF, CDC | NICHD | This committee supports the objectives of improving developmental and behavior screening. |
| HHS Global Health Collaborative | Committee, Work group, Advisory group, or Task Force | ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIMH | This interagency working group meets to provide a forum within the HHS that identifies Global Health issues relevant to the HHS Global mental health agenda. |
| HHS H5N1 Gain-of-Function Review Group (HHG Review Group) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | The Framework for Guiding HHS Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza (HPAI) H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets requires that certain research proposals undergo additional review at both the funding agency and Departmental (HHS) levels prior to funding. The HHS Department-level review is performed by the HHG Review Group, which brings to bear multidisciplinary interagency expertise in science, countermeasure development and availability, national security, law, public health preparedness and response, biodefense, select agent regulations, and science and public health policy. The purpose of the HHS Department-level review includes review of the funding agency''s risk assessment, consideration of whether additional factors may alter assessment of whether the research can be funded, determination of which measures are needed to mitigate risks, consideration of the overall HHS influenza research portfolio, and determination of whether the proposal is acceptable for HHS funding. |
| HHS Initiative on Multiple Chronic Conditions | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, OS | OD/OSP, NIA, OD/DPCPSI/OBSSR | Recognizing the importance of Multiple Chronic Conditions (MCC) to patients, caregivers, and the health care system, the Assistant Secretary for Health convened an HHS-wide work group on MCC to identify options for improving the health of this population. The work group, in conjunction with other stakeholders, developed Multiple Chronic Conditions: A Strategic Framework. The Framework serves as a national-level roadmap for assisting HHS programs and public and private stakeholders to improve the health of individuals with MCC. http://www.hhs.gov/ash/initiatives/mcc/ |
| HHS Intersection of HIV/AIDS, Violence Against Women and Girls (VAWG), & Gender-Related Health Disparities Working Group | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA, OS, SAMHSA | NIMH, NIAAA, NICHD, NIDA | This interagency workgroup coordinates with the White House to report on the Intersection of HIV/AIDS, Violence Against Women and Girls (VAWG), and Gender-Related Health Disparities, providing updates to the report and advancing research in this area. http://www.whitehouse.gov/sites/default/files/docs/vaw-hiv_working_group_report_final_-_9-6--2013.pdf |
| HHS Measurement Policy Council | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA | NLM | The HHS Measurement Policy Council was convened in early 2012 to begin the work of aligning measures across HHS. Composed of senior-level representatives from Agencies and operating divisions across HHS, the group also addresses new measure development and implementation, and measurement policy. The Council has so far reviewed nine topics to date: hypertension control, hospital-acquired conditions/patient safety, HCAHPs, smoking cessation, depression screening and care coordination, HIV/AIDS, perinatal, and obesity/BMI. While these measures are used for Federal programs, the Measurement Policy Council supports State and private-sector efforts to adopt core measure sets for further harmonization and alignment across the health and health care community. NLM serves on this council. http://www.ahrq.gov/workingforquality/about.htm |
| HHS National HIV/AIDS Strategy Implementation Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD/DPCPSI/OAR | Trans Department of Health and Human Services (DHHS) Committee charged with addressing issues of and/or related to AIDS. https://www.whitehouse.gov/administration/eop/onap/nhas/ |
| HHS National Promotores de Salud Initiative | Public Education Campaign | AHRQ, CDC, CMS, HRSA, SAMHSA | NHLBI | Community health workers (CHWs) and promotores de salud are frontline public health workers who serve as a link between health/social services and communities to facilitate access to services and improve the quality and cultural competency of service delivery. The purpose of the collaborative activity was to establish the National Promotores de Salud Initiative in partnership with HHS agencies to: establish a steering committee, develop a national recognition for promotores, and develop a HHS Portal for promotores and a national database system to connect with the promotores networks. http://minorityhealth.hhs.gov/templates/content.aspx?ID=8935 |
| HHS Nutrition Policy Board | Committee, Work group, Advisory group, or Task Force | ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA | NIDDK | This Board coordinates the Department''s nutrition policy development and program implementation and is the principle point of contact with USDA for nutrition policy. |
| HHS Secretary''s Initiative on Serious Mental Illness (SMI) | Committee, Work group, Advisory group, or Task Force | ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIMH | The HHS Action Plan includes activities addressing the needs of individuals with serious mental illness (SMI) as well as those at high risk for developing SMI. This plan targets three goals: reducing the duration of untreated SMI through early engagement in care; improving the quality of care through stronger measurement and accountability; and, increasing access to community-based treatment and support services. |
| HHS Tissue and Organ Donor Epidemiology Study (TODES) Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NHLBI | This Working Group supports the design and conduct of HHS Tissue and Organ Donor Epidemiology Study (TODES). |
| HHS Tobacco Control Implementation Steering Committee | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, SAMHSA | NIDA, NCI | Comprising senior HHS leaders and tobacco control experts, the committee monitors the overall implementation of the Tobacco Control Strategic Action Plan to ensure effective coordination and collaboration across the Department and with other federal agencies and to provide support to the Food and Drug Administration’s role of regulating tobacco products. The Steering Committee meets regularly to set priorities, develop plans for cross-agency implementation of strategic actions, and promote information exchange and collaboration. |
| HHS Viral Hepatitis Interagency Working Group | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIDDK, CC, NCCIH, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIMHD, OD/DPCPSI/OAR | The HHS Viral Hepatitis Interagency Working Group was created by the Office of the Assistant Secretary for Health to address a report sponsored by the Institute of Medicine entitled Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The group meets to discuss collaborations and activities directed at achieving the goals for viral hepatitis research and control highlighted in the IOM report. http://iom.edu/Reports/2010/Hepatitis-and-Liver-Cancer-A-National-Strategy-for-Prevention-and-Control-of-Hepatitis-B-and-C.aspx |
| HHS Working Group on the Epilepsies | Committee, Work group, Advisory group, or Task Force | ACL, CDC, CMS, FDA, HRSA, OS | NIA, NICHD, NIMH, NINDS | The purpose of this group, which is led by the Office of the Assistant Secretary for Health, Department of Health and Human Services (HHS), is to increase communication among agencies sponsoring epilepsy-related activities and explore opportunities for increased coordination. The National Institute of Neurological Disorders and Stroke (NINDS) is the lead Institute representing the National Institutes of Health on the Working Group. |
| HIV Prevention Trials Network (HPTN) 065 | Research Initiative | CDC | NIAID, NIDA, NIMH | HIV Prevention Trials Network (HPTN) 065 is a feasibility study of an enhanced testing, linkage to care, and treatment approach to HIV prevention in the U.S. |
| HIV/AIDS Cancer Match Study | Research Initiative | CDC | NCI | Investigators have used data from the NCI HIV/AIDS Cancer Match Study, in conjunction with data from the CDC surveillance program on the number of HIV-infected people in the U.S., to estimate the contribution of the HIV epidemic to the occurrence of Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer. http://hivmatch.cancer.gov/ |
| Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings | Research Initiative | AHRQ | CC | The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model. http://globalhealth.duke.edu/research/project?pid=149&s=105&p=10&t=0&loc=0&rfm=0 |
| HPV Working Group for the Advisory Committee on Immunization Practices (ACIP) | Committee, Work group, Advisory group, or Task Force | CDC | NCI | HPV Working Group for the Advisory Committee on Immunization Practices ACIP Work Groups (WGs) serve in a key scientific role in support of vaccine policy development by the ACIP. ACIP WGs conduct extensive background reviews of relevant research data to develop options for recommendations for use of vaccines in the civilian population of the United States. WGs are convened solely to gather scientific information related to vaccines and the diseases they prevent, to analyze relevant issues and data, and to draft policies or options for review, deliberation and vote by the ACIP. The duties of this position include participation in teleconferences and meetings, as well as preparation time for these meetings. |
| HRSA Interagency Committee On Emergency Medical Services For Children Research | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | This committee supports improving emergency medical services for child research. |
| Human Immunology Project Consortium Collaboration on Mechanism Studies of Influenza Vaccination | Research Initiative | FDA | NIAID | The NIAID-funded Human Immunology Project Consortium (HIPC) supports an Infrastructure/Opportunity Fund (IOF) to create a shared research infrastructure for ongoing development of the immune profiling network, support collaborative projects, pilot projects, and new research opportunities for the HIPC investigators. |
| IAA with CDC for HPTN 052: A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples | Other | CDC | NIAID | These clinical studies are based on data collected in Africa and Thailand. There is a correlation between HIV viral load (blood levels) and HIV transmission. Specifically, the higher the viral load in the blood, the more likely the chance for transmission. Antiretroviral therapy (ART) reduces the viral load in the blood, as well as in genital secretions (for both men and women), and the drugs can be detected in semen and vaginal and cervical secretions. This information strongly suggests that ART may reduce the risk that HIV-infected people will transmit HIV. HPTN 052 compares the HIV-infection rates of two groups of HIV-serodiscordant couples. http://www.hptn.org/research_studies/hptn052.asp |
| ICARE: Interagency Collaborative to Advance Research in Epilepsy | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS | NINDS, FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH | The Interagency Collaborative to Advance Research in Epilepsy (ICARE) is an interagency epilepsy working group that includes broad representation across the NIH ICs involved in epilepsy-related research, as well as across HHS and other Federal agencies and multiple epilepsy research and patient advocacy groups with a primary focus on biomedical research. The purpose of this group, which is led by the National Institute of Neurological Disorders and Stroke, is to increase communication among institutes and agencies sponsoring epilepsy-related research and explore opportunities for increased coordination. The group’s annual meetings provide a forum for sharing information about ongoing and planned epilepsy research activities, highlighting advances, discussing needs and opportunities, and promoting increased collaboration toward common research goals. http://www.ninds.nih.gov/research/epilepsyweb/researchers/ICARE/index.htm |
| Image-guided Interventional Therapeutics | Research Initiative | FDA | CC, NCI | This collaboration will lead to safer and more effective treatment planning and performance of image-guided interventions and therapeutic drug delivery. The results of all of these studies of image guided interventions and related technologies and the models used to study them will have a direct impact on the effectiveness and consistency of the FDA Center for Devices and Radiological Health''s preclinical review of device applications while meeting the primary research goal of optimizing image guided interventions and pre-clinical modeling of those interventions. Regulatory science and translational therapeutics have overlapping goals when it comes to drugs and devices combination therapies. |
| Improving Technical Standards and Molecular Tools for Probiotics Research and Development | Research Initiative | FDA | NCCIH | In 2008, the USDA Agricultural Service initiated a Memorandum of Understanding (MOU) with NCCAM to exchange expertise in technology development and partner research initiatives to advance the field of probiotic biology and role in human health. The MOU consists of a five year plan defining common mission goals; expected benefits from the exchange of research expertise and resources; and demonstration projects based on NIH/NCCAM funded U01 cooperative agreements. The long-term goal of the MOU is to develop trans-agency networked initiatives. In 2012, the unique resources of the USDA Agricultural Research Service and the Human Microbiome Project investigators were successfully implemented as a parallel comparative biotechnologies validation and standardization prototype with targeted molecular approaches. |
| Influenza Risk Management Meeting | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | The Influenza Risk Management Meetings provide members (including ASPR/BARDA, CDC, FDA, and NIH) with a venue to discuss issues relating to the U.S. Department of Health and Human Services (HHS) response to pandemic influenza. Subjects for discussion include but are not limited to considerations of vaccine and antiviral stockpiles and clinical trial response to influenza outbreaks such as H7N9 and H3N2v. |
| Influenza Vaccine Manufacturing Improvement Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | The Influenza Vaccine Manufacturing Improvement Group aims to optimize donor strains, improve sterility assays, and develop alternative potency assays. |
| Information Exchange webinars | Other | ATSDR | NIEHS | To identify potential areas of collaboration and scientific information exchange between the two agencies and Superfund Research Program (SRP) grantees http://www.niehs.nih.gov/research/supported/centers/srp/about/partnerships/research_to_risk/index.cfm |
| Institute of Medicine Consensus Study on Accessible and Affordable Hearing Health Care for Adults | Meeting/ Workshop | CDC, FDA | NIDCD, NIA | The IOM proposes to establish an ad hoc committee that will address how to improve accessibility to and affordability of hearing health care (HHC) for adults, with a focus on nonsurgical devices and services. The IOM will consider HHC from the health care and population health perspective, including the regulatory environment, access, and affordability. http://iom.nationalacademies.org/Activities/HealthServices/HearingHealthCareForAdults.aspx |
| Integrating Prevention Science and Public Policy | Meeting/ Workshop | ACF, CDC | NIAAA, NCI, NHLBI, NICHD, NIDA, NIMH, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ORWH | The Society for Prevention Research (SPR) envisions a wellness-oriented society in which evidenced-based programs and policies are continuously applied to improve the health and wellbeing of its citizens. The SPR Annual Meeting provides unique opportunities to advance this vision by providing an integrated forum for the exchange of new concepts, methods, and results from prevention and public health-related research, and communication between scientists, public policy leaders and practitioners concerning the implementation of evidence-based preventive interventions. http://www.preventionresearch.org/2012-annual-meeting/ |
| Inter-agency Adult Literacy Research Group | Committee, Work group, Advisory group, or Task Force | ACF | NICHD | Inter-agency working group highlights adult literacy activities within and across departments and agencies to inform inter-agency understanding of proposed and ongoing efforts focused on adult literacy (research and practice) and to facilitate enhanced communication, cooperation and coordination (as appropriate) across the federal government. • Recent activities have been led by the US Dept. of Education (specifically the Office of Career, Technical and Adult Education and National Center for Education Statistics at the Institute of Education Sciences) to highlight and disseminate findings from the recent Programme for the International Assessment of Adult Competencies (PIAAC). The PIAAC provides a snapshot of adult’s skills in literacy, numeracy and problem solving in an electronic context and gives both a national and international viewpoint on the competencies of adults. The engagement activities have been important to translate the implications of the findings to research, policy and practice audiences across the federal government. Also, these offices have proactively been meeting and working with federal partners to convey and understanding of upcoming reports that will focus on adult populations of particular interest to NIH – incarcerated populations, young adults and older adults. The PIAAC includes information that provides insight into the link between adult competencies, education and health important to the mission of NIH. The partners at ED have explicitly engaged with audiences at NIH around the linkage to health in the current PIAAC and thinking forward to the next planned assessment in approximately 8-10 years. |
| Inter-Society Coordinating Committee (ISCC) for Practitioner Education in Genomics | Committee, Work group, Advisory group, or Task Force | CMS, HRSA | NHGRI, NCI, NEI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIGMS, NIMH, NINDS, NINR, NLM | This education collaborative facilitates sharing interactions among professional societies, agencies, and health systems. It intends to enhance the accrual of knowledge and skill among practitioners applying genomic results to clinical care. In its start-up phase, the ISCC focused primarily on physicians and dentists. It has since expanded to engage and collaborate with allied practitioner groups such as nurse practitioners, physician assistants, pharmacists, genetic counselors, and nurses comprising integrated health care teams. It will continue to add other relevant professions and add to the reviewed and searchable educational resources on its website. http://www.genome.gov/27554614 |
| Interactive Publications | Resource Development | CDC | NLM | NLM collaborated with the CDC National Center for Health Statistics to convert the CDC''s, "Health US in Brief", to interactive form, which can be viewed using NLM''s Panorama software. In addition, another important document was converted to interactive form--a Data Brief called Death in the United States. Interactive Publications are scientific multimedia documents that give readers more information from an article than is available in the published form (electronic or print) by enabling interaction with the included media (tables, graphs, images, videos, biomedical image studies, etc.). NLM conducts research into models for highly interactive multimedia documents that could transform the next generation of publishing in biomedicine. We focus on the standards, formats, authoring and reading tools necessary for the creation and use of such interactive publications that, in addition to text, contain media objects relevant to biomedical research and clinical practice: video, audio, bitmapped images, interactive tables and graphs, and clinical digital imaging and communications in medicine (DICOM) images such as x-rays, CT, MRI, and ultrasound. http://www.cdc.gov/nchs/hdi.htm |
| Interagency Agreement for Communications on Prevention of Underage Tobacco Use | Public Education Campaign | FDA | NCI | The FDA Center for Tobacco Products (CTP) and the NCI Office of Communications and Education are collaborating on an Interagency Agreement in which CTP will provide funds to NCI to provide planning, formative research, target messaging, creative content, outreach strategies, and communications support for a campaign to prevent underage tobacco use as it relates to FDA’s authorities under the Tobacco Control Act. Primary focus areas include multi-ethnic journalist training and outreach; development of a partnership strategy, digital strategy, and social marketing tools; digital gaming best practices; and formation of a CTP communications workgroup comprised of subject matter experts. |
| Interagency Artificial Pancreas Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIDDK, NIBIB, NICHD | The Interagency Artificial Pancreas Working Group is a group of multi-disciplined scientists and clinicians from the Food and Drug Administration (FDA) and the NIH to support the Artificial Pancreas Initiative. The goals of this initiative are to provide infrastructure for narrowing the gap between basic biomedical knowledge and clinical application of novel technologies, and to cross-fertilize and partner with stakeholders in order to identify and overcome the clinical and scientific challenges to the development of an artificial pancreas. Through collaborative efforts, such as workshops, the group strives to develop innovative strategies to achieve their goals. |
| Interagency Autism Coordinating Committee (IACC) | Committee, Work group, Advisory group, or Task Force | ACF, ACL, CDC, CMS, FDA, HRSA, SAMHSA | NIMH, NICHD, NIDCD, NIEHS, NINDS | In accordance with the Autism Collaboration, Accountability, Research, Education, and Support (CARES) Act of 2014, the Interagency Autism Coordinating Committee (IACC), a federal advisory committee, is charged with coordinating all efforts with the Department of HHS and across member federal agencies concerning autism spectrum disorder (ASD). The committee was established in an effort to accelerate progress in ASD biomedical research and services efforts by improving coordination and communication across the Federal Government and by working in partnership with the autism community. The committee is composed of officials from many different federal agencies involved in autism research and services, as well as adults on the autism spectrum, parents and family members, advocates, researchers, and other community stakeholders. Member agencies include NIH, CDC, FDA, CMS, ACL, ACF, AHRQ, and HRSA within HHS, as well as the Department of Education, Department of Defense, and the Environmental Protection Agency. In accordance with the Autism CARES Act, the committee is charged with providing advice to the HHS Secretary regarding activities and issues related to ASD. The IACC is also tasked with developing and annually updating a strategic plan for ASD research, monitoring federal activities related to autism, and preparing an annual summary of advances in ASD research. http://iacc.hhs.gov |
| Interagency Chemical Risk Assessment Working Group | Committee, Work group, Advisory group, or Task Force | OS | NINDS, NIAID | Department of Homeland Security led effort to determine chemical hazards and develop Chemical Risk Threat Assessment list of priority chemicals. |
| Interagency Committee on Assistive Technology (ICAT) | Committee, Work group, Advisory group, or Task Force | ACL | NICHD | This committee seeks to improve research on assistive technology. |
| Interagency Committee on Disability Research (ICDR) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIDCD | A Government-wide group, the Interagency Committee on Disability Research (ICDR), meets monthly to discuss the issues related to identifying people with disabilities and coordinate research in this area. http://www.icdr.us/ |
| Interagency Coordinating Committee for Newborn Screening | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA | NICHD | This committee makes recommendations for screening certain disorders, developing a system to adjudicate newborn screening expansion, and assist states in implementing programs to test for the recommended conditions. |
| Interagency Coordinating Committee on Fetal Alcohol Syndrome (ICCFASD) | Other | ACF, AHRQ, CDC, HRSA, IHS, SAMHSA | NIAAA, NICHD, NIDA | The Interagency Coordinating Committee on Fetal Alcohol Syndrome (ICCFASD) was created in October 1996 in response to recommendations of an expert committee of the Institute of Medicine that NIAAA chair an effort to coordinate Federal activities on Fetal Alcohol Syndrome (FAS) and other disorders associated with prenatal alcohol exposure. ICCFASD works to improve communication, cooperation, and collaboration among disciplines and federal agencies that address issues of health, education, developmental disability, research, justice, and social services relevant to FAS and related disorders caused by prenatal alcohol exposure. The ICCFASD meets twice a year and frequently arranges special conferences; the most recent was Oct. 31-Nov. 2, 2011 on Recognizing Alcohol-related neurodevelopmental disorder (ARND) in Primary Health Care of Children. http://www.niaaa.nih.gov/ICCFASD |
| Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIDDK, NICHD, NINDS | Coordinates federal efforts to understand how pituitary human growth hormone may have led to the development of Creutzfeldt - Jakob disease in participants of the National Hormone and Pituitary Program. http://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/public-health-service/Pages/public-health-service-interagency-coordinating-committee-human-growth-hormone-creutzfeldt-jacob-disease.aspx |
| Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) | Committee, Work group, Advisory group, or Task Force | ACF, CDC, IHS, OS, OSG, SAMHSA | NIDA, NIAAA | The Consolidated Appropriations Act of 2004 directed the Secretary of Health and Human Services (HHS) to establish the Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) and to issue an annual report summarizing all Federal agency activities related to preventing underage alcohol use. HHS made ICCPUD a standing committee to provide ongoing, high-level leadership on this issue and to serve as a mechanism for coordinating Federal efforts aimed at preventing and reducing underage drinking. The Substance Abuse and Mental Health Services Administration (SAMHSA) serves as the lead ICCPUD agency. https://www.stopalcoholabuse.gov/default.aspx |
| Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) | Research Initiative | ATSDR, CDC, FDA | NIEHS, NCI, NEI, NIAID, NLM | The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) is an interagency committee of 15 Federal agencies that carries out specific duties prescribed by the ICCVAM Authorization Act, P.L. 106-545. The ICCVAM is administered by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), a component of the NIEHS. NICEATM in collaboration with ICCVAM and its international collaborators in Japan, the EU, and Canada conducts research studies to evaluate the scientific validity of proposed new safety testing methods. NICEATM and ICCVAM also conduct international scientific peer review evaluations of proposed safety methods, and forward recommendations on scientific valid methods to Federal agencies, which must adopt the proposed methods or provide a basis for not adopting it. NICEATM and ICCVAM also organize scientific workshops to evaluate the current state of the science on a wide range of toxicological and other safety endpoints. http://ntp.niehs.nih.gov/?objectid=61BA4EF0-C880-CB0E-6C33B90B6612ABCF |
| Interagency Dual Use Outreach Working Group (IDOWG) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | Developing strategies to educate the research community about Dual Use Research of Concern (DURC) and the DURC-related USG policies http://www.phe.gov/s3/Pages/default.aspx |
| Interagency Group on Alzheimer''s Disease and Related Dementias for implementation of the National Alzheimer''s Project Act | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA | NIA | This interagency group was established by HHS in response to the Congressional directive to address Alzheimer disease. Under the National Alzheimer’s Project Act, HHS created three sub-groups on Research, Long Term Services, and Clinical Services. The Veteran’s Administration, National Science Foundation, and Department of Defense are also involved in this effort. http://aspe.hhs.gov/daltcp/napa/ |
| Interagency Midazolam Product Coordination Team | Committee, Work group, Advisory group, or Task Force | FDA, OS | NINDS | A collaboration led by the Department of Health and Human Services (HHS) to facilitate activities, both research and regulatory, related to the Food and Drug Administration (FDA) approval of midazolam for use in treating nerve agent exposure. |
| Interagency Middle Eastern respiratory syndrome MERS-CoV Working Group on Medical Countermeasures | Committee, Work group, Advisory group, or Task Force | CDC | NIAID | The Working Group focuses on potential MERS-CoV countermeasures, to include therapeutics (i.e., antivirals, monoclonal antibodies, and others) and vaccines. The working group was asked to assess the following: a) inventory of potential therapeutics (and vaccines) under development/investigation and by what groups b) how far along are they in pre-clinical development (in-vitro, animal studies/mice/non- human primates) and what data are available c) timelines for animal studies and scale-up including when human trials (phase 1, phase 2, open-label studies) can be started d) safety and regulatory issues for IND, EUA, and clinical studies e) prioritization for clinical trials based upon pre-clinical data and scientific assessment of available data |
| Interagency Modeling and Analysis Group (IMAG) | Committee, Work group, Advisory group, or Task Force | FDA | NIBIB, CSR, NCI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/DPCPSI/OBSSR | The Interagency Modeling and Analysis Group (IMAG) is comprised of program directors from nine government agencies in the U.S. including the National Institutes of Health (NIH), the National Science Foundation (NSF), Department of Energy (DOE), Department of Defense (DOD), the United States Department of Agriculture (USDA), the National Aeronautics and Space Administration (NASA), the United States Department of Veterans Administration (USDVA), the Food and Drug Administration (FDA), and the Intelligence Advanced Research Projects Activity (IARPA). The purpose of IMAG is to bring together program officers who have a shared interest in supporting modeling and analysis methods in biomedical, biological and behavioral systems. IMAG has promoted and supported a wide variety of modeling over the past 13 years, notably the multi-scale modeling (MSM) initiative, which was originally a multi-agency funding opportunity announcement and continued on by different IMAG agencies through separate funding opportunity announcements. The most recent MSM Consortium Meeting was held in September 2015. http://www.nibib.nih.gov/research/featured-programs/interagency-modeling-and-analysis-group-imag |
| Interagency Pain Research Coordinating Committee (IPRCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA | NINDS, NCCIH, NIDA, NIDCR, NINR | The Interagency Pain Research Coordination Committee is an Affordable Care Act mandated committee to coordinate pain research activities across the government. http://iprcc.nih.gov/ |
| Interagency Public Access Working Group | Other | ACL, AHRQ, CDC, FDA, OS | OD/OSP, OD/OER | On February 22, 2013, the Director of the White House Office of Science and Technology Policy (OSTP), Dr. John Holdren, issued a memorandum to all agency and department heads entitled, “Increasing Access to the Results of Federally Funded Scientific Research.” The memo directed federal agencies with more than $100 million in annual conduct of research and development to develop plans for increasing public access to peer-reviewed scientific publications and digital data resulting from federally funded research investments. Within HHS, six operating divisions and the Office of the Secretary meet this threshold. The HHS operating divisions have aligned their work through a common set of guiding principles and a framework around which they could develop implementation plans tailored to the needs of their research communities, taking into account their unique missions and legal authorities. OSTP also maintains federal-wide interagency working group. http://www.hhs.gov/open/publicaccess/index.html |
| Interagency Select Agent Review Group (ISARG) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID, OD/OM/OB, OD/OSP | The Interagency Select Agent Review Group (ISARG), composed of members from the Centers for Disease Control and Prevention (CDC), the Department of Justice, the Department of State, the NIH-OD and BARDA advises the National Institute of Allergy and Infectious Diseases (NIAID) on whether facilities and procedures at NIAID-funded foreign research sites are comparable to those required by the Select Agent Regulations for domestic institutions before Select Agent work at the foreign site may proceed. |
| Interagency Task Force on Antimicrobial Resistance (ITFAR) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, OS | NIAID | The Interagency Task Force on Antimicrobial Resistance (ITFAR) is a coordinating committee within the U.S. government for research on antimicrobial resistance. http://www.cdc.gov/drugresistance/itfar/ |
| Interagency Workgroup on Child Abuse and Neglect | Committee, Work group, Advisory group, or Task Force | ACF | NICHD, CSR, NIAAA, NIDA, NIMH, NINDS, OD/DPCPSI/OBSSR | The overall goals of the FEDIAWG are: • To provide a forum through which staff from relevant Federal agencies can communicate and exchange ideas concerning child maltreatment related programs and activities; • To collect information about Federal child maltreatment activities; and • To provide a basis for collective action through which funding and resources can be maximized. |
| Interagency Workgroup on Child Abuse and Neglect | Committee, Work group, Advisory group, or Task Force | ACF, ACL, CDC, IHS, SAMHSA | NIMH, NICHD, NIDA | The Federal Interagency Workgroup on Child Abuse and Neglect meets to provide a forum through which staff from relevant federal agencies can communicate and exchange ideas concerning the prevention of child maltreatment and other related issues. http://www.acf.hhs.gov/programs/cb/fediawg/index.htm |
| Interagency Workgroup on Technology to Facilitate Aging in Place | Research Initiative | ACL, CMS, FDA | NIA, NCI, NHLBI, NIBIB, NINDS, NINR | The purpose of this Trans-NIH/Inter-Agency group is to develop new platforms for everyday life technology that will enhance the common goals of multiple NIH institutes and other federal government agencies by improving the capability to rapidly conduct peer-reviewed technology research to facilitate aging in place, with a special emphasis on people from underrepresented groups. A platform is a group of technologies that are used as a base upon which other applications, processes or technologies are developed. http://silvrnetwork.org/ |
| Interagency Working Group on Neuroscience | Other | CDC, FDA | NIMH, NIA, NIDA, NINDS, NINR, OD/DPCPSI/OBSSR | By Executive Order, the White House Office of Science and Technology Policy established the Interagency Working Group on Neuroscience (IWGN) by action of the National Science and Technology Council to foster collaboration across agencies and to coordinate federal investments in neuroscience research. The IWGN will coordinate activities in neuroscience research across the Federal Government with a focus on the fundamental understanding of learning, brain development and plasticity, and brain health and recovery. The IWGN will enhance federal efforts related to: improving our understanding of learning and cognition and applying this understanding to improvements in education and other areas; improving our understanding of a variety of neurological conditions and injuries; and developing appropriate resources, tools, techniques, interventions, and therapies to assist in research, treatment, and recovery. The IWGN includes members from the Departments of Agriculture, Defense, Education, Energy, Health and Human Services, Homeland Security, Justice, and Veterans Affairs, as well as the Central Intelligence Agency, Environmental Protection Agency, National Aeronautics and Space Administration, the National Science Foundation, and the Office of the Director of National Intelligence. https://www.whitehouse.gov/sites/default/files/microsites/ostp/NSTC/charter_2015_nstc_cos_working_group_on_neuroscience.pdf |
| INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support | Resource Development | CMS, FDA | NHLBI | The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) is a national registry for patients who are receiving mechanical circulatory support device therapy to treat advanced heart failure. This registry was devised as a joint effort of the National Heart, Lung, and Blood Institute (NHLBI), the Centers for Medicare and Medicaid Services (CMS), the U.S. Food and Drug Administration (FDA), clinicians, scientists, and industry representatives, in conjunction with the University of Alabama at Birmingham and the United Network for Organ Sharing. http://www.intermacs.org/ |
| International Cancer Control Partnership | Other | CDC | NCI | The National Cancer Institute and the Union for International Cancer Control convened global partners including CDC to cooperate in assisting countries to develop and implement quality cancer plans linked to Non-communicable Disease (NCD) control. This International Cancer Control Partnership, ICCP, believes that prioritizing cancer is critical to reaching the “25x25” goal. ICCP partners will assist countries by: creating a searchable database of current cancer control plans from around the globe; performing analysis of gaps and highlighting priority areas for inclusion in plans; training appropriate personnel to develop plans with targets and evaluation strategies; providing planners with relevant existing materials and tools; and offering technical assistance. ICCP partners will use their collective state, country and regional-level planning experience to guide plan development and implementation and will ensure planners utilize effective, evidence-based strategies to help meet the global NCD targets. http://www.iccp-portal.org/ |
| International Conference on Betel Quid and Areca Nut | Meeting/ Workshop | CDC | NCI, NIAID, NIDCR | Tobacco and areca nut are used in a variety of forms and with other added ingredients throughout Asia and the Pacific. Common forms of areca nut use include: betel quid, a combination of betel leaf, areca nut, and slaked lime, which may be used with or without tobacco and is typically assembled for the customer; and gutka, a packaged product containing areca nut, slaked lime, and tobacco. Other ingredients and flavorants are often added according to local preferences and customs (e.g., sweeteners; catechu; or spices such as cardamom, saffron, cloves, anise seeds, turmeric, and mustard). While both tobacco and areca nut are known carcinogens, other ingredients may also contribute to the toxic or addictive properties of the product. Betel quid and areca nut use is common in Asian and Pacific countries. The 2009–2010 Asian Betel–Quid Consortium study found that use of betel quid with tobacco among adults aged 15 and older ranges widely across several countries in the region. For example, prevalence is high in Nepal (males, 43.6%; females, 34.9%) and among women in Indonesia (31.7% among females, compared to 10.4% among males). The CDC Global Adult Tobacco Survey in India (2009–2010) shows that about 6.2% percent of all adults aged 15 years and older (7.5% of males and 4.9% of females) report using betel quid with tobacco. Betel quid, is a risk factor for oral and esophageal cancers, and has shown effects on the cardiovascular, nervous, GI and metabolic, respiratory, and reproductive systems. The International Agency for Research on Cancer Monograph 85 (2004) examined the carcinogenic effects of betel quid and areca nut chewing and concluded that betel quid, both with and without tobacco, is carcinogenic to humans. However, the relative contribution of specific ingredients to the carcinogenic and addictive properties of betel quid is not well characterized. Additionally, the practice of betel quid use, added ingredients, and cultural role vary widely across the region. Moreover, tobacco control policies and interventions are not necessarily applied to betel quid chewing, even when the product contains tobacco. More research is needed to understand effective prevention and control of betel quid use (alone or in combination with cigarette smoking and/or alcohol), screening and treatment for related cancers, policy and economic impacts, cessation, and basic biology. This proposed conference will focus on understanding the impact of use of areca nut and betel quid, both with and without tobacco, and all its variants, addiction issues, and the associated cancers and other oral health issues, specifically cancers of the lip, mouth, tongue, pharynx, and esophagus. http://www.cvent.com/events/international-conference-on-betel-quid-and-areca-nut/event-summary-e891e99e74434273b0b92c8cc1c8b687.aspx |
| Intradepartmental Council for Native American Affairs (ICNAA) | Committee, Work group, Advisory group, or Task Force | ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIMHD | The purpose of this collaborative activity is to support activities of the Intradepartmental Council for Native American Affairs (ICNAA), including tribal consultation sessions and development of the annual tribal consultation report. http://www.hhs.gov/intergovernmental/tribal/abouticnaa/icnaa_mission.html |
| Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NCI, NIAID | The Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC) makes technically based recommendations to the APHIS/CDC Select Agent and Toxin Program on restricted experiments of Select Agents and Toxins and the exclusion and exemption of attenuated strains. The Committee also conducts a biennial review of the Select Agents and Toxins list for HHS and overlap agents and toxins. http://www.nicbr.mil/ |
| Investigations of Early Life Determinants of Pediatric and Adult Malignancies in a Population | Research Initiative | CDC | NCI | In collaboration with investigators from the U.S. Centers for Disease Control and Prevention (CDC) and the China CDC, the National Cancer Institute (NCI) is assessing risk of pediatric leukemia and other pediatric cancers in a large population of offspring of mothers enrolled in a community intervention program of peri-conception folic acid supplementation in China. Pediatric cancer risks will be compared in offspring of mothers treated vs offspring of mothers not treated with folic acid supplements. |
| IOM Consensus Study: Public Health Approaches to Reduce Vision Impairment and Promote Eye Health. | Meeting/ Workshop | CDC | NEI | The Institute of Medicine will conduct a consensus study to examine the core principles and public health strategies to reduce visual impairment and promote eye health in the United States. The study will describe limitations and opportunities to improve vision and eye health surveillance; reduce vision and eye health disparities; promote evidence-based strategies to improve knowledge, access and utilization to eye care; identify comorbid conditions and characterize their impact; and, promote health for people with vision impairment. The study will also examine the potential for public and private collaborations at the community, state, and national levels to elevate vision and eye health as a public health issue. http://iom.nationalacademies.org/Activities/PublicHealth/ReduceVisionImpairment.aspx |
| It’s a Noisy Planet. Protect Their Hearing® Public Education campaign | Public Education Campaign | CDC | NIDCD | The National Institute on Deafness and Other Communication Disorders (NIDCD) sponsors, It’s a Noisy Planet Protect Their Hearing®, a national public education campaign to increase awareness among parents of children ages 8 to 12 about the causes and prevention of noise-induced hearing loss (NIHL). The campaign disseminates messages through print and digital materials, community-based events, school presentations, and other methods. The campaign launched in October 2008 as a follow up to the NIDCD''''s Wise Ears! campaign, which increased awareness about preventing NIHL among workers, employers, and Americans of all ages from 1999 to 2008. The CDC’s National Institute for Occupational Safety and Health (NIOSH) has actively collaborated with the NIDCD for both campaigns. http://www.noisyplanet.nidcd.nih.gov |
| Joint Committee and Joint Commission Meetings | Meeting/ Workshop | CDC, FDA, OS | NCI, FIC, NIAID | US State Department establishes collaborative agreements with foreign governments in fields of science and technology. These Joint Committee and Joint Commission Meetings (JCMs) facilitate discussion on selected topics creating cross-talk among the equivalent government agencies leading towards future collaborations. The Office of the HHS Secretary (OS), through the Office of Global Affairs (OGA), organizes the operational divisions of the Department of Health and Humans Services (HHS); The Fogarty International Center (FIC) facilitates the participation of NIH Institutes and Centers. For FY2011, JCMs were convened for Brazil, Colombia, and Mexico. |
| Joint Fellowship Program | Training Initiative | FDA | NCI | The objective of the NCI-FDA Joint Fellowship Training Program is to train a cadre of scientists in research and research-related regulatory review, policies, and regulations so that they develop a skill set that bridge the two disparate processes. Fellows will learn to build awareness of regulatory requirements into the early stages of the medical product development process and develop strategies to improve planning throughout research and regulatory review. http://iotftraining.nci.nih.gov/ |
| Kaposi Sarcoma and HHV8 in Sickle Cell and Other Ugandan Populations | Research Initiative | CDC | NCI | Epidemiological studies are being conducted to assess small-area variation of HHV8 and to learn about socio-demographical and environmental risk factors for HHV8 and Kaposi sarcoma in Uganda. |
| Kidney Interagency Coordinating Committee (KICC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NIDDK, NHLBI, NIA | The goal of the Kidney Interagency Coordinating Committee (KICC) is to encourage cooperation, communication, and collaboration among all federal agencies involved in kidney research and other activities. The National Kidney Disease Education Program (NKDEP) convenes KICC annually to share information on various agencies’ programs and activities related to chronic kidney disease (CKD) and to discuss ways to improve the coordination of Federal responses to CKD. The KICC Consists of Federal Representatives involved in CKD programs. http://nkdep.nih.gov/federal-response-to-ckd.shtml |
| Laboratory-Developed Tests (LDT) Interagency task force | Other | CDC, CMS, FDA | OD/OSP, NLM | The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) put together an interagency task force to expand their collaboration around oversight of laboratory-developed tests (LDTs). FDA issued draft guidance in October 2014 for overseeing the quality of LDTs, proposing that the FDA oversee the tests alongside CMS, which regulates labs through the Clinical Laboratory Improvement Amendments (CLIA). |
| Leadership Forums in Cancer Control Planning | Meeting/ Workshop | CDC | NCI | The goal of the Cancer Control Leadership Forum Program is to increase the capacity of participating countries from target regions to initiate or enhance cancer control planning and implementation through a multi-sectoral approach. The three-day Forum is the focal point of a three-part process spanning approximately 18 months and is an opportunity for each country to develop an action plan to move their cancer control planning efforts forward and to exchange experiences about creating and implementing comprehensive cancer control plans with other countries in the region. |
| Leprosy Research Support in Armadillos (Dasypus Novemcinctus) | Other | HRSA | NIAID | The Leprosy Research Support and Maintenance of an Armadillo Colony – Post Genome Era interagency agreement provides standardized research reagents to investigators worldwide to assist in the development of skin test antigens used to detect leprosy. This agreement supports collaborative research to continuously improve biochemical, microbiological and immunological models for leprosy research in an effort to provide the most up-to-date resource and expertise for mycobacterial researchers. |
| Let''s Move/HHS Healthy Weight, Nutrition and Physical Activity Work Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIDDK, NCI, NHLBI, NICHD, OD/DPCPSI/ODP | The Department of Health and Human Services (HHS) Healthy Weight, Nutrition and Physical Activity Work Group aims to improve dietary and physical activity behaviors through targeted sector initiatives. |
| Linkage to Care Committee for Adolescents with HIV/AIDS | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | The purpose of this committee is to collaborate with other HHS agencies to improve the outcome of adolescents with HIV/AIDS. |
| Logical Observation Identifiers Names and Codes (LOINC) | Resource Development | AHRQ, CDC, CMS, HRSA, IHS, OS | NLM | This activity supports the maintenance, distribution, and continued development of LOINC®, a set of universal codes and names to identify laboratory and other clinical observations which facilitates the exchange and pooling of clinical results for clinical care, outcomes management, public health and research. The Regenstrief Institute, Inc., an internationally renowned healthcare and informatics research organization, maintains the LOINC database and supporting documentation, and the RELMA mapping program. http://www.nlm.nih.gov/research/umls/loinc_main.html |
| Long-term Oxygen Treatment Trial | Research Initiative | CMS | NHLBI | The Long-term Oxygen Treatment Trial is a randomized controlled clinical trial to assess the efficacy of around-the-clock, supplemental oxygen therapy in subjects with chronic obstructive pulmonary disease and moderately severe hypoxemia. NHLBI will administer and oversee the study, and Medicare will cover the costs of items and medical services that are generally available through that program to beneficiaries enrolled in the trial. https://jhuccs1.us/lott/Default.asp |
| Lupus Federal Working Group | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS | NIAMS, NCCIH, NEI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH | The Lupus Federal Working Group, established on behalf of the HHS Secretary by the NIH, facilitates collaboration among NIH components, other Federal agencies, voluntary and professional organizations, and industry groups with an interest in lupus. http://www.niams.nih.gov/About_Us/Committees/lupus_fwg.asp |
| Lyme and Tick-borne Diseases Work Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | This work group involves members from agencies including the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and the NIH with the purpose of continued coordination and communication of activities, policy updates, events, agency highlights, and other shared interests relating to Lyme disease and other tick-borne diseases. |
| Mapping of the Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT) and International Classification of Disease (ICD) Clinical Terminology | Resource Development | CDC, OS | NLM | The U.S. Department of Health and Human Services (HHS) has set a goal for the nationwide implementation of an interoperable health information technology infrastructure to improve the quality and efficiency of health care. Achieving this goal will require that key clinical data elements are captured or recorded in detailed, standardized form (using standard vocabularies, codes, and formats) as close to their original sources (patients, health care providers, laboratories, diagnostic devices, etc.) as possible. If these standardized clinical data can also be used to generate HIPAA- compliant billing transactions automatically, this will provide another incentive for adoption of clinical data standards. For automated generation of bills from clinical data to become a reality, robust mappings from standard clinical terminologies to the HIPAA code sets must be created. In preparation for the transition to ICD-10-CM in 2015, a map from SNOMED CT to ICD-10-CM is being created. http://www.nlm.nih.gov/research/umls/mapping_projects/snomedct_to_icd9cm_reimburse.html |
| Maternal and Child Health (MCH) Research Pediatric Practice Based Research Network (PBRN) Initiative | Research Initiative | HRSA | NICHD | The purpose of this document is to amend the original agreement. This agreement is for the NIH to contribute funding to the HRSA to fund, oversee, and manage a cooperative agreement on a topic of mutual interest to the agencies. The funds will be used to support a pediatric practice-based applied research network that will engage in coordinated multi-centered research activities, focusing on translating research to practice, and cultivate new researchers from among the practice-based constituency of the research network. |
| Media-Smart Youth Campaign Outreach | Meeting/ Workshop | OS | NICHD | In FY15, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) coordinated with the U.S. Department of Health and Human Services Center for Faith-Based and Neighborhood Partnerships to promote the Media-Smart Youth: Eat, Think, and Be Active! health education curriculum. NICHD staff led a training webinar, hosted by the Partnership Center, to train 200 leaders across the country in implementing Media-Smart Youth. In addition, NICHD received valuable input from the Partnership Center about possible outreach strategies, which helped lead to a successful outreach pilot program in FY15, the Media-Smart Youth Teen Leaders. Through this program, groups of teens--with adult supervision--implemented the Media-Smart Youth program at 50 sites around the county. This approach increased awareness and use of NICHD’s Media-Smart Youth curriculum, while cutting costs of each program by 80%, as compared to a previous community mini-grant program. |
| Medical Countermeasures Surveillance Integrated Program Team | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | This team was created to identify the regulatory science research required for real‐time tracking and evaluation of medical countermeasures (MCMs) during public health emergencies. The team is developing a comprehensive Action Plan to identify and facilitate the development of systems that can be used to monitor MCM safety and clinical benefit during an event. |
| Medical Education Partnership Initiative (MEPI) | Training Initiative | CDC, HRSA | FIC, NCI, NHGRI, NHLBI, NIMH, NINDS, NINR, OD/DPCPSI/OAR, OD/DPCPSI/ORWH, OD/DPCPSI/OSC | The Medical Education Partnership Initiative (MEPI) is intended to build human capacity for health in Africa by strengthening the medical education system in an environment that values and nurtures research in President’s Emergency Plan for AIDS Relief (PEPFAR)-funded countries. This program also works to build clinical and research capacity in Africa as part of a retention strategy for faculty of medical schools and clinical professors. The 15 awards administered by FIC/NIH are now in a no-cost extension year to complete their activities. NIH/MEPI works in collaboration with OGAC, HRSA, USAID, DOD, Peace Corps, African Ministries of Health, as well as international agencies, including the World Health Organization, World Bank, and Welcome Trust. http://www.fic.nih.gov/Programs/Pages/medical-education-africa.aspx |
| Medical Eligibility Criteria Committee | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The purpose of this committee is to provide guidance on medical eligibility issues. |
| Medical Expenditure Panel Survey (MEPS) | Health Survey | AHRQ | NCI | The Medical Expenditure Panel Survey (MEPS) is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States. MEPS is the most complete source of data on the cost and use of health care and health insurance coverage. http://meps.ahrq.gov/mepsweb/ |
| Medicare Benefit Postcard | Public Education Campaign | CMS | NEI | The National Eye Institute (NEI) worked with the Centers for Medicare and Medicaid Services (CMS) to develop and disseminate a Medicare benefit card in English and Spanish which describes eligibility for the Medicare benefit for glaucoma and diabetic eye disease. The postcards are distributed to Medicare beneficiaries, the general public, and to health professionals. http://www.nei.nih.gov/nehep/programs/visionandaging/medicare.asp |
| Memorandum of Understanding (MOU) between the FDA Center for Devices and Radiological Health and NIH/NINDS | Other | FDA | NINDS | This MOU provides a mechanism for addressing cross-cutting issues related to the development of devices for neurological disorders, from bench science to clinical studies and FDA approval. http://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/DomesticMOUs/ucm446756.htm |
| Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS | Other | FDA | NINDS | This Memorandum of Understanding (MOU) provides a mechanism for addressing cross-cutting issues related to therapy development for neurological disorders, from bench science to clinical trials and FDA approval and licensure. http://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/DomesticMOUs/ucm114903.htm |
| Memorandum of Understanding Between National Toxicology Program (NTP) and NIH/NIEHS, FDA, and CDC/NIOSH | Other | CDC, FDA | NIEHS | The interagency NTP, established in 1978 and administratively headquartered at NIH/NIEHS, is an ongoing cooperative effort to evaluate substances of public health concern, develop improved methods, strengthen the science base in toxicology, and provide information important for decisions to safeguard public health. This MOU between FDA, NIH/NIEHS, CDC/NIOSH and NTP affirms a commitment to provide resources dedicated toward carrying out NTP’s mission and outlines various administrative and managerial actions the agencies will take to support NTP’s activities. http://ntp.niehs.nih.gov |
| Microbiological Testing of Live Biotherapeutic Products | Resource Development | FDA | NIAID | The research and manufacturing community has a need for regulatory tools to determine the identity, potency, and purity of new probiotic products currently under development. This project will develop tools for identifying these products, therefore satisfying one of the regulatory requirements for product characterization needed by the FDA for evaluation. |
| Microphysiological Systems for Drug Efficacy and Toxicity Testing | Research Initiative | FDA | NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/DPCPSI, OD/DPCPSI/ORWH | The Microphysiological systems initiative aims to develop 3-D human tissue chips that accurately model the structure and function of human organs, such as the lung, liver and heart. Once developed, researchers can use these models to predict whether a candidate drug, vaccine or biologic agent is safe or toxic in humans in a faster and more cost-effective way than current methods. More than 30 percent of promising medications have failed in human clinical trials because they are determined to be toxic despite promising pre-clinical studies in animal models. These organs-on-chips will enable scientists to predict more accurately how effective a therapeutic candidate would be in clinical studies. To help streamline the therapeutic development pipeline, NIH, in collaboration with the Defense Advanced Research Projects Agency (DARPA) and the U.S. Food and Drug Administration (FDA), is leading this initiative to improve the process for predicting whether drugs will be safe in humans. http://www.ncats.nih.gov/research/reengineering/tissue-chip/tissue-chip.html |
| Microsystems Team | Committee, Work group, Advisory group, or Task Force | FDA | NIDDK, NINDS | The NIH has identified a critical need for improved model systems to predict efficacy, safety, bioavailability, and toxicology outcomes for candidate therapeutics. This NIH Funding Opportunity Announcement (FOA), supported by funds from the NIH Common Fund and participating NIH IC''s, invites applications for projects that will develop accurate cellular and organ microsystems representative of human physiology for the evaluation of drug efficacy and toxicity. By definition, these cellular and organ microsystems will have a multicellular architecture representing the characteristics and functions of the tissue of origin and will demonstrate a reproducible and viable operation under physiological conditions over a long culture period. It is anticipated that these bio-engineered human tissue models could lead to the development and commercialization of microsystems that will enable rapid and high fidelity evaluation of safety and efficacy for candidate therapeutics. http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-022.html |
| Mind Your Risks | Public Education Campaign | CDC, CMS | NINDS | The Mind Your Risks campaign is designed to create awareness and action about the fact that risk factors for stroke, particularly hypertension, may be linked to cognitive impairment and dementia. http://www.mindyourrisks.nih.gov/ |
| Minority Health Outreach | Public Education Campaign | AHRQ | NEI | The National Eye Health Education Program (NEHEP) worked with the Office of Minority Health throughout the year to promote eye health awareness. http://www.minorityhealth.hhs.gov/Blog/BlogPost.aspx?BlogID=52 |
| Minority HIV/AIDS Prevention and Treatment Activities | Training Initiative | OS | NICHD | The purpose of this IDDA is to provide support for prevention and treatment activities in the Consolidated and Further Continuing Appropriations Act, 2015 (P.L. 113-235). The goal is to improve retention in care for HIV+ youth through service defragmentation, best practices, and training on motivational interviewing for outreach workers. |
| Models of Infectious Disease Agent Study (MIDAS) (RFA) | Research Initiative | CDC | NIGMS, FIC | Models of Infectious Disease Agent Study (MIDAS) is a collaboration of research and informatics groups to develop computational models of the interactions between infectious agents and their hosts, disease spread, prediction systems and response strategies. The models will be useful to policymakers, public health workers and other researchers who want to better understand and respond to emerging infectious diseases. If a disease outbreak occurs, the MIDAS network may be called upon to develop specific models to aid public officials in their decision-making processes. http://www.nigms.nih.gov/Research/SpecificAreas/MIDAS/Pages/default.aspx |
| mPOWER mHealth Group | Research Initiative | CDC, CMS, FDA, HRSA, IHS | NINR, CIT, FIC, NCCIH, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/DPCPSI/OBSSR | Mobilizing Research supports the development, promotion, and dissemination of a wireless health research recruitment and data platform. In addition to being a primary data collection mechanism, the platform would be a data repository for both basic and applied health science, making validation and standardization of mobile health tools accessible. |
| Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group | Committee, Work group, Advisory group, or Task Force | ACL, CMS, FDA | NIBIB, NCI, NHLBI, NIA, NIAMS, NICHD, NIDCD, NIDCR, NINDS | The Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group (IWG), originally organized under the auspices of the Subcommittee on Biotechnology of the National Science and Technology Council (NSTC), was established in 2000 to provide a forum for federal agencies involved in tissue science and engineering to stay informed of each other’s activities and coordinate research efforts. Its five-year plan was renewed in 2002 and new Terms of Reference were introduced in 2007. The MATES group now works independently of NSTC and is comprised of many participating agencies. The principal purpose of the MATES IWG is to provide a platform across which member agencies can interact and exchange information on tissue engineering efficiently and effectively. It is the means by which Federal agencies involved in tissue engineering stay informed of each other’s activities and coordinate their efforts in a timely and efficient manner. The MATES IWG organized and co-chaired the opening symposium of the 2014 meeting of the Tissue Engineering and Regenerative Medicine International Society (TERMIS), held December 13-16, 2014. MATES members responded to a GAO review of regenerative medicine in FY15 and MATES is mentioned in the report that was released in June 2015. http://www.tissueengineering.gov/ |
| Multinational Influenza Seasonal Mortality Study (MISMS) Research | Research Initiative | OS | FIC, NHLBI, NIAID, NLM | The Multinational Influenza Seasonal Mortality Study (MISMS) was originally initiated to analyze national and global mortality patterns associated with influenza virus circulation. The focus of MISMS has since expanded to evaluate the interaction between the epidemiology, ecology, and evolutionary dynamics of influenza and other rapidly transmissible respiratory viruses, including natural selection, reassortment, migration, and antigenic change. Multinational and bilateral collaborations developed by MISMS collect, analyze, and disseminate research findings through scientific publications, training workshops, and communication tools for investigators and decision-makers. Our research findings inform numerous national governments, multilateral organizations, and research stakeholders on interventions for both pandemic and seasonal influenza. To date, data have been acquired from more than 35 countries (representing ~3.2 billion people), resulting in over 130 publications. http://www.origem.info/misms/index.php |
| Muscular Dystrophy Coordinating Committee (MDCC) | Committee, Work group, Advisory group, or Task Force | ACL, CDC, FDA, HRSA | NINDS, NHLBI, NIAMS, NICHD | This Committee coordinates activities across NIH and with other Federal health programs and activities relevant to the various forms of muscular dystrophy. http://www.ninds.nih.gov/about_ninds/groups/mdcc/ |
| My Family Health Portrait | Resource Development | CDC, HRSA, OSG | NHGRI, NCI, NICHD | My Family Health Portrait is the Web-based tool from NHGRI and the U.S. Surgeon General''s Family History Initiative that helps individuals track their family health history. Using any computer, an Internet connection and an up-to-date Web browser, individuals can provide health information to build a drawing of their family tree and a chart of their family health history. Both the chart and the drawing can be printed and shared with family members and an individual''s doctor. https://familyhistory.hhs.gov/FHH/html/index.html |
| Naloxone Workgroup | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIDA | The goal of this Workgroup is to discuss ways to implement the use of naloxone as emergency treatment for opioid overdose. |
| Nanomaterial Registry | Resource Development | CDC, FDA | NCI, NIBIB, NIEHS | The Nanomaterial Registry is an authoritative, fully curated resource available to the public that archives research data on nanomaterials and their biological and environmental implications. https://www.nanomaterialregistry.org/ |
| Nanotechnology Characterization Laboratory | Research Initiative | FDA | NCI, NIEHS | The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The NCL serves as a national resource and knowledge base for cancer researchers and facilitates the development and translation of nanoscale particles and devices for clinical applications. http://ncl.cancer.gov/ |
| National Action Alliance for Suicide Prevention (NAASP) | Committee, Work group, Advisory group, or Task Force | ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA | NIMH, NIAAA, NIDA, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The National Action Alliance for Suicide Prevention (NAASP) is a public-private partnership for advancing the National Strategy for Suicide Prevention. The mission of the NAASP is to champion suicide prevention as a national priority, to catalyze efforts to implement high priority objectives of the NAASP, and to cultivate the resources needed to sustain progress. The former NIMH Director was an ex officio member of the NAASP Executive Committee and served as Co-Chair of the NAASP Research Task Force. Additional NIMH staff members serve on task forces pertaining to LGBT Youth, Military and Veterans, Youth in Justice Settings, and American Indian/Alaska Natives. In 2014, NIMH staff contributed to and served as guest editors, authors, and co-authors of a journal supplement about suicide. In 2014, the National Action Alliance for Suicide Prevention’s Research Prioritization Task Force (RPTF) released the Nation’s first suicide research agenda: A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives. The Research Agenda includes an overarching goal to advance suicide prevention research more rapidly, seeking ways to reduce suicide deaths and attempts by 20% in five years and by 40% or greater in ten years, if multiple actions, informed by research, were fully implemented. In 2015, the RPTF released the first portfolio analyses of suicide research funding in the U.S. by federal and private funders. http://actionallianceforsuicideprevention.org/ |
| National Advisory Board for Medical Rehabilitation Research | Committee, Work group, Advisory group, or Task Force | CDC, CMS | NICHD, CSR, NCATS, NCI, NHLBI, NIA, NIAMS, NIBIB, NIDCR, NINDS, NINR | The National Advisory Board for Medical Rehabilitation Research (NABMRR) is a Federal Advisory Committee that is composed of researchers, clinicians, and members of the public that advise the Directors of the National Center for Medical Rehabilitation Research, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institutes of Health on issues related to research in medical rehabilitation. The Board includes Ex Officio members from various Federal Departments and Agencies (VA, DoD, NSF, NIDILRR, AHRQ, FDA) to aid in the coordination of Federal programs, activities, projects, and plans for the same with respect to the conduct of research related to rehabilitation of individuals with disabilities. In 2015, the Board provided advice and consultation on: the development of a NIH Rehabilitation Research Plan, the review and marketing of a Medical Rehabilitation Research Infrastructure Network, the structure and funding of training opportunities for rehabilitation scientists, and concept approval for programs planned by the NCMRR. http://www.nichd.nih.gov/about/advisory/nabmrr/pages/index.aspx |
| National Advisory Committee on Children and Disasters | Committee, Work group, Advisory group, or Task Force | OS | NICHD | The National Advisory Committee on Children and Disasters provides expert advice and consultation to the HHS Secretary on comprehensive planning and policies to meet the needs of children before, during, and after a disaster or other public health emergency. |
| National Ambulatory Medical Care Survey (NAMCS) Asthma Supplement - Interagency agreement with CDC/NCHS | Health Survey | AHRQ, CDC | NIEHS, NHLBI, NIAID, NICHD | Developed a survey of a national sample of primary care health providers and specialists likely to see asthma patients to gauge implementation of the NHLBI Guidelines for the Diagnosis and Management of Asthma. http://www.cdc.gov/namcs/ |
| National Amyotrophic Lateral Sclerosis (ALS) Registry | Resource Development | ATSDR, CDC | NINDS | The National ALS Registry is a congressionally mandated registry for persons in the U.S. with ALS. It is the only population-based registry in the U.S. that collects information to help scientists learn more about who gets ALS and its causes. http://wwwn.cdc.gov/als/ |
| National Asthma Control Initiative (NACI)/National Asthma Education and Prevention Program (NAEPP) | Public Education Campaign | CDC, FDA | NHLBI, NIAID, NIEHS | The National Asthma Control Initiative (NACI) is a national effort to facilitate implementation of the National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. The NAEPP, which was initiated in 1989, seeks to enhance the quality of life for patients with asthma and decrease asthma-related morbidity and mortality by improving asthma awareness, diagnosis, and treatment. http://www.nhlbi.nih.gov/health/prof/lung/asthma/naci/ |
| National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA) | Committee, Work group, Advisory group, or Task Force | AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS | NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR | The Federal Liaison Group on Asthma is a subcommittee of the National Asthma Education and Prevention Program that is charged with addressing ways to strengthen and improve the coordination of asthma-related activities across agencies of the Federal Government. The group provides a forum for federal agencies with major interest in asthma to exchange ideas and explore collaborative activities. |
| National Blood Disorders Program | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, OS | NHLBI, NIMHD | The National Heart, Lung, and Blood Institute (NHLBI) established the National Blood Disorders Program in accordance with the Institute’s strategic plan of moving scientific discovery from causes to cures. The program’s purpose is to coordinate a national effort to improve the management of hematological disorders focused on the implementation of evidence-based clinical practice guidelines to prevent, detect, and treat, complications. |
| National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs) | Committee, Work group, Advisory group, or Task Force | FDA | NCI | Scientific Steering Committees (SSCs) are composed of leading cancer experts and advocates from outside the Institute as well as NCI senior investigators who meet regularly to: (1) increase the transparency and openness of the trial design and prioritization process; (2) enhance patient advocate and community oncologist involvement in clinical trial design and prioritization; (3) convene Clinical Trial Planning Meetings to identify critical questions, unmet needs, and prioritize key strategies. http://www.cancer.gov/about-nci/organization/ccct/steering-committees |
| National Coalition for Oversite of Assisted Reproductive Technologies (NCOART) | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NICHD | The National Coalition for Oversight of Assisted Reproductive Technologies (NCOART) has become a successful forum for discussion of issues by organizations involved in the assisted reproductive technologies (ART) in the United States. |
| National Collaborative on Childhood Obesity Research (NCCOR) | Committee, Work group, Advisory group, or Task Force | CDC | NICHD, NCI, NHLBI, NIDDK, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The National Collaborative on Childhood Obesity Research (NCCOR) brings together four of the nation’s leading research funders – the Centers for Disease Control and Prevention, the National Institutes of Health, the Robert Wood Johnson Foundation, and the U. S. Department of Agriculture – to address the problem of childhood obesity in America. NCCOR focuses on efforts that have the potential to benefit children, teens, their families, and the communities in which they live. A special emphasis is put on the populations and communities in which obesity rates are highest and rising the fastest. NCCOR''''s goals are to identify intervention needs, improve child obesity surveillance, improve research and evaluation methodologies, and provide national leadership to implement evidence-based practice and policy. NCCOR also works with many non-health partners to develop sustainable environmental design and food systems strategies to reach high risk populations and communities. http://www.nccor.org/ |
| National Coordinated Child Safety Initiative Steering Committee | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA | NICHD | The Child Safety Network is supported by the National Coordinated Child Safety Initiative Steering Committee which will work to create new synergy among public and private stakeholders and to support the activities of the Child Safety Collaborative Innovation and Improvement Network (CoIIN) strategy teams. The Steering Committee will provide advice to the Child Safety CoIIN and help to communicate the lessons and accomplishments of the Child Safety CoIIN to a broad national audience that will include public health professionals, policymakers, funders, and families. http://www.childrenssafetynetwork.org/coiin/expert-support-national-coordinated-child-safety-initative-steering-committee |
| National Council on Youth Sports Safety | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The National Council on Youth Sports Safety (NCYSS), Inc. is a 501(c)(3) that executes its work through a multidisciplinary panel of national experts on various subject matter including medicine, public health, public policy, youth and professional sports, and technology and equipment manufacturing. http://www.youthsportssafety.org/ |
| National Diabetes Education Program (NDEP) | Public Education Campaign | CDC | NIDDK | Established in 1997, the National Diabetes Education Program (NDEP) is a federally-funded program sponsored by NIH and CDC and includes more than 200 partners at the federal, state and local levels that work together to improve the treatment and outcomes for people with diabetes, promote early diagnosis, and prevent or delay the onset of type 2 diabetes. http://www.ndep.nih.gov |
| National Drug Facts Chat Day | Public Education Campaign | CMS | NIDA, NIAAA, NIMH | The National Institute on Drug Abuse (NIDA) and several partner U.S. Department of Health and Human Services agencies and National Institutes of Health Institutes "Chat" in real time with high school students across the country. The students ask questions (anonymously) on drugs and get research-based responses directly from NIDA and other government scientists. http://drugfactsweek.drugabuse.gov/chat/ |
| National Food and Nutrient Analysis Program (NFNAP) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, IHS | NCI, NEI, NHLBI, NIA, NICHD, NIDDK, OD/DPCPSI/ODP, OD/DPCPSI/ORWH | The generation of original analytical data for foods at the U.S. Department of Agriculture (USDA) is conducted through the National Food and Nutrient Analysis Program (NFNAP) in collaboration with multiple groups including the Department of Health and Human Services (HHS) and other federal agencies. NFNAP includes statistically based sampling plans for Key Foods, and analysis of foods by qualified laboratories. The five Specific Aims of the NFNAP are to: 1) establish a monitoring program for Key Foods and critical nutrients. Key Foods are frequently consumed foods and ingredients, which contributed, collectively, more than 75% of the intake of any specific nutrient for the U.S. population; 2) conduct comprehensive analyses of selected Key Foods; 3) develop databases for high priority foods consumed by U.S. ethnic subpopulations; 4) develop databases for new bioactive components; and 5) develop a validated database for ingredients in dietary supplements. Analytical data generated through the NFNAP are compiled and released in annual updates of the USDA National Nutrient Database for Standard Reference (SR). They are also used to calculate estimates for related foods not analyzed, to assess nutrient variability, and to evaluate methods for estimating the nutrient content of multi-ingredient foods. These values will be used by the Food Surveys Research Group (FSRG), Agricultural Research Service (ARS) to develop the Food and Nutrient Dataset for Dietary Surveys used in the “What We Eat in America” (WWEIA) component of NHANES. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/FactSheets/NDL_FactSheet_NFNAP.pdf |
| National Forum for Heart Disease and Stroke Prevention | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NHGRI, NINDS | The Forum was founded to implement a public health action plan to prevent heart disease and stroke. |
| National Glycohemoglobin Standardization Program (NGSP) | Public Education Campaign | CDC | NIDDK | The purpose of the NGSP (originally the National Glycohemoglobin Standardization Program) is to standardize Hemoglobin A1c test results to those of the Diabetes Control and Complications Trial (DCCT) and United Kingdom Prospective Diabetes Study (UKPDS) which established the direct relationships between HbA1c levels and outcome risks in patients with diabetes. http://www.ngsp.org/ |
| National Health and Aging Trends Study (NHATS) | Health Survey | CMS, OS | NIA | The National Health and Aging Trends Study (NHATS) will examine how the daily lives of older adults change as they age. This research will help scientists understand the social and economic consequences of late-life disability for individuals, families, and society. http://www.nhats.org/ |
| National Health and Nutrition Examination Survey (NHANES) | Health Survey | CDC, FDA, OS | OD/DPCPSI/ODP, NCI, NHLBI, NIA, NIDDK | A program of studies designed to assess the health and nutritional status of adults and children in the United States. The survey is unique in that it combines interviews and physical examinations. http://www.cdc.gov/nchs/nhanes.htm |
| National Health and Nutrition Examination Survey (NHANES) - Audiometric Exams and Hearing-Related Questions | Health Survey | CDC | NIDCD | To provide support to the National Center for Health Statistics (NCHS), CDC for audiometry testing and related questions on hearing loss and noise exposure in adults ages 20 to 69 years in the National Health and Nutrition Examination Survey (NHANES) for data collection years 2015–2016. The study collects pure-tone, air conduction hearing thresholds at .5, 1, 2, 3, 4, 6, and 8 kHz in each ear separately, as well as otoscopic exams, tympanometry, and acoustic reflexes on representative samples of the non-institutionalized U.S. population in sound-treated booths meeting recommended ANSI standards. Questionnaire information about tinnitus (frequency and degree of burden), use of hearing aids and other assistive devices, as well as exposure to firearms or other sources of loud noise are collected in home interviews prior to the subjects’ visit to the mobile exam centers (MECs) for audiometric exams. A similar hearing component was part of earlier NHANES, 1999–2004, and NHANES 2011–2012 conducted on a representative samples of U.S. adults, ages 20 to 69 years. One of the Healthy People 2010 goals is to assess (with the goal of reducing) noise-induced hearing loss in adults. For this purpose, audiograms are examined and “notches” identified in the higher frequency ranges at 3, 4, or 6 kHz as a surrogate marker of noise exposure. Computer algorithms to identify the notches have been developed. The NHANES, 1999–2004, data serve as a baseline, but to assess progress on this goal in Healthy People 2020, hearing thresholds of U.S. adults must be measured again in NHANES. NCHS directs the data collection contractor (i.e., WESTAT) in establishing and revising protocols for the hearing component and in preparing training and field manuals. NCHS provides NIDCD with an opportunity to collaboratively review summary data for purposes of quality control during the data collection period and, also, provides NIDCD with a data file for quality review approximately three months before the Public Use data release. http://www.cdc.gov/nchs/nhanes.htm |
| National Health and Nutrition Examination Survey (NHANES) - Physical Activity and Muscle Strength Components | Research Initiative | CDC | NCI, NHLBI, NIA, NIDDK, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH | For the National Health and Nutrition Examination Survey (NHANES) 2011-14, the National Cancer Institute proposed and coordinated funding from multiple NIH Institutes and the Department of Defense for two components: a new technology physical activity monitor to be worn on the wrist and a measurement of muscle strength using a hand-grip dynamometer. The wrist-worn accelerometer will provide the first objective measurement of sleep duration in a nationally representative sample, in addition to measuring physical activity movement. The muscle-strength measure will provide an indicator of total body strength for children, adults, and older adults who are NHANES participants. http://riskfactor.cancer.gov/studies/nhanes/ |
| National Health and Nutrition Examination Survey (NHANES) Cardiovascular Component | Health Survey | CDC | NHLBI, NCI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK | The purpose of this collaboration is to inform the National Institutes of Health (NIH) and the Nation on the status of key measures of cardiovascular, pulmonary, and sleep health, such as blood pressure, serum lipid levels, risk factors for disease, airway flow limitation, reports of efforts to control weight, and reports of sleep disturbances, and disease prevalence in the US civilian population. NIH identifies key cost-effective basic measures for these conditions and behaviors, relevant to its mission and amenable to being utilized in a mobile hospital setting. NIH staff work with National Center for Health Statistics (NCHS) staff to implement the most cost-effective of the measures, to monitor and help manage the survey in progress, and to evaluate and publish the resulting data. http://www.cdc.gov/nchs/nhanes/about_nhanes.htm |
| National Health and Nutrition Examination Survey (NHANES) Oral Health Component | Health Survey | CDC | NIDCR | The periodic oral health component of the National Health and Nutrition Examination Survey (NHANES); included enamel fluorosis imaging study for inclusion in future NHANES. http://www.cdc.gov/nchs/nhanes.htm |
| National Health and Nutrition Examination Survey 2005-2006, Allergy Component, Interagency Agreement with CDC/NCHS | Health Survey | CDC | NIEHS, NIAID | This collaborative project developed and implemented an allergy/asthma focused component for the National Health and Nutrition Examination Survey (NHANES). The allergy component, included in NHANES 2005-2006, enabled a more robust and generalizable investigation of the role of allergen/endotoxin exposures and IgE-mediated sensitization in allergic diseases than previously possible, increasing the knowledge of complex relationships between allergen and endotoxin exposures, allergic sensitization and allergic diseases, including asthma. This survey component queried on allergy and asthma prevalence and symptoms, measured levels of common indoor allergens and endotoxin in household dust, and quantified total and 19 allergen-specific immunoglobulin E levels in serum of study participants. |
| National Health and Nutritional Examinations Surveys Interest Group | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The National Health and Nutrition Examination Survey (NHANES) is a program of studies designed to assess the health and nutritional status of adults and children in the United States. The survey is unique in that it combines interviews and physical examinations. |
| National Health Interview Survey (NHIS) | Health Survey | CDC | NCI, NCCIH, NIDDK | The National Health Interview Survey (NHIS) - started in 1957 - is a continuous, nationwide in-person survey of approximately 35,000 households, or about 87,500 persons, in the civilian non-institutionalized population. The NHIS over samples African-American and Hispanic respondents. NCI periodically sponsors a Cancer Control Supplement (CCS) which is administered to a randomly selected sample of 39,000 adults. http://www.cdc.gov/nchs/nhis.htm |
| National Health Interview Survey (NHIS): 2013 Respiratory/Asthma Questions | Health Survey | CDC | NHLBI | The purpose of the collaborative activity is support development and implementation by the National Health Interview Survey (NHIS) of measures that could be used to assess progress towards achieving Healthy People 2020 respiratory/asthma objectives. The National Heart, Lung and Blood Institute and the National Center for Health Statistics collaborate on this activity. http://www.cdc.gov/nchs/nhis.htm |
| National Hispanic Science Network (NHSN) | Meeting/ Workshop | AHRQ, CDC, SAMHSA | NIDA, NIAAA, NIMH | The National Hispanic Science Network is dedicated to improving the health equity of Hispanics. It has broad representation from academic and government agencies, including several National Institutes of Health Institutes and Centers, the Centers for Disease Control and Prevention, the Substance Abuse and Health Services Administration, and the Agency for Healthcare Research and Quality. http://nhsn.med.miami.edu/ |
| National Institute on Deafness and Other Communication Disorders (NIDCD) Directory of Organizations | Resource Development | AHRQ, CDC, CMS | NIDCD | The National Institute on Deafness and Other Communication Disorders (NIDCD) Directory of Organizations is designed to encourage networking among individuals and organizations with an interest in the diseases and disorders of human communication. The directory is maintained in an online database accessible to the public from the NIDCD website. The NIDCD pays to maintain the directory, however several U.S. Department of Health and Human Services agencies are featured in it. http://www.nidcd.nih.gov/directory/ |
| National Interagency Confederation for Biological Research | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NCI, NIAID | The mission of the National Interagency Confederation for Biological Research is to develop unique knowledge, tools, and products by leveraging advanced technologies and innovative discoveries to secure and defend the health of the American people. http://www.nicbr.mil/ |
| National Kidney Disease Education Program (NKDEP) | Public Education Campaign | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS | NIDDK, NHLBI | The National Kidney Disease Education Program (NKDEP) is an initiative of the National Institutes of Health, designed to reduce the morbidity and mortality caused by kidney disease and its complications. NKDEP aims to improve early detection of chronic kidney disease (CKD), facilitate identification of patients at greatest risk for progression to kidney failure, promote evidence-based interventions to slow progression of CKD, and support the coordination of Federal responses to CKD. http://www.nkdep.nih.gov |
| National Longitudinal Mortality Study | Health Survey | CDC | NIA, NCI, NHLBI | A national, longitudinal, mortality study to study the effects of differentials in demographic and socio-economic characteristics on mortality. http://www.census.gov/did/www/nlms/ |
| National Mental Health Study Field Test | Other | SAMHSA | NIMH | NIMH is collaborating with the Substance Abuse and Mental Health Services Administration (SAMHSA) to develop a cross-sectional national mental health study designed to (1) estimate the prevalence of a number of specific mental disorders, (2) investigate disorder correlates and patterns of care, and (3) provide a platform for follow-up studies on subgroups of interest. The initial, currently funded, project will execute the steps necessary to build the instrument, obtain Office of Management and Budget clearance, and field test all procedures prior to launching the main study. |
| National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NCI, NIBIB | Interagency effort to coordinate and stimulate creation of the knowledge, tools, and methods necessary to develop and test nanosensors and to track the fate of engineered nanomaterials in the body, consumer products, the workplace, and the environment. http://www.nano.gov/SensorsNSIPortal |
| National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology Knowledge Infrastructure: Enabling National Leadership in Sustainable Design | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NCI, NIBIB | Interagency effort to provide a community-based, solutions-oriented knowledge infrastructure to accelerate nanotechnology discovery and innovation. http://www.nano.gov/NKIPortal |
| National Research Action Plan (NRAP) | Research Initiative | CDC | NIDA, NIAAA, NIMH, NINDS | This Executive Order directed the Department of Defense, Veterans Affairs, Health and Human Services, and Department of Education to develop a National Research Action Plan on post-traumatic stress disorder, other mental health conditions, and traumatic brain injury to improve the coordination of agency research into these conditions and reduce the number of affected men and women through better prevention, diagnosis, and treatment. http://www.whitehouse.gov/sites/default/files/uploads/nrap_for_eo_on_mental_health_august_2013.pdf |
| National Robotics Initiative | Research Initiative | FDA | NIBIB, NEI, NIA, NICHD, NIDCD, NINDS, NINR, OD/DPCPSI/OBSSR | The Office of Science and Technology Policy (OSTP) created a "National Robotics Initiative" to promote research in a variety of robot-related topics. The National Institutes of Health (NIH) joined as a major civilian aspect of this coordinated interagency plan which incorporates the following funding agencies: NIH, National Science Foundation (NSF), National Aeronautics and Space Agency (NASA), U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA). An MOU was issued for the period FY 2012-2016. A meeting of Principal Investigators was held in November 2015. http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503641&org=CISE |
| National Science Advisory Board for Biosecurity | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/OSP, NIAID | NSABB is a Federal Advisory Committee established in 2004 to provide advice to the USG and leadership on biosecurity and issues related to dual use research. The NSABB is an influential committee and its reports and recommendations have shaped policy development. The NSABB also undertakes domestic and international outreach and education efforts to raise awareness of issues related to biosecurity. Currently the NSABB is part of a White House-initiated deliberative process to evaluate the risks and benefits associated with certain studies that could generate pathogens with pandemic potential. http://osp.od.nih.gov/office-biotechnology-activities/biosecurity/nsabb |
| National Security Staff Combatting Antibiotic-Resistant Bacteria sub-Interagency Policy Committee (NSS CARB sub-IPC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID, NLM | Development of National Strategic Plan for combating antibiotic resistant bacteria. |
| National Security Staff Dual Use Research of Concern Interagency Policy Committee (NSS DURC IPC) | Committee, Work group, Advisory group, or Task Force | CDC, OS | OD/OSP, NIAID | Develops policy options for U.S. government oversight of dual use research of concern (DURC). |
| National Security Staff Dual Use Research of Concern Sub-Interagency Policy Committee (NSS DURC Sub-IPC) | Committee, Work group, Advisory group, or Task Force | CDC, OS | OD/OSP, NIAID | Develops policy options for U.S. government oversight of dual use research of concern (DURC). |
| National Survey of Family Growth | Health Survey | ACF, CDC | NICHD | The purpose of this IAA is to provide funds to the NCHS to continue support of the National Survey of Family Growth. The NICHD contribution will supplement the collection of data on contraceptive practices, fertility, and background factors among women and men 15-44 years of age. This will support continuous interviewing for a cumulative data file. The National Survey of Family Growth (NSFG) gathers information on family life, marriage and divorce, pregnancy, infertility, use of contraception, and men’s and women’s health. The survey results are used by the U.S. Department of Health and Human Services and others to plan health services and education programs, and to do statistical studies of families, fertility, and health. http://www.cdc.gov/nchs/nsfg.htm |
| National Toxicology Program (NTP) Executive Committee | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, FDA | NIEHS, NCI | The National Toxicology Program (NTP) was established as a department-wide effort within the Public Health Service (PHS) on November 15, 1978. The program is comprised of the relevant PHS activities within the U.S. Food and Drug Administration, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention, and the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health. The NIEHS Director serves as NTP Director and reports to the Assistant Secretary for Health. The NTP Executive Committee reviews progress on NTP activities directed toward carrying out its mission. http://ntp.niehs.nih.gov/about/org/ec/index.html |
| National Toxicology Program (NTP) Literature-Based Evaluations of Shift work at Night, Light at Night and Circadian Disruption | Committee, Work group, Advisory group, or Task Force | CDC | NIEHS, NHLBI | Evaluation team was organized to provide scientific input on NTP (Office of Health Translation and Assessment and the Office of the Report on Carcinogens) literature-based evaluations of cancer and non-cancer effects of Shift work at Night, Light at Night and Circadian Disruption. Conferences calls with external scientific experts were convened in 2014 and 2015, and a workshop is planned for 2016. http://ntp.niehs.nih.gov/go/41532 |
| Native American Research Center for Health (NARCH) | Research Initiative | AHRQ, HRSA, IHS, OS | NIDA, CSR, NCI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, OD/DPCPSI/OBSSR | Native American Research Center for Health is a grant program that provides funds to enhance research, research infrastructure and training among American Indian and Alaska native programs and academic partners. This National Institutes of Health-wide program supports partnerships between American Indian (AI), Alaska Native (AN), or Tribally-based organizations and institutions that conduct intensive academic-level biomedical, behavioral and health services research in an effort to build a research infrastructure of core components for capacity building and to reduce health disparities in AI/AN communities. This funding mechanism develops opportunities for conducting research, research training and faculty development to meet the needs of American Indian/Alaska Native (AI/AN) communities. As a developmental process, Tribes and Tribal organizations are able to build a research infrastructure, including a core component for capacity building and the possibility of reducing the many health disparities so prevalent in AI/AN communities. http://www.ihs.gov/Research/index.cfm?module=narch |
| Natural Experiments and Effectiveness Studies in the Prevention and Control of Diabetes | Research Initiative | CDC | NIDDK | This project will focus on population-targeted interventions that health systems, communities, and governments can undertake to reduce the incidence of diabetes and its complications. This project will also strengthen the capacity of CDC and NIDDK to conduct vital health services and health policy research related to diabetes prevention and care. |
| Natural History of Oral HPV Infection in the U.S. Population | Research Initiative | CDC | NCI | This collaboration is aimed at investigating the epidemiology of oral HPV infection within the NHANES. During 2015, NCI and CDC/NCHS investigators conducted a pilot study to evaluate the feasibility of conducting a natural history study of oral HPV infection within NHANES. |
| NCI Clinical Trials and Translational Research Advisory Committee (CTAC) | Committee, Work group, Advisory group, or Task Force | CMS, FDA | NCI | The Clinical Trials and Translational Research Advisory Committee makes recommendations on the National Cancer Institute-supported national clinical trials enterprise to build a strong scientific infrastructure by bringing together a broadly developed and engaged coalition of stakeholders involved in the clinical trial process. http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm |
| NCI National Cancer Informatics Program (NCIP) Nanotechnology Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NCI, NHLBI, NIBIB, NIEHS | The National Cancer Institute National Cancer Informatics Program (NCIP) Nanotechnology Working Group (NCIP Nano WG) was established in 2008 for researchers with a specific interest in informatics and computational approaches to nanotechnology, with a particular emphasis on nanomedicine. The goal of this Working Group is to demonstrate the scientific potential of federating nanotechnology databases through pilot projects aimed at integrated semantic search and retrieval of nanomedicine and nanotoxicology datasets that are applicable across nanoscience. The NCIP Nano WG comprises over 20 active participants from academia, government and industry with diverse interests. https://nciphub.org/groups/nanowg |
| NCI/CDC Cooperative Agreements for Cancer Control Activities in Low and Middle Income Countries | Other | CDC | NCI | NCI is partnering with CDC in Kenya and Indonesia to fund cancer control activities through the CDC cooperative agreement, via an interagency agreement between NCI/CGH and CDC. The activities that will take place under this agreement include cancer registry strengthening and related cancer control activities. |
| NCI/FDA Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD) | Resource Development | FDA | NCI | An agreement has been reached by the U.S. Food and Drug Administration and the National Cancer Institute to manage and share information about clinical investigators using the Federal Investigator Registry of Biomedical Information Research Data, or FIREBIRD, system. Drug makers are encouraged to also submit information about investigators electronically to the new registry. FIREBIRD is the first module of an expected suite of software programs that will comprise a system called the Clinical Research Information Exchange (CRIX). CRIX is intended to support the biomedical and biopharmaceutical research community by streamlining the document and data exchange process. The resulting reduction of paperwork is expected to increase the efficiency and lower the cost of conducting clinical trials. https://cabig.nci.nih.gov/tools/FIREBIRD |
| NCI/FDA Memorandum of Understanding for Drug Related Information | Resource Development | FDA | NCI | The National Cancer Institute (NCI) Enterprise Vocabulary Services is working with the U.S. Food and Drug Administration (FDA) to develop and support controlled terminology in several areas. More than 10,000 FDA terms and codes are stored in the NCI Thesaurus. http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/fda |
| NCI/FDA Memorandum of Understanding for Proteomics | Research Initiative | FDA | NCI | This Memorandum of Understanding (MOU), signed in 2007 and renewed in 2012, establishes an official relationship in clinical proteomic regulatory science between the NCI (Office of Cancer Clinical Proteomics Research) and the FDA. Active areas of research collaboration include sample collection, preparation, storage and processing; bioinformatics and data analysis; discovery and validation of biomarkers; and surrogate biomarkers of cancer development and drug response, including standardization among technology platforms and assay standards development. http://proteomics.cancer.gov/aboutoccpr/partners/fedinternational |
| NEI/FDA Symposium – Ocular Inflammatory Diseases | Meeting/ Workshop | FDA | NEI | Meeting with FDA to develop outcome variables for use in clinical trials of drugs in ocular inflammatory diseases. |
| NEI/FDA Symposium: NEI-FDA Diabetic Retinopathy Clinical Trial Endpoints Symposium | Meeting/ Workshop | FDA | NEI | Meeting with FDA to develop outcome variables and study designs for use in clinical trials of treatments for diabetic retinopathy. |
| Nested Case-Controlled Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners | Research Initiative | CDC | NCI | A retrospective cohort mortality and nested case-control study of about 12,315 non-metal miners (278,041 person-years) to investigate risk of lung cancer in relation to quantitative measures of exposure to diesel exhaust. |
| Neural Interfaces Conference | Meeting/ Workshop | FDA | NIBIB, CSR, NEI, NIA, NICHD, NIDCD, NINDS | The Neural Interfaces research community consists of investigators, supported by grants or contracts, who are working in areas that include functional neuromuscular/electrical stimulation, auditory prosthesis, cortical prosthesis, neuromodulation, microelectrode array technology, brain computer/machine interfaces and other related areas. Conferences were held in 2010 and 2012 and most recently in June 2014. The next planned conference is scheduled to be held in June 2016. http://www.neuralinterfacesconference.com/index.htm |
| Newborn Screening Coding and Terminology Guide | Resource Development | CDC, HRSA, OS | NLM, NHGRI, NHLBI, NICHD | This ongoing collaboration develops, supplements and publicizes a free online resource with guidance to help promote efficient electronic exchange of standardized newborn screening data. Related efforts include studying the screening process for diseases including severe combined immunodeficiency (SCID), lysosomal storage disorders (LSDs), and critical congenital heart disease (CCHD), and developing standard codes for ordering and reporting the results of newborn screening for SCID, CCHD, and other conditions added to the Uniform Recommended Screening Panel by the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. http://newbornscreeningcodes.nlm.nih.gov/ |
| Newborn Screening Federal Partners Committee | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD, NHLBI, NLM | The National Institutes of Health, Health Resources and Services Administration, Centers for Disease Control and Prevention (CDC), the American College of Medical Genetics and the Genetic Alliance meet monthly, in person or online, to discuss and coordinate current activities and initiatives in newborn screening. Topics include the activities of the Newborn Screening Translational Research Network Coordinating Center, the Clearinghouse of Newborn Screening Information, Sickle Cell Screening Programs, the CDC Newborn Screening Quality Assurance Program, and the Regional Newborn Screening Collaboratives. |
| Newborn Screening Pompe Pilot Study | Research Initiative | CDC, FDA, HRSA | NICHD | The purpose of this research initiative is establishing a resource to be used to support the development and rapid data collection of Pompe Disease to be added to the Recommended Uniform Screening Panel (RUSP) and to pilot the development and rapid data collection of a Pompe Disease newborn screening assay. This project supports the development of a Pompe Disease screening method in the newborn screening environment by establishing a pool of high throughput newborn screening laboratories (state and private) with the capacity to screen a large number of newborns in relatively short periods of time (12-18 months). These groups address follow-up and educational needs stemming from pilot studies for the newborn screening system. |
| Newborn Screening Quality Improvement Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NICHD | This committee seeks to improve the quality of newborn screening. |
| Newborn Screening Technical Assistance and Evaluation Program (NewSTEPs) Steering Committee | Committee, Work group, Advisory group, or Task Force | HRSA | NICHD | Steering committee for the Newborn Screening Technical Assistance and Evaluation Program (NEWSteps). NEWSteps is a cooperative agreement related to newborn screening that the Health Resources and Services Administration funds. |
| NEWSteps Steering Committee | Committee, Work group, Advisory group, or Task Force | HRSA | NICHD | This steering committee supports the mission of NEWSteps which is to achieve the highest quality for newborn screening systems by providing relevant, accurate tools and resources and to facilitate collaboration between state programs and other newborn screening partners. |
| NEXT Generation Health study | Research Initiative | HRSA | NICHD | NEXT is a 7-year longitudinal assessment of a representative sample of U.S. adolescent and young adults, starting when they are in the 10th grade. The goals of the NEXT longitudinal study include: to identify the trajectory of adolescent health status and health behaviors from mid-adolescence through the post high school years; to examine individual predictors of the onset of key adolescent risk behaviors and risk indicators during this period; to identify genetic, personal, family, school, and social/environmental factors that provide or sustain positive health behaviors; to identify transition points in health risk and risk behaviors and changes in family, school, and social/environmental precursors to these transitions, and to examine the role of potential gene-environment interactions in the development of health status and health behaviors. nhttps://www.nichd.nih.gov/about/org/diphr/hbb/research/pages/next.aspx |
| NHLBI Federal COPD Workshop | Committee, Work group, Advisory group, or Task Force | ACL, CDC, CMS, FDA, HRSA, IHS | NHLBI, NCCIH | The Senate Appropriations Committee in FY2012 encouraged the National Heart, Lung and Blood Institute (NHLBI) "to work with community stake-holders and other Federal Agencies, including CDC, to develop a national action plan to respond to the growing burden of this disease." In response to this congressional encouragement, NHLBI hosted in Bethesda, Maryland, on May 3, 2013, a forum of representatives from Federal Agencies and Institutes to share information about current activities related to Chronic Obstructive Pulmonary Disease (COPD) and discuss opportunities for further cooperation and enhanced effectiveness of the Federal response to this serious public health problem. http://www.nhlbi.nih.gov/meetings/workshops/COPD-workshop.htm |
| NIAID Universal Influenza Vaccine Working Group | Committee, Work group, Advisory group, or Task Force | CDC, OS | NIAID | HHS Working group established to facilitate the development of universal influenza vaccines and move them toward clinical trials. |
| NIAID-CDC Joint U.S. Partnership Implementing TB Elimination Research (JUPITER) | Committee, Work group, Advisory group, or Task Force | CDC | NIAID | Through weekly teleconferences, the Joint U.S. Partnership Implementing TB Elimination Research (JUPITER) facilitates cooperation, communication, and collaboration on tuberculosis between the National Institute of Allergy and Infectious Diseases (NIAID) and the Centers for Disease Control and Prevention (CDC). This approach helps ensure that Federal activities are coordinated and not duplicated, and stimulates collaborations where appropriate. |
| NIAID/CDC Dual Use Research of Concern (DURC) Risk Mitigation Reviews | Other | CDC | NIAID | The Centers for Disease Control and Prevention (CDC) Division of Select Agents and Toxins Division will provide technical assistance in evaluating the sufficiency of the biosecurity and/or biosafety measures incorporated into risk mitigation plans received from institutions, and cross-check risk mitigation plans and research conducted using select agents and toxins against information in the Federal Select Agent Program (FSAP) database. |
| NIAID/CDC Select Agents Laboratory Inspections | Other | CDC | NIAID | The Centers for Disease Control and Prevention (CDC) Division of Select Agents and Toxins laboratory inspectors visit foreign National Institute of Allergy and Infectious Diseases (NIAID) grantees on behalf of NIAID to ensure that foreign select agents laboratories follow safety, security, and training standards comparable to those for U.S. institutions. |
| NICHD Data Archiving and Specimen Hub (DASH) committee | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NICHD | The NICHD Director will consult the NICHD DASH Committee composed of NICHD staff with the appropriate policy knowledge. The Committee will provide oversight over the management and performance of NICHD DASH. Specialized sub-committees related to data submission, data access (such as the Data Access Committee), and quality control will report to the DASH Committee. In order to maintain policies consistent with evolving technological and ethical considerations, the NICHD Director will solicit, on an as needed basis, recommendations on the NICHD DASH Policy Statement from external experts representing public and scientific stakeholders through the NICHD Council. The NICHD DASH Committee will establish and maintain operating policies and procedures for NICHD DASH to address issues including, but not limited to: • Privacy and confidentiality of research participants, • Interests of individuals and groups, • Data submission procedures, • Data access and use procedures, and • Data security mechanisms based on the content and level of risk. |
| NICHD-Maternal and Child Health (MCH) Electronic Health Record (EHR) | Research Initiative | HRSA | NICHD | NICHD paid money in 2012-13-14 on this Interdepartmental Delegation Authority (IDDA) that provided funds for the Maternal and Child Health (MCH) Electronic Health Record (EHR) Pediatric Practice Based Research Network (PBRN) Initiative. Although NICHD did not provide funding for this research initiative in 2015 the money paid on the first 3 years was to be used over the entire 5 year period. In 2015 the publication "Comparative Effectiveness Research Through a Collaborative Electronic Reporting Consortium" as epublished. |
| Nicotine Research Cigarettes (SPECTRUM) | Committee, Work group, Advisory group, or Task Force | FDA | NIDA | This partnership with the Food and Drug Administration (FDA) is for the production of produce research cigarettes. |
| NIEHS Patterns of Co-Exposure in Danish Women of Reproductive Age | Research Initiative | CDC | NIEHS | This study characterizes exposure to National Health and Nutrition Examination Survey (NHANES) chemicals in a set of 50 Danish women participating in a time to pregnancy study that will also include follow-up of offspring. |
| NIH Biomarkers Consortium | Research Initiative | CMS, FDA | NIMH, NCCIH, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NINDS | The Biomarkers Consortium develops, validates, and qualifies biological markers (biomarkers) to speed the development of medicines and therapies for detection, prevention, diagnosis, and treatment of disease and to improve patient care. The NIH Public Private Partnership Program coordinates NIH participation in the sponsored Biomarkers Foundation for the National Institutes of Health (FNIH) consortium. The consortium is an umbrella which encompasses research projects, ongoing working groups, as well as occasional workshops and conferences. http://biomarkersconsortium.org |
| NIH Gabriella Miller Kids First Common Fund Working Group | Committee, Work group, Advisory group, or Task Force | CDC | NICHD, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NIDA, NIDCR, NIDDK, NIEHS, NINDS, OD/DPCPSI/ORIP, OD/DPCPSI/OSC | The NIH Gabriella Miller Kids First Common Fund Working Group supports the goals and initiatives of the NIH Gabriella Miller First Common Fund Pediatric Research Program. In fiscal year 2015, in accordance with the Gabriella Miller Kids First Research Act, Congress appropriated $12.6 million to the NIH Common Fund to support pediatric research. The Common Fund’s Gabriella Miller Kids First Pediatric Research program (Kids First) is planning to develop a data resource for the pediatric research community of well-curated clinical and genetic sequence data that will allow scientists to identify genetic pathways that underlie specific pediatric conditions but that may also be shared between apparently disparate conditions. In order to make a significant impact within the available fiscal year 2015 budget, the program will collect data from the following types of pediatric conditions: •Childhood cancers – Either those that have a suspected genetic component, or, as a jump start for the Precision Medicine Initiative which NIH expects to launch in fiscal year 2016, the program will also collect data from childhood sarcomas that have failed to respond to treatment. •Structural birth defects - related to a problem with body parts and structure and include conditions like cleft lip, misshaped heart valves, abnormal limbs, problems related to the growth and development of the brain and spinal cord. The integrated data resource will allow researchers to explore whether shared genetic pathways may contribute to both cancer and structural birth defects. |
| NIH Guide for Grants and Contracts | Resource Development | AHRQ, CDC, FDA | OD/OER, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI | The National Institutes of Health (NIH) Guide for Grants and Contracts is the official publication for NIH medical and behavioral grant policies, guidelines, and funding opportunities, and is used by other U. S. Department of Health and Human Services (HHS) agencies to disseminate Funding Opportunity Announcements (FOAs) to its 50,000 subscribers. http://grants.nih.gov/grants/guide/index.html |
| NIH Recombinant DNA Advisory Committee (RAC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NCI, NHGRI, NIAID, NINDS | The Recombinant DNA Advisory Committee (RAC) advises the National Institutes of Health on the safe and ethical conduct of basic and clinical research involving recombinant DNA. It reviews protocols and provides recommendations for each protocol to enhance the scientific and ethical design. The RAC also discusses safety data and other emerging issues for the field of gene therapy. This year the RAC hosted a meeting to develop biosafety guidelines for gain-of-function research with H5N1 which led to the amendment of the NIH Guidelines for Research with Synthetic and Recombinant Research. The RAC also hosted a meeting of mid-level investigators to examine the scientific and other challenges that gene therapy will face in the next decade and a meeting to discuss optimization of the design of clinical trials using gene modified T cells in order to realize the potential of this immunotherapy while minimizing the risk to subjects. http://oba.od.nih.gov/rdna_rac/rac_about.html |
| NIH Translational Research Interest Group | Committee, Work group, Advisory group, or Task Force | FDA | NCI, CC, CIT, CSR, NCATS, NCCIH, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI, OD/OER, OD/OIR, OD/OSP | As Chair of the National Institutes of Health (NIH) Translational Research Interest Group (TRIG), the National Cancer Institute (NCI) staff has coordinated Forums, Workshops, NIH Bench-to-Bedside Awardees’ Lecture Series, and Monthly Seminar Series to help bridge the gap between laboratory research and clinical applications; suggestions of topics and speakers for the Annual NIH Research Festivals; and nominations of speakers for the NIH Wednesday Afternoon Lecture Series and the NIH Director’s Lecture Series. NCI staff has informed TRIG members of scientific events coordinated with other NIH Scientific Interest Groups and Working Groups. http://sigs.nih.gov/trig/ |
| NIH-CDC-IDSA Guidelines for Treatment of HIV Related Opportunistic Infections Among Adults and Adolescents | Committee, Work group, Advisory group, or Task Force | CDC | CC | The National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, and the Centers for Disease Control and Prevention (CDC) have developed guidelines for treatment of opportunistic infections (OIs) among adults and adolescents infected with human immunodeficiency virus (HIV). These guidelines are intended for clinicians and other health-care providers who care for HIV-infected adults and adolescents, including pregnant women; they complement companion guidelines for treatment of OIs among HIV-infected children and previously published guidelines for prevention of OIs in these populations. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm |
| NIH-CMS senior leadership Forum | Committee, Work group, Advisory group, or Task Force | CMS | NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/OSP | The CMS-NIH Senior Leadership Forum is comprised of NIH Director Francis Collins, CMS Administrator Marilyn Tavenner, and Senior Staff from both agencies. It convenes twice yearly. Meetings focus on identifying and troubleshooting areas where increased communication and specific activities (including policies and programs) will benefit the mission of both organizations. Recent topics have included creating a system for early alerts regarding NIH-supported research findings of interest to CMS; NIH-supported research findings of interest to Centers for Medicare & Medicaid Services (CMS) in high impact conditions such as diabetes, schizophrenia, post-acute stroke care, prevention of pre-term birth, lung cancer computed tomography screening, tobacco cessation, genomics, etc.; enhancing investigator access to CMS data through the use of Data Enclaves; development of common data elements (CDEs) to enhance the conduct of clinical research; and collaboration with the CMS Innovation Center to develop a Funding Opportunity Announcement , “Low Cost, Pragmatic Patient-Centered Randomized Controlled Intervention Trials,” issued and funded by NIH. |
| NIH-FDA Clinical Trial Protocol Template Workgroup | Committee, Work group, Advisory group, or Task Force | FDA | NIAID, NCATS, NCI, NIAAA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS | The purpose of this workgroup is to develop a standardized clinical trial protocol template to be used by NIH investigators submitting protocols to FDA |
| NIH-FDA Joint Leadership Council | Committee, Work group, Advisory group, or Task Force | FDA | OD/OSP, NCATS, NCCIH, NCI, NHLBI, NIAID, NIDDK, NIMH, NINDS | The Joint Leadership Council will work together to help ensure that regulatory considerations form an integral component of biomedical research planning, and that the latest science is integrated into the regulatory review process. Such collaboration and integration will advance the development of new products for the treatment, diagnosis and prevention of common and rare diseases and enhance the safety, quality, and efficiency of the clinical research and medical product approval enterprise. The formation of the Leadership Council represents a commitment on the part of both agencies to forge a strong partnership and to leverage the strengths of each agency toward this common goal. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm201654.htm |
| NIH/President''s Emergency Plan for AIDS Relief (PEPFAR) Collaboration for Implementation Science and Impact Evaluation | Research Initiative | CDC | NIAID, NCI, NICHD, NIMH, OD/DPCPSI/OAR | In FY 2011 a NIH/President’s Emergency Plan for AIDS Relief (PEPFAR) Request for Application (RFA) was issued for 3-year grant projects on Implementation Science in PEPFAR. Funding began in FY 2012. This RFA went out concurrently with a Centers for Disease Control and Prevention (CDC) RFA. The two agencies worked together to ensure awards were complementary and that there was no overlap. http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-11-003.html |
| NIH/President''s Emergency Plan for AIDS Relief (PEPFAR) Prevention of Maternal Child HIV Transmission (PMTCT) Implementation Science Alliance | Other | CDC | FIC, NIAID, NICHD, NIMH, OD/DPCPSI/OAR, OD/DPCPSI/ORWH | Using the NIH/President’s Emergency Plan for AIDS Relief (PEPFAR) Collaboration for Advancing Implementation Science in Prevention of Maternal Child HIV Transmission (PMTCT) request for applications (RFA) as a platform, the NIH-PEPFAR PMTCT Implementation Science Alliance promoted collaboration between implementation science researchers and program implementers and policy makers on the ground. Basing this work on actual implementation research issues rather than hypothetical examples, this project provided a unique function, serving as the “connective tissue” over 2 years for the PIs and collaborators and program implementers on the ground. In this capacity, the Alliance created a forum for the network of grantees, PMTCT implementers, and policymakers on a regular basis enabling cross-fertilization of ideas, insights and experiences as the research and the field progress. |
| NIH/President''s Emergency Plan for AIDS Relief (PEPFAR) Supplement | Research Initiative | CDC, SAMHSA | NIAID, NIAAA, NICHD, NIDA, NIDDK | One-year awards for implementation science projects addressing critical questions for President''s Emergency Plan for AIDS Relief (PEPFAR) programs. |
| Northwest Portland Tribal Registry Project | Resource Development | IHS | NCI | Over the past 10 years, health care delivery for Northwest American Indians and Alaska Natives has evolved from a centralized system maintained by the Indian Health Service (IHS) to a diverse and complex environment. The Northwest Tribal Registry Project was developed in January 1999 by the Northwest Tribal Epidemiology Center, a tribally operated program located at the Northwest Portland Area Indian Health Board (NPAIHB) in Portland, Oregon. http://surveillance.cancer.gov/disparities/native/portland.html |
| Novel Vaccines and Poliomyelitis Disease | Meeting/ Workshop | CDC, FDA | FIC | Meeting and workshop with the FDA, CDC, World Health Organization, and the Bill & Melinda Gates Foundation to discuss issues related to the biomedical and regulatory sciences related to novel vaccines and their utilization against poliomyelitis disease. |
| Nutrition Coordinating Committee (NCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, IHS, OS | NIDDK, CC, CIT, CSR, FIC, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR | Nutrition Coordinating Committee (NCC) operates as an NIH-wide forum to review, stimulate, and encourage the support of nutrition research and training to better define the role of nutrition in the promotion and maintenance of health and in the prevention and treatment of disease. The NCC also plays a key role in the development of nutrition research policy at the NIH. The mandate of the Nutrition Coordinating Committee NCC is to review, stimulate, and encourage the necessary support of nutrition research and training and to define the role of nutrition in health promotion and disease prevention and management. NCC membership includes a representative and alternate from the 20 NIH Institutes and 7 Centers. In addition, offices and agencies within the Department of Health and Human Services (HHS), U.S. Department of Agriculture (USDA), and the Department of Defense (DOD) have also appointed liaison representatives to the Committee. The NCC meets monthly to provide an open forum for members to report on current and future nutrition research, policy activities, and research funding and training opportunities. http://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/nutrition-coordinating-committee/Pages/default.aspx |
| Occupational Exposure to Bisphenol A in the United States | Research Initiative | CDC | NIEHS | The purpose of this project is to assess occupational exposure to bisphenol A (BPA) in a cross-section of industries and jobs where BPA is either produced or processed. |
| Office for Human Research Protections/Office of Extramural Research Training Initiative | Meeting/ Workshop | OS | OD/OER | The National Institutes of Health (NIH) Office of Extramural Research (OER) collaborated with the Office for Human Research Protections (OHRP) to provide comprehensive training at both NIH Regional Meetings for the extramural community and to NIH staff on Human Research Participant Protections. |
| Office of AIDS Research Advisory Council (OARAC) | Committee, Work group, Advisory group, or Task Force | CDC | OD/DPCPSI/OAR, NICHD | The Office of AIDS Research Advisory Council provides advice to the Director of the Office of AIDS Research (OAR) on the planning, coordination, and evaluation of research and other activities in respect to AIDS conducted or supported by the NIH. OARAC also advises the Secretary of Health and Human Services and the Director of NIH, on AIDS research programs, the development and annual review of the comprehensive plan for the conduct and support of all HIV/AIDS activities of the agencies of NIH, including research policies and priorities, and the coordination of domestic and international NIH AIDS efforts. http://www.oar.nih.gov/oarac/ |
| Office of Science and Technology Mo99 Stakeholders Working Group | Committee, Work group, Advisory group, or Task Force | CMS, FDA, OSG | NIBIB, NCI | Coordinate the efforts of multiple stakeholders (Department of State, Department of Energy, Department of Homeland Security, Department of Health and Human Services, private sector) to establish a stable, long-term domestic supply of Mo99 (molybdenum-99) for medical purposes. Such a supply needs to be consistent with current international goals (to which the US is an active participant) of reduction in the use of high-enriched uranium in all reactors, including Mo99 production facilities, as well as full cost recovery solutions. |
| Oligonucleotide and sequencing services from FDA | Research Initiative | FDA | NICHD | This inter-agency agreement (IAA) is for the purpose of meeting the needs of a Eunice Kennedy Shriver National Institute of Child Health and Human development (NICHD) intramural lab that requires oligonucleotide and sequencing services from the Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA). The NICHD, NIH agrees to pay the FDA for these services. |
| Oral Health, Cancer Care, and You | Public Education Campaign | CDC | NIDCR, NCI, NINR | A series of publications to inform health care providers and patients about steps they can take before, during, and after cancer treatment to reduce the risk and impact of the often painful side effects. http://www.nidcr.nih.gov/OralHealth/Topics/CancerTreatment/ |
| Osteoporosis and Related Bone Diseases—National Resource Center | Resource Development | OS | NIAMS, NIA, NICHD, NIDCR, NIDDK, OD/DPCPSI/ORWH | Provides patients, health professionals and the public with an important link to resources and information on metabolic bone diseases, including osteoporosis, Paget’s disease of the bone and osteogenesis imperfecta. http://www.bones.nih.gov |
| P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma | Research Initiative | FDA | NIDCD | At the FDA, Dr. Weinberg is transducing murine keratinocytes with combinations of oncogenes found in human squamous cell carcinomas to determine if they generate transformation and tumors in laboratory environment conditions. Dr. Van Waes’ laboratory at NIDCD will study how these oncogene driven tumors in mice deregulate keratinocytes and host immune responses, as well as response to various standard, molecular and immune therapies. http://ioftraining.nci.nih.gov/weinberg.html |
| Panel workgroup for updating US Pediatric HIV treatment guidelines | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NICHD, NIAID | NICHD is the lead for updating the US Pediatric HIV treatment guidelines and serves as executive secretary. The Department of Health and Human Services (HHS) Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children (the Panel), a working group of the Office of AIDS Research Advisory Council (OARAC), reviews new data on an ongoing basis and provides regular updates to the guidelines. The guidelines are available on the AIDSinfo website at http://aidsinfo.nih.gov. These updated guidelines address the use of combination antiretroviral therapy (cART) for HIV-infected infants, children, and adolescents. Guidance on management of adverse events associated with use of antiretroviral (ARV) drugs in children and a detailed review of information about safety, efficacy, and pharmacokinetics (PK) of ARV agents in children is also included. |
| Partners in Information Access for the Public Health Workforce | Resource Development | AHRQ, CDC, HRSA, OS | NLM | Partners in Information Access for the Public Health Workforce is a collaboration of U.S. government agencies, public health organizations, and health sciences libraries which provides timely, convenient access to selected public health resources on the Internet. http://phpartners.org/ |
| Partnership for Tuberculosis (TB) and TB/HIV Research | Research Initiative | CDC | NIAID | NIH/CDC partnership to develop methods and strategies to improve upon drug susceptibility testing methods for Pyrazinamide (PZA) and discovery of transcriptional markers of viable Mycobacterium tuberculosis (MTB) during treatment, markers of persistence, and markers of treatment response in active pulmonary Tuberculosis (TB). |
| Partnership for Tuberculosis (TB) and TB/HIV Research -2 | Resource Development | CDC | NIAID | Support for whole genome sequencing (WGS) of isolates and bioinformatics/analytic support for WGS to characterize TB drug resistance mutations. This is a joint CDC/NIAID effort to develop a comprehensive database of resistance polymorphisms and phenotypic correlations from clinical samples from various sites worldwide. |
| Pathogen Detection Project | Resource Development | CDC, FDA | NLM | The Pathogen Detection Project is a tri-agency collaboration that is combining data from pathogen outbreaks with other information to determine the major source of contamination. The project is conducted via a centralized system that integrates sequence data for bacterial pathogens obtained from food, the environment, and human patients. A number of public health agencies in the US and internationally are collecting samples from these sources to facilitate active, real-time surveillance of pathogens and foodborne disease. The agencies sequence the samples and submit the data to NCBI/NLM/NIH, which analyzes the sequences against others in its database to identify closely related sequences. The aim is to uncover potential sources of contamination by linking isolates from food or the environment to human illness and to quickly report the sequence relationships to public health scientists in order to aid trace back investigations and outbreak response. The collaborative project is currently focusing on sequencing and analyzing the four bacterial groups that are the major causes of foodborne illness in the US: Campylobacter; Escherichia coli and Shigella; Listeria; and Salmonella. Collaborating agencies include FDA, CDC, USDA-Food Safety and Inspection Service, and Public Health England. http://www.ncbi.nlm.nih.gov/pathogens/ |
| Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain | Meeting/ Workshop | AHRQ, CDC, FDA, IHS, OS, SAMHSA | NIDA, NCI, NIA, NINDS, OD/DPCPSI/ODP | The workshop and report addressed four questions: 1) What is the long-term effectiveness of opioids for treatment for chronic pain? 2) What are the safety and harms of opioids in patients with chronic pain? 3) What are the effects of different opioid management strategies? 4) What is the effectiveness of risk mitigation strategies for opioid treatment? The information in this report is intended to help health care decision-makers--patients and clinicians, health system leaders, and policymakers, among others--make well-informed decisions and thereby improve the quality of health care services. http://prevention.nih.gov/p2p/default.aspx |
| Pathways to Prevention- Integration of worksite health promotion and total worker health | Meeting/ Workshop | AHRQ, CDC | NHLBI | The goal is to understand the scientific evidence related to integration of worksite health promotion and occupational safety and health protection, including factors that influence the effectiveness of an integrated approach, and to develop recommendations for further research. https://prevention.nih.gov/programs-events/pathways-to-prevention |
| Pediatric Abusive Head Trauma-Reviewing the Evidence Advancing Science | Meeting/ Workshop | HRSA | NINR, NHLBI, NICHD, NIDA, NIGMS, NIMH, NINDS | The developmental sequelae of children who suffer maltreatment related injuries is understudied and there is a need to bring together researchers from different disciplines who study and provide a continuum of services to these children. Thus, the purpose of this conference was to build on the 2002 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sponsored conference on Inflicted Childhood Neurotrauma, review advances in the science from multiple disciplinary perspectives and to address definitional issues as well as implications for treatment, intervention and long-term outcomes for children. This meeting was an advisory to the new Pediatric Trauma & Critical Illness Branch (PTCIB) of NICHD and the proceedings will be used to inform a research agenda. This workshop was sponsored by PTCIB. The purpose of the meeting was to examine current findings on inflicted childhood neurotrauma, or Abusive Head Trauma (AHT), and related priorities. Day 1 of the workshop began with two presentations, one establishing a research agenda for AHT and a broad overview of what is and is not known about AHT, followed by a roundtable discussion. Then there were two sessions, one on basic research in AHT and one on clinical, epidemiological, and translational research, each followed by a roundtable discussion. Day 2 began with a session reviewing highlights from the previous day, followed by a roundtable discussion. Participants then divided into three workgroups: basic science; clinical science; and treatment, outcomes, prevention, and rehabilitation. After completing their discussions, workgroups presented their findings. This workshop was sponsored by the Pediatric Trauma and Critical Illness Branch (PTCIB) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The purpose of the meeting was to examine current findings on inflicted childhood neurotrauma, or AHT, and related priorities. Day 1 of the workshop began with two presentations, one establishing a research agenda for AHT and a broad overview of what is and is not known about AHT, followed by a roundtable discussion. Then there were two sessions, one on basic research in AHT and one on clinical, epidemiological, and translational research, each followed by a roundtable discussion. Day 2 began with a session reviewing highlights from the previous day, followed by a roundtable discussion. Participants then divided into three workgroups: basic science; clinical science; and treatment, outcomes, prevention, and rehabilitation. After completing their discussions, workgroups presented their findings. |
| Pediatric-PMTCT PEPFAR working group | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The Pediatric-PMTCT PEPFAR working group supports the objectives of the U.S. President''s Emergency Plan for AIDS Relief (PEPFAR) and prevention of mother-to-child transmission (PMTCT). Beginning with the President''s Mother and Child HIV Transmission Initiative in 2002, and then expanding with the launch of the U.S. President''s Emergency Plan for AIDS Relief (PEPFAR) in 2003, prevention of mother-to-child transmission (PMTCT) has been a central focus of U.S. Government global HIV/AIDS efforts. Congress established the Expert Panel on Prevention of Mother-to-Child Transmission of HIV in Section 309 of H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. Its purposes are to provide an objective review of PEPFAR''s PMTCT activities, and provide recommendations to the U.S. Global AIDS Coordinator and the appropriate Congressional committees for further scale-up of services to achieve the ambitious target of reaching 80 percent of pregnant women in countries most affected by HIV/AIDS in which the U.S. has HIV/AIDS programs. |
| Pertussis Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID | The objective of the Pertussis Working Group is to share information and promote collaborations among U.S. Department of Health and Human Services (HHS) agencies in order to better understand the recent resurgence of pertussis in the U. S. and identify potential strategies to address the problem. |
| PhenX Tobacco Regulatory Research (TRR) Working Groups | Committee, Work group, Advisory group, or Task Force | FDA | NIDA | The FDA and the NIH Tobacco Regulatory Science Program (TRSP) are seeking to expand the depth and breadth of tobacco-related measures that can enhance cross-study analysis in large-scale research. Use of the selected consensus measures will facilitate the comparison of results from different studies and the combination of studies to create larger sample sizes, increasing statistical power and the ability to detect more subtle and complex associations. The measures will be housed within the PhenX Toolkit (https://www.phenxtoolkit.org/). PhenX is a repository for measures identified as central in a field, developed with funding from the NHGR https://www.phenx.org/Default.aspx?tabid=814 |
| Pilot Studies Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NICHD | This is a short term project oriented committee. |
| Pink Ribbon Red Ribbon | Meeting/ Workshop | CDC | NCI | Pink Ribbon Red Ribbon (PRRR) is a partnership to leverage public and private sector investments to address breast and cervical cancers in developing countries. It is being implemented in several countries in sub-Saharan Africa. The National Cancer Institute and Centers for Disease Control and Prevention provide technical assistance in implementation strategies to the PRRR countries. This assistance involves drafting guidelines for monitoring and evaluation of prevention and treatment services as well as developing communication strategies. http://www.ncbi.nlm.nih.gov/pubmed/24101785 |
| Planning and Design for Post-Acute Care Assessment Instruments and Data Elements | Resource Development | CMS | NLM | The ultimate goal of this work is to improve quality of care and interoperability of computerized data in acute hospitals and post-acute care (PAC) settings through use of health informatics and real-time transfer of patient information. The National Library of Medicine (NLM) and Centers for Medicare & Medicaid Services (CMS) collaborate on planning and design for the Continuity Assessment Record & Evaluation (CARE) instrument and its data elements, and those of other CMS post-acute care assessment tools; develop logical data model and software applications that promote compliance and compatibility with Federal Health Architecture consolidated health informatics (CHI) standards; adopt Federal government-wide health information interoperability standards associated with Meaningful Use; and improve data and messaging for the Medicare program. This collaboration benefits from NLM''s role as central U.S. Department of Health and Human Services (HHS) coordinating body for clinical terminology standards, and provides NLM specific and usage-based feedback on the utility of such standards in this environment. |
| Policy and Research Needs to Maximize Independence and Support Community Living-A Workshop | Meeting/ Workshop | ACL, CMS, FDA | NHLBI, NIA | Identify and discuss policies that catalyze innovation Identify how to improve care coordination and facilitate community integration Explore research and policy gaps and needs Determine current state of integration of service delivery and finance. http://iom.nationalacademies.org/Activities/Aging/AgingDisabilityForum/2015-OCT-06.aspx |
| Polyhalogenated Aromatic Hydrocarbons (PHAH) and Thyroid Cancer | Research Initiative | CDC | NCI | Polyhalogenated aromatic hydrocarbons are being measured in banked serum/plasma samples from cohort studies to evaluate the association with thyroid cancer incidence. |
| Population Assessment of Tobacco and Health (PATH) Study | Health Survey | FDA | NIDA | The Population Assessment of Tobacco and Health (PATH) Study is the first large-scale National Institutes of Health (NIH)/U.S. Food and Drug Administration (FDA) collaboration since Congress granted FDA the authority to regulate tobacco products in the Family Smoking Prevention and Tobacco Control Act (FSPTCA) in 2009. The PATH Study is a national longitudinal cohort study that will follow an estimated 59,000 U.S. household residents ages 12 years and older for at least three years. Objectives are to assess initiation and use patterns; to study trends in tobacco-product use cessation and relapse; to monitor behavioral and health impacts, including in risk perceptions and other tobacco-related attitudes; and to assess differences in tobacco-related attitudes, behaviors, and health outcomes among racial/ethnic, gender, and age subgroups. The PATH Study will also collect biospecimens from adults to analyze biomarkers of tobacco use and related health outcomes. By measuring and accurately reporting on the social, behavioral, and health effects associated with tobacco-product use in the U.S., the PATH Study will provide an empirical evidence base to help inform FDA’s decisions about changes in tobacco products in meeting the objectives of the 2009 FSPTCA. http://www.PATHStudyInfo.nih.gov |
| Post-traumatic Stress Disorder (PTSD)/Trauma Brain Injury (TBI) Workgroup | Committee, Work group, Advisory group, or Task Force | OS | NIMH, NIAAA, NIDA, NINDS | A 2012 White House Executive Order, emphasizing support of Service Members, Veterans, and their families as a "top priority," called for an urgent increase in the Departments of Health and Human Services (HHS), Defense (DoD), and Veterans Affairs (VA) research coordination to address the problems of PTSD, TBI, and suicide. Section 5 of this Executive Order requested a National Research Action Plan (NRAP) to develop biomarkers, define the pathophysiology, and develop new treatments for PTSD. HHS charged NIMH to lead this effort along with a parallel effort for TBI led by NINDS, with both Institutes working closely with VA and DoD. In 2013, the NRAP was released in response to the Executive Order. Prior investments integrating the molecular, genomic, and brain circuitry changes that give rise to PTSD in the context of environmental factors provide the requisite foundation to respond to this White House request for biomarkers for risk prediction, as well as new targets for medications, and other therapies to treat PTSD. This investment has the potential to revolutionize the care for individuals at high risk for PTSD and prevent the development of chronic complex treatment-resistant PTSD. Additionally, in 2014, the White House and the Office of Management and Budget created a Cross Agency Priority Goal (CAP-G) to improve mental health outcomes for Service Members, Veterans, and their families. To achieve this goal, HHS (NIH), VA, and DoD are supporting research that will standardize and integrate measurements for TBI, PTSD, and suicide prevention research funded by the agencies. Also, the PTSD/TBI workgroup is tasked to develop and test suicide risk assessments and suicide prevention, and treatment interventions for Service Members and Veterans. The agencies meet weekly on these efforts and report quarterly on progress. http://www.whitehouse.gov/the-press-office/2012/08/31/executive-order-improving-access-mental-health-services-veterans-service |
| Postpartum Initiative/Conference | Meeting/ Workshop | CDC, HRSA | NICHD, NIMH | In FY2015 NICHD has been working on a Postpartum Depression initiative/conference that is due to launch in FY2016. The National Child and Maternal Health Education Program (NCMHEP) is currently working on a Postpartum Depression initiative for its next topic area. The NCMHEP Coordinating Committee is made up of 32 organizations including HHS agencies (CDC, OMH, ORWH, OWH, and MCHB) This initiative will include print materials and a social media component. We will also be using a video that was produced by NIMH on postpartum depression. The initiative is focused on raising awareness amongst pregnant women and their families about PPD. We want them to know that PPD has more than just depression symptoms and it can occur during pregnancy and in the postpartum period through the first year of the child’s life. Also that it not uncommon and that there is help and treatment so women do not need to suffer in silence. The initiative has a tentative launch date of January 2016. |
| Practical Oral Care for People with Developmental Disabilities | Public Education Campaign | CDC | NIDCR, NICHD | A series of publications designed to equip dental professionals in the community with the information they need to deliver quality oral health care to people with special needs. http://www.nidcr.nih.gov/OralHealth/Topics/DevelopmentalDisabilities |
| Practice-Based Research and Implementation: Developing a Framework for Collaboration to Reduce Mental Health Disparities | Meeting/ Workshop | SAMHSA | NIMH | NIMH and the Substance Abuse and Mental Health Services Administration (SAMHSA) host an annual webinar to enhance understanding of the development of collaborative approaches to behavioral health services. These collaborative efforts will accelerate the dissemination of research-based material and treatment information to communities. These conversations will identify ways to align ongoing efforts to address disparities in mental health outcomes across diverse populations. The information resulting from this discussion will be used to develop an action plan and help to enhance the partnership between NIMH and SAMHSA. |
| Preclinical Assessment of Phage Therapy for Pathogen Decolonization | Research Initiative | FDA | NIAID | This project addresses key regulatory considerations relevant to using bacteriophages for decolonization of the drug-resistant nosocomial pathogens, vancomycin-resistant enterococci (VRE) and methicillin-resistant staphylococcus aureus (MRSA). These include characterizing pathogen resistance to phage, defining phage mixtures ("cocktails") to circumvent resistance, optimizing mouse models to evaluate pathogen decolonization and identifying endpoints that support claims for clinical benefit (e.g., reduced risk of disease transmission). |
| PregSource Management Team | Committee, Work group, Advisory group, or Task Force | CDC, CMS, HRSA | NICHD, NCCIH, NHLBI, NIEHS, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH | In consultation with the PregSource Partners, the PregSource Management Team: • Finalizes selection of topics for inquiry • Works closely with PregSource contractor to develop site • Assures compliance with applicable NIH policies and procedures, including IRB approval • Develops content for online and app-based versions • Oversees outreach efforts to bolster participation • Monitors overall function and usage of PregSource • Participates in analysis and interpretation of data • Reports results in publications and presentations |
| President''s Commission on the Study of Bioethical Issues | Committee, Work group, Advisory group, or Task Force | OS | CC | Christine Grady participates as a Commissioner on the Presidential Commission for the Study of Bioethical Issues. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The Commission undertakes study of issues presented to them by the President and the Secretary of Health and Human Services. http://www.bioethics.gov/ |
| President''s Task Force on Environmental Health Risks and Safety Risks to Children | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, OS | NIEHS, NCI, NHLBI, NIAID, NICHD | The Secretary of the Department of Health and Human Services and the Administrator of the Environmental Protection Agency co-chair the Task Force, which is focused on coordinating Federal actions in this area, and which comprises representatives of 17 federal departments and White House offices. The Task Force currently focuses on priority areas including climate change, asthma disparities, healthy homes, and chemical exposures. NIEHS staff co-chair the climate change and chemical exposures subcommittees. http://www.epa.gov/children/presidents-task-force-environmental-health-and-safety-risks-children |
| President’s Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention | Research Initiative | CDC | NIAID, FIC, NCI, NIAAA, NIDA, NIMH, OD/DPCPSI/OAR | This President’s Emergency Plan for AIDS Relief (PEPFAR) activity focuses on testing treatment as prevention on the population level in South Africa and Zambia. This activity was initiated through the HIV Prevention Trials Network (HPTN), with support of multiple National Institutes of Health (NIH) Institutes and Centers, PEFPAR, and the Bill & Melinda Gates Foundation. The Requests for Application (RFA) was issued concurrently with a Centers for Disease Control and Prevention (CDC) RFA for combination prevention, and the agencies have worked together to ensure that the studies are complementary and do not overlap. http://www.pepfar.gov/ |
| Preventing HIV in Adolescent Girls and Young Women Taskforce | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | In August 2014, the “Preventing HIV in Adolescent Girls and Young Women Task Force” was formed in response to a request from the Office of the Global AIDS Coordinator (OGAC) to articulate PEPFAR/South Africa’s strategy to address the high rates of HIV incidence and infection in 15-24 year old females. Despite slight HIV prevalence declines over the past decade young South African women continue to experience rapid increases in HIV infection rates beginning in late adolescence. Declining HIV knowledge and increased risk behavior, despite significant treatment scale up and the availability of new prevention tools, are concerning trends among young women. Representatives from NICHD, CDC and other government agencies joined the OGAC-led task force to develop the strategy and implementation plan. In December 2014, PEPFAR launched the DREAMS initiative: DREAMS is an ambitious partnership to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries. The goal of DREAMS is to help girls develop into Determined, Resilient, Empowered, AIDS-free, Mentored and Safe women. |
| Prevention Research Centers | Research Initiative | CDC | NCI | The Prevention Research Centers program funds community-based research projects at 37 academic research centers across the U.S.; 5 developmental and 32 comprehensive centers. These centers: Conduct research projects that promote health and prevent disease; Build research teams of multidisciplinary faculty; Seek solutions, strategies, and policies that address public health problems; Participate in research networks that address priority health issues, such as healthy aging, cancer prevention & control, and obesity prevention; Build long-term relationships for engaging communities as partners in research; Conduct research in directions guided by advisory boards of community leaders; Develop and deliver trainings that enhance the public health workforce; and Conduct additional research funded by other federal agencies, foundations, and nonprofit organizations. http://www.cdc.gov/prc/ |
| Prevention Research Coordinating Committee (PRCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, OS | OD/DPCPSI/ODP, CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH, OD/OLPA | The NIH Prevention Research Coordinating Committee (PRCC) serves as a venue for exchanging programmatic and scientific information of interest to the NIH, as well as for planning and implementation of collaborative activities. As a trans-NIH committee, the PRCC provides a broad perspective on the current state-of-the-science, and disseminates to NIH Institutes and Centers information about prevention-related activities sponsored by Federal and non-Federal organizations. The PRCC also serves as an advisory body to the Director of ODP and makes recommendations regarding scientific, programmatic, and policy issues. ODP coordinates the activities of the PRCC. https://prevention.nih.gov/prevention-research/prcc |
| Prevention with Positives Intervention HIV Clinics (Y01-MH-1318) | Research Initiative | CDC | NIMH, NIAID | The Prevention with Positives Intervention HIV Clinics is a collaboration with CDC to conduct an HIV clinic-based comparison of a comprehensive prevention program for people living with HIV targeting multiple health behaviors (sexual risk, medication adherence, clinic attendance) and health outcomes (viral load, retention in care). In FY15, the comprehensive intervention completed enrollment and intervention in three HIV clinics in the US, and the delayed intervention was launched in three comparison clinics. Clinic-based data will serve as the metric for intervention outcomes and the data will be analyzed for publication. |
| Promoting Semantic Interoperability of Laboratory Data Test Results | Resource Development | CDC, FDA | NLM | CDC and NLM encourage considering ways that FDA could accelerate specifications of LOINC codes that apply to each test result that a lab/test instrument or kit can generate. Availability of the right LOINC codes with each instrument test kit will greatly simplify the correct assignment of codes by laboratory for sending to clinician''s medical record system. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm453897.htm |
| Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE) | Committee, Work group, Advisory group, or Task Force | ACF, CDC, FDA, OS, SAMHSA | NIAID, NIAMS, NICHD, NINDS, NLM | The PHEMCE advances national preparedness for natural, accidental, and intentional threats by coordinating medical countermeasure-related efforts within HHS and in cooperation with PHEMCE interagency partners. NIAID has representatives on many groups within PHEMCE. http://www.phe.gov/Preparedness/mcm/phemce/Pages/mission.aspx |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NINDS, NIAID | The U.S. Department of Health and Human Services (HHS) Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) leads the mission to develop and acquire medical countermeasures that will improve public health emergency preparedness as well as prevent and mitigate the adverse health consequences associated with chemical, biological, radiological and nuclear (CBRN), and naturally occurring threats. https://www.medicalcountermeasures.gov/ |
| Quantitative Data Mining for Drug-Adverse Event Safety Signal Detection Using MEDLINE | Research Initiative | FDA | NLM | The objective of this initiative between the National Library of Medicine (NLM) Cognitive Science Branch and the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA) is to develop a mutually beneficial automated data mining analytical tool in which NLM’s electronic databases and resources (including MEDLINE) are utilized to support the FDA’s mission related to enhancing postmarket drug safety surveillance and safe use. http://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162057.htm |
| Racial Disparities in Prostate Cancer Incidence Rates by Census Division in the United States, 1999-2008 | Research Initiative | CDC | NCI | An analysis of the National Program of Cancer Registries database to assess census division differences by race (white, black) in trends of prostate cancer. |
| Radiation Biodosimetry Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | This working group is focused on regulatory and scientific issues regarding technologies and devices for radiation biodosimetry. The working group assisted in drafting new Food and Drug Administration (FDA) Center for Device and Radiological Health (CDRH) guidance for industry. |
| Radiation Emergency Medical Management (REMM) | Resource Development | CDC, OS | NLM, NCI | This activity is to develop a comprehensive web resource. Radiation Emergency Medical Management (REMM) is a mechanism to collect, evaluate, collate, store and make available electronically to health care professionals immediate, up-to-date, evidence-based clinical information they would use to treat civilian patients and others affected by radiation incidents. http://www.remm.nlm.gov/ |
| Radiation/Nuclear Biodosimetry Team | Committee, Work group, Advisory group, or Task Force | OS | NIAID | Team members participate in the review of white papers as well as proposals and progress reviews for Biomedical Advanced Research and Development Authority (BARDA)-funded contracts supporting the development of novel biodosimetry platforms. |
| Radiation/Nuclear Technical Evaluation Review Panel | Committee, Work group, Advisory group, or Task Force | OS | NIAID | The National Institute of Allergy and Infectious Diseases (NIAID) participates on the Radiation/Nuclear Technical Evaluation Review Panel to review white papers and proposals received by the U.S. Department of Health and Human Services (HHS) Biomedical Advanced Research and Development Authority (BARDA) for the development of radiation and nuclear medical countermeasures. NIAID provides scientific and programmatic critiques and reviews of selected submissions. |
| Radiobiology Bioterrorism Research and Training Group (RABRAT) | Meeting/ Workshop | FDA, OS | NCI | This activity involves monthly meetings to discuss research initiatives, funding opportunities, training, conferences, publications and other events and information related to preparing the U.S. Government to respond to nuclear terrorism. http://dctd.cancer.gov/ProgramPages/rrp/partnerships_radiation_bioterrorism.htm |
| Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center | Training Initiative | FDA | CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS | This activity is sponsored by the Clinical Pharmacology Program, Office of Clinical Research Training and Medical Education (OCRTME) at The National Institutes of Health (NIH) Clinical Center (CC) and it consists of elective rotations at the Office of Clinical Pharmacology (OCP) and the Office of New Drugs (OND) of the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research for NIH staff with a primary focus on clinical fellows and research fellows who expressed an interest in learning more about FDA regulatory sciences applicable to drug development research. Rotating fellows are mentored by FDA staff on the required elements of an Investigational New Drug (IND) application and the key elements of the FDA review process from a regulatory perspective. This program also established a mechanism for FDA scientific reviewers at the OCP to rotate at the NIH CC and to interact with members of a clinical research team, thus acquiring a better perspective on clinical research protocol implementation and the requirements of an Institutional Review Board (IRB) at the NIH. http://intranet.cc.nih.gov/clinicalresearchtraining/curriculumcert/FDAClinPharm.pdf |
| Recruiting Older Adults into Research (ROAR) Tookit | Research Initiative | ACL, CDC | NIA | Download toolkit with easy to use, customizable materials that feature information on recruitment of older adults into clinical research. https://www.nia.nih.gov/health/publication/roar-toolkit |
| Reentry Research Network | Committee, Work group, Advisory group, or Task Force | ACF, SAMHSA | NIDA, OD/DPCPSI/OBSSR | This is a subgroup that reports to the Federal Interagency Reentry Council. The purpose of this group is to bring together numerous federal agencies to make communities safer, assist those returning from prison and jail to becoming productive, tax-paying citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration. |
| Regional Grant Writing and Scientific Peer Review Workshop | Meeting/ Workshop | CDC | NCI, CSR, FIC, NHLBI, NIAID, NICHD, NIDA, NIMH, NINDS, OD/DPCPSI/OAR, OD/DPCPSI/ODP | The Center for Global Health of the U.S. National Cancer Institute (NCI) in collaboration with the South African Medical Research Council (SAMRC) will hold regional grant writing and peer review workshops to encourage investigators to address public health issues through research. The objectives of the workshops are to (1) increase the participation of scientists from mid- to low-resource countries in the research grant process; (2) develop strategies for sustainable research support and collaborations, and; (3) use competitive research as a tool to address global health issues. |
| Registry of Patient Registries (RoPR) Project | Committee, Work group, Advisory group, or Task Force | AHRQ | NIDDK, NLM | The Agency for Healthcare Research and Quality (AHRQ) is working to design and deploy Registry of Patient Registries (RoPR), which will create a searchable central listing of patient registries in the United States that will be integrated with ClinicalTrials.gov. As part of this project, broad consultations were carried out with relevant groups. Staff of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) participated extensively in these consultations. |
| Report on Carcinogens (RoC) Evaluation of Cobalt and Cobalt Compounds that Release Cobalt In Vivo | Committee, Work group, Advisory group, or Task Force | ATSDR | NIEHS | Collaborated on preparing the Report on Carcinogens (RoC) evaluation of cobalt and cobalt compounds that release cobalt in vivo for possible listing in the RoC. The RoC is a congressionally mandated, science-based, public health report that identifies substances in our environment that are cancer hazards for people living in the U.S. http://ntp.niehs.nih.gov/go/730697 |
| Research in diabetes mellitus, its complications, and obesity | Research Initiative | IHS | NIDDK | The objectives are to identify the determinants and understand the progression of type 2 diabetes, obesity, and other chronic diseases in Pima Indians. |
| Research to Guide Practice Enhancing HIV/AIDS Platforms to Address NCDs in Low Resource Settings (PEPFAR-NCD) | Other | CDC | FIC, NCI, NHLBI, NIAID, NICHD, NIDDK, NIMH, NIMHD, NINDS, NINR, OD/DPCPSI/OAR, OD/DPCPSI/ORWH | The goal of the President''s Emergency Plan for AIDS Relief (PEPFAR) non-communicable diseases (NCD) project (PEPFAR-NCD), a collaboration between PEPFAR implementing partners, is to articulate research priorities that incorporate prevention, care and treatment for non-communicable diseases into HIV/AIDS platforms in low- and middle-income countries (LMICs). The PEPFAR-NCD project focuses on people living with HIV (PLWH), many of whom are being treated successfully for HIV, but who are increasingly experiencing co-morbid diseases or conditions such as cardiovascular disease, diabetes, cancer, and depression. This project has produce landscape analyses and is establishing research agendas, priorities, and products, including modeled data, to enhance NCD services through PEPFAR platforms. http://www.fic.nih.gov/About/Staff/Policy-Planning-Evaluation/Pages/pepfar-ncd-project.aspx |
| Research-Tested Intervention Program Database (RTIPs) | Resource Development | SAMHSA | NCI | The Research-Tested Intervention Program Database (RTIPs) is a searchable database of cancer control interventions and program materials and is designed to provide program planners and public health practitioners easy and immediate access to research-tested materials. http://rtips.cancer.gov/rtips/index.do |
| Revision of CDC Guidelines | Committee, Work group, Advisory group, or Task Force | CDC | CC | The collaboration serves to revise guidelines for managing occupational exposures to HIV and managing healthcare workers infected with hepatitis B. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6103a1.htm?s_cid=rr6103a1_e |
| Ruth L. Kirschstein National Research Service Award Program | Training Initiative | AHRQ, HRSA | OD/OER | The National Institutes of Health Ruth L. Kirschstein National Research Service Award (Kirschstein-NRSA) program provides predoctoral and postdoctoral training in biomedical, behavioral, and clinical research, including health services and primary care research, to meet the nation’s needs for investigators in these fields. To help foster the training of health services and primary care researchers, a portion of the Kirschstein funds are annually transferred to the Agency for Healthcare Research and Quality and Health Resources and Services Administration by the NIH Budget Office, in accordance with Public Law 1118, Section 219 of the Public Health Service Act. http://grants.nih.gov/training/nrsa.htm |
| RxNorm | Resource Development | FDA | NLM | RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary. http://www.nlm.nih.gov/research/umls/rxnorm/ |
| Sabbatical in Clinical Research Management Program | Training Initiative | FDA, OS | CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK | Experienced investigators come to the National Institutes of Health (NIH) to learn about management of a clinical research enterprise, including topics such as planning and budget development, protocol writing and tracking and scientific review. Sabbaticals are self-directed, meaning that the participant chooses from a list of electives and helps determine how much time to spend studying each topic. The electives are offered by leaders at the NIH and other U.S. Department of Health and Human Services agencies with the NIH Clinical Center being the most heavily involved. http://www.cc.nih.gov/training/sabbatical/index.html |
| Safety and Efficacy Evaluations of Topical Microbicide (TM) Biomedical Prevention (BP) Products in the Repeat Low-Dose Macaque SIV/SHIV Infection Model | Research Initiative | CDC | NIAID | The National Institute of Allergy and Infectious Diseases (NIAID) and Centers for Disease Control and Prevention (CDC) recognize the need to perform preclinical safety and efficacy evaluations of candidate products in the repeat low-dose (RLD) macaque SIV/SHIV infection model established by CDC. NIAID established an interagency agreement with CDC to: 1) conduct safety and efficacy evaluations of Topical Microbicide/Biomedical Prevention products in the RLD macaque model, including pharmacokinetic/pharmacodynamic analyses of candidate biomedical prevention products; 2) utilize relevant macaque species, virus strains, and routes of infection to accomplish the proposed evaluations; and 3) perform other macaque studies as needed. |
| SAMHSA Recovery Month | Public Education Campaign | SAMHSA | NIDA | The Substance Abuse and Mental Health Services Administration (SAMHSA) annual public health observance for people in recovery from substance abuse; The National Institute on Drug Abuse (NIDA) is part of SAMHSA''s inter-agency planning committee and a promotional partner. http://www.recoverymonth.gov/ |
| Scientific Review and Promotion of CDC''s Tip From Former Smokers Video--Marlene''s Ad | Public Education Campaign | CDC | NEI | Drs. Frederick Ferris and Emily Chew provided a scientific review of the CDC''s ad which featured a woman with age-related macular degeneration who got it because she smoked. The National Eye Health Education Program assisted with promotion of the final video. https://www.youtube.com/watch?v=MmKgm--EQUU |
| SEARCH for Diabetes in Youth | Research Initiative | CDC | NIDDK | SEARCH is a multi-center study that identifies cases of diabetes in children/youth, providing data on incidence and prevalence in the U.S. as well as data on diabetes management and complications. http://www.searchfordiabetes.org |
| Sequencing Quality Control (SEQC) Toxicogenomics (TGMX) Study | Research Initiative | FDA | NIEHS | To compare TGMX results between microarray and RNA-seq. http://www.fda.gov/ScienceResearch/BioinformaticsTools/MicroarrayQualityControlProject/ |
| Sleep Disorders Research Advisory Board | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NCATS, NCCIH, NCI, NIA, NICHD, NIDA, NIDDK, NINDS, NINR, OD/DPCPSI/OBSSR | The Advisory Board shall advise, assist, consult with, and make recommendations to the Director of the National Institutes of Health, through the Director of the Institute, and the Director of the Center concerning matters relating to the scientific activities carried out by and through the Center and the policies respecting such activities, including recommendations. (42 USC § 285b–7) http://www.nhlbi.nih.gov/meetings/sdrab/index.htm |
| Smokefree.gov | Resource Development | CDC, OS | NCI, OD/DPCPSI/OBSSR | Smokefree.gov is intended to help individuals quit smoking. Different people need different resources as they try to quit. The information and professional assistance available on this Web site can help to support both immediate and long-term needs as individuals become, and remain, a nonsmoker. Smokefree.gov allows individuals to choose the help that best fits their needs. This collaboration also includes a number of smoking cessation text message programs throughout the world: China, Caribbean, Guam, American Samoa, and Samoa. http://smokefree.gov/ |
| Smoking Cessation Services During CDC TIPS II Campaign | Public Education Campaign | CDC | NCI | To assist in ensuring that 1-800-QUIT-NOW''s counseling services and the National Cancer Institute''s text messaging service and web site (Smokefree.gov) have adequate capacity to meet the expected increased demand for services during the Centers for Disease Control and Prevention TIPS Campaigns |
| Smoking Cessation Workgroup | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, OS, SAMHSA | NIDA, NCI | Discussion of current HHS initiatives on efforts to support smoking cessation. |
| Society for Prevention Research Annual Meetings | Meeting/ Workshop | ACF, CDC | NIDA, NCI, NIAAA, NICHD, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The Society for Prevention Research was formed in 1991 and has grown from a small group of researchers focused on drug and alcohol abuse prevention and mental health to become a leading scientific organization devoted to advancing prevention science, with 700+ members and a multidisciplinary prevention focus that emphasizes drug abuse, mental health and HIV/AIDS prevention in addition to diverse, public health domains (e.g., obesity, violence, translational science). The annual meetings promote cross-fertilization of theory, methods, and intervention and provide an opportunity to enhance understanding of the underlying mechanisms of health-related issues with the goal of building the science of effective strategies, and for prevention and health promotion. http://preventionscience.org |
| Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women''s Health | Research Initiative | FDA | OD/DPCPSI/ORWH, NIAMS, NICHD, NIDA, NIDDK, NIMH | The Specialized Centers of Research (SCOR) programs are large Center Programs (P50) that consist of 11 Centers that conduct interdisciplinary research focused on health issues that affect women and examine sex/gender contributions to health and disease. The currently funded SCORs are interdepartmental, intercollegiate, interinstitutional and focus on sex differences in musculoskeletal health, tobacco, addiction, substance abuse, reproductive health, urinary tract, depression, metabolic disorders and pain. The SCOR mechanism promotes collaborative research among scientists with varied expertise in order to achieve research objectives that are less likely to occur through other grant mechanisms. http://orwh.od.nih.gov/sexinscience/researchtrainingresources/scor.asp |
| Specificity and Quality of Influenza Specific Antibodies | Research Initiative | FDA | NIAID | This collaboration supports the evaluation of specificity and quality of influenza specific antibodies in human subjects that have been vaccinated or naturally infected with influenza. Specific tasks include the construction of phage display libraries, production of recombinant proteins, development of surface plasmon resonance assays and the use of these technologies to measure antibody affinity maturation. |
| Standardization of Methods to Generate Spiked Clinical Samples for Use in Studies to Support FDA Clearance of Diagnostics for Low Prevalence Pathogens | Research Initiative | FDA | NIAID | The National Institutes of Health (NIH) has been working with the Food and Drug Administration (FDA) to develop standardized methods to generate clinical samples to assess the performance of diagnostic tests. |
| Standards for Genetic Testing Report | Research Initiative | AHRQ, CDC, OS | NLM, NHGRI | This activity aims to develop a standard reporting format for genetic variations using Logical Observation Identifiers Names and Codes (LOINC) and HL7, for electronic medical records health information exchange, and activities of the Office of the Secretary. |
| State Cancer Profiles | Resource Development | CDC | NCI | The objective of the State Cancer Profiles Web site is to provide a system to characterize the cancer burden in a standardized manner in order to motivate action, integrate surveillance into cancer control planning, characterize areas and demographic groups, and expose health disparities. The focus is on cancer sites for which there are evidence based control interventions. Interactive graphics and maps provide visual support for deciding where to focus cancer control efforts. http://statecancerprofiles.cancer.gov/ |
| Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of Youth with Undiagnosed HIV Infection (SMILE in CARING for YOUTH) | Research Initiative | CDC | NICHD, NIDA, NIMH | The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) was awarded grant money to expand their project of increasing availability of HIV testing for adolescents 12-24 and the provision of adolescent-focused healthcare services for those adolescents who are diagnosed with HIV infection. The project’s expansion includes all the ATN sites across the U.S. The Eunice Kennedy Shriver National Institute of Child Health and Human Development is collecting data to evaluate the effectiveness of adolescent oriented linkage to care services for the HIV infected adolescents. This collaboration has the potential to improve the health of American youth, both by identifying those with undiagnosed HIV and bringing them into adolescent-friendly treatment programs and by reducing the chances of them further spreading the virus to others. There is a committee "SMILE in CARING for YOUTH" that monitors activities related to the National Institutes of Health-Centers for Disease Control and Prevention collaboration on enhancing treatment and retention in care of HIV youth. |
| Structured Data Capture (SDC) Initiative | Resource Development | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS | NLM, NCI | The Structured Data Capture (SDC) Initiative is sponsored by the Department of Health and Human Services, Office of the National Coordinator (ONC), as part of the Standards and Interoperability Framework, a program developed to foster collaboration between the public and private sectors to promote interoperable exchange of health data and information. The SDC mission is to develop and validate a data architecture and exchange standards so that a structured set of data can be accessed from electronic health record systems, merged with comparable data and made accessible for purposes other than clinical care, such as research, patient safety and public health. The SDC Working Group on Common Data Elements and Forms, chaired by NLM/NIH with NCI/NIH participation, evaluated and selected two ISO standards to serve as the basis for definitions of Common Data Elements and electronic Case Report Forms (eCRF) under the initiative: ISO/IEC 11179 (Metadata Registries and Data Elements metamodel) and ISO/IEC 19763-13 (Forms metamodel). |
| Structured Data Capture Forms and Common Data Element Working Groups | Other | AHRQ, CDC, FDA | NCI, NLM | This working group designed a Structured Data Capture (SDC) form and Data Element structure, as well as developed XML artifacts and an implementation guide. Provided expertise on ISO 11179 and 19763-13. We participated in a connectathon with CDC and FDA in 2015, and are monitoring activity ongoing. The 2016 connectathon is testing version 2 for the form design, we intend to realign our forms to enable transformation between NCI forms and SDC forms once the standard is stabilized. http://wiki.siframework.org/Structured+Data+Capture+Initiative |
| Study of Cancer Among United States Firefighters | Research Initiative | CDC | NCI | A retrospective cohort study to evaluate the relationship between occupational exposures of firefighters and cancer risk. http://www.cdc.gov/niosh/firefighters/ffcancerstudy.html |
| Sub-SPIRIT Ebola Environment Sampling Concept of Operations | Committee, Work group, Advisory group, or Task Force | FDA, OS, SAMHSA | NICHD | The goal of this effort is to develop concepts of operations (CONOPS) for strategic research, including both controlled-environment and systematic field studies, to improve our understanding of the real-world environmental fate and transport of the Ebola virus to provide additional data to support public health efforts to protect at-risk workers and the public. |
| Subpopulations and Intermediate Outcome Measures in Chronic Obstructive Pulmonary Disease (COPD) | Research Initiative | FDA | NHLBI | SPIROMICS (SubPopulations and Intermediate Outcome Measures In Chronic Obstructive Pulmonary Disease Study) is an observational study of COPD (Chronic Obstructive Pulmonary Disease) that seeks to identify practical intermediate outcome measures and mechanistically homogeneous subgroups of patients with the disease. The study was developed in cooperation with the U.S. Food and Drug Administration and will be implemented with industrial partners. http://www2.cscc.unc.edu/spiromics |
| Sudden Death in the Young (SDY) Registry | Resource Development | CDC, HRSA | NINDS, NHLBI | The Sudden Death in the Young (SDY) Registry is a surveillance system to track sudden deaths in youths less than or equal to 19 years of age in up to 10 states and gather clinical data and a DNA sample to be used for research to explore the causes and risk factors for sudden death in the young. The SDY Registry is a collaboration between the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), and Centers for Disease Control and Prevention (CDC). http://www.nhlbi.nih.gov/news/press-releases/2013/nih-and-cdc-launch-registry-for-sudden-death-in-the-young.html |
| Sudden Unexpected/Unexplained Infant Death (SUID)/Sudden Infant Death Syndrome (SIDS) workgroup | Meeting/ Workshop | ACF, CDC, FDA, HRSA, IHS | NICHD | NICHD co-chairs with HRSA, a Federal Sudden Unexpected/Unexplained Infant Death (SUID) /Sudden Infant Death Syndrome (SIDS) Workgroup. The partner agencies include the Administration for Children and Families (ACF); Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, and Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH); Food and Drug Administration (FDA); Maternal and Child Health Bureau (MCHB), Health Resources and Services Administration (HRSA); the Indian Health Service (IHS); Division of Information and Education, HHS Office of Minority Health (OMH); Consumer Product Safety Commission (CPSC); and Office of the Deputy Assistant Secretary of Defense, Military and Community Family Policy, Family Advocacy Program, Department of Defense (DoD). The common commitment of the ACF, CDC, NIH, FDA, HRSA, IHS, HHS/OMH, CPSC, and DoD is to address the public health challenges of SIDS and SUID and opportunities for prevention in the United States. The purpose of the partnership is to establish and enhance relationships among Federal agencies with responsibilities for SIDS and SUID. The partner agencies intend to work together to improve communication and coordination, and to collaborate on a range of activities designed to reduce, and, ultimately, eliminate SIDS and SUID, including the elimination of racial, ethnic and socio-economic disparities. In 2015 proactive and reactive letters were drafted, reviewed and approved by the SUID/SIDS federal workgroup with the intent of encouraging internal and external stakeholders to promote and share safe sleep messages through images and asking people to support safe sleep messages. |
| Suicide Mortality Surveillance | Other | CDC | NIMH | Through the Suicide Mortality Surveillance project, the Centers for Disease Control (CDC) will develop and refine a rapid suicide mortality surveillance system. Monitoring the trends in cause-specific mortality is critical for identifying emerging public health problems and in generating evidence for health policy development, implementation, and evaluation. Timely information is important for monitoring severity of the disease or condition, allocating resources, and facilitating preventive and control programs. The results from this study will yield valuable information about the validity, feasibility, and timeliness of the enhanced vital statistics system for rapid suicide surveillance. |
| Support for Implementation of Agency Public Access Policies | Resource Development | AHRQ, CDC, FDA, OS | NLM | NIH Public Access Policy was created by NIH and established in statute by Congress in the Consolidated Appropriations Act 2008, P. L. 110-161, enacted on 12/26/2007. It ensures that the public can access without charge peer-reviewed journal articles arising from NIH-funded research. Since 2008, the PubMed Central (PMC) database has served as the repository for journal articles subject to the NIH Public Access Policy. The Office of Science and Technology Policy (OSTP) coordinated the development of public access policies across federal science agencies, and OSTP released a directive in February 2013 to increase public access to scientific publications and digital data. NIH is collaborating with five divisions and offices in HHS and four agencies outside HHS to use PMC and related services in support of their public access policies. Interagency agreements have been signed with AHRQ, ASPR, CDC, and FDA within HHS, as well as NASA, NIST and VA. Agreements are also being discussed with the Administration for Community Living (ACL) in HHS, and EPA. Researchers from CDC and VA began depositing manuscripts in PMC in early 2015. FDA and NIST, along with the other agencies expect to begin 2016. |
| Support for the Federal Interagency Forum on Child and Family Statistics | Research Initiative | ACF, AHRQ, CDC, HRSA, SAMHSA | NICHD, NIDA, NIMH | The purpose of this IAA is to provide funds to support the work of the Federal Interagency Forum on Child and Family Statistics (Forum). The purpose of the Forum is to foster collaboration among Federal agencies that produce or use statistical data on children and families. Specifically, the Forum seeks to improve both the quality and use of data on children and families by investigating questions of data quality, data measurement, and data integration; identifying information gaps and data inconsistencies; widening access to information on children and families through the annual publication American’s Children: Key National Indicators of Well-Being and other means; coordinating the development and use of statistical data bases among Federal agencies ; promoting communication among data producers, researchers, and public policymakers; and addressing concerns regarding collection, access, and dissemination of data. http://childstats.gov |
| Surveillance, Epidemiology and End Results (SEER) - Medicare Database | Resource Development | CMS | NCI | The Surveillance, Epidemiology, and End Results (SEER)-Medicare data are a unique resource that can be used for research related to the health care provided to persons with cancer. The database results from the linkage of two large population-based data sources: the SEER cancer registries data and the Medicare enrollment and claims files. http://healthservices.cancer.gov/seermedicare/ |
| Surveillance, Epidemiology, and End Results (SEER) Program | Resource Development | CDC | NCI | The Surveillance, Epidemiology, and End Results (SEER) program is the premier source for cancer statistics in the U.S. It collects information on incidence, prevalence and survival from specific geographic areas representing 26 percent of the US population. Through SEER, we develop reports on all of these information areas plus cancer mortality for the entire country. The site is intended for anyone interested in U.S, cancer statistics or cancer surveillance methods. http://seer.cancer.gov/ |
| Survive and Thrive Global Development Alliance Steering Committee | Committee, Work group, Advisory group, or Task Force | ACL | NICHD | The Survive and Thrive Global Development Alliance aims to reduce maternal, neonatal, and child mortality and promote health in low-resource countries, by increasing access to evidence-based, health interventions, technologies, and training. |
| Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT) | Resource Development | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NLM | This activity provides support for SNOMED CT, a systematically organized computer processable collection of medical terminology covering most areas of clinical information such as diseases, findings, procedures, microorganisms, pharmaceuticals etc. It allows a consistent way to index, store, retrieve, and aggregate clinical data across specialties and sites of care. It also helps organizing the content of medical records, reducing the variability in the way data is captured, encoded and used for clinical care of patients and research. http://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html |
| Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling | Research Initiative | FDA | NIDCR, NIDCD | The activity will test new animal models of head and neck squamous cell cancer with targeted treatments using Interleukin-13 Receptor alpha 2 antagonists. |
| Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | NHLBI, NCMHD, NIAID, NICHD, NIEHS, NINR | The Action Plan to Reduce Asthma Disparities promotes collaboration and coordination among Federal agencies to leverage existing resources to address the multi-leveled causes of asthma disparities. The Action Plan outlines four key strategies to improve the quality of care for children who have asthma and promote community programs and resources to support clinicians, children, and their families in following best practices for asthma management. |
| TB Therapeutics Research Coordination Forum | Committee, Work group, Advisory group, or Task Force | CDC | NIAID | The purpose of the TB (Tuberculosis) Therapeutics Research Coordination Forum (“the Forum”) is to support and sustain discussion, information sharing, and decision making to coordinate clinical trials of new TB drug combinations. The overall goal is to advance new therapies rapidly and cost-effectively while maintaining the highest standards of scientific rigor. The Forum will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations. |
| Technical and Clinical Consultation to Indian Health Service in Kidney Disease | Public Education Campaign | IHS | NIDDK | A National Institute of Diabetes and Digestive and Kidney Diseases senior staff member serves as Chief Clinical Consultant for Nephrology for the Indian Health Service. |
| Technical Consultation on Viral Hepatitis (HCV) Infection in Young Injection Drug Users | Meeting/ Workshop | CDC, OS, SAMHSA | NIDA, NIAID, NIDDK | This collaboration brings Federal and non-Federal clinician/researchers from academia, state public health departments and community together to present and discuss current research and other information on an emerging epidemic of viral hepatitis (HCV) infection in the 15-30 year group of Injection Drug Users (IDUs). http://www.drugabuse.gov |
| Technical Resources Assistance Center and Information Exchange (TRACIE) | Resource Development | OS | NLM | This activity is to develop the Technical Resources Assistance Center and Information Exchange (TRACIE), a resource center, database, and methodology for healthcare facilities and coalitions to obtain information and assistance in emergency preparedness and response. https://asprtracie.hhs.gov |
| Teen Dating Violence Workgroup | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA, OS, SAMHSA | NICHD, NIAAA, NIDA, NIMH | The idea for the group developed out of a workshop on teen dating violence that the National Institute of Justice, an agency in the Office of Justice Programs, Department of Justice, hosted in July 2006. In addition to researchers and practitioners in the field, representatives from several Federal agencies were invited to the workshop. The Federal representatives who attended the workshop decided that it would be mutually beneficial to continue meeting and eventually formed a working group of all Federal agencies with an interest in understanding and preventing teen dating violence. The group is intended to be a forum for information sharing, cooperation, and collaboration. The Violence Against Women Act of 2005 includes a new emphasis on addressing teen dating violence. Recognizing that adolescents experience high rates of sexual assault and intimate partner violence, the Act provides for the provision of education and services to children and youth. The Workgroup is attentive to the congressional mandate to address teen dating violence. The first meeting of the Workgroup was held in September 2006 and meetings are quarterly. One goal of the group is to keep each other informed about teen dating violence efforts and initiatives in each of our agencies. Another goal is to develop collaborative projects that encourage the pooling of resources to combat relationship abuse and violence among adolescents. The Workgroup currently has 30 active participants, representing 19 Federal agencies. The members of the Workgroup hope that we can count on our agencies to support our collaborative efforts, including the ongoing sharing of information, continued attendance at meetings, and consideration of support for proposed ideas that come out of the Workgroup. http://www.nij.gov/topics/crime/intimate-partner-violence/teen-dating-violence/research-agenda.htm |
| Text4baby | Public Education Campaign | ACF, AHRQ, CDC, CMS, HRSA, IHS, SAMHSA | NIDCR, NICHD, NIDA, NIDDK | Free health text messaging service for pregnant women and new mothers. Those who text "BABY" (or “BEBE” for Spanish) to 511411 receive weekly text messages, timed to their due date or their baby''s birth date through the baby’s first year. Messages, which have been vetted by both government and non-profit health experts, deal with topics such as nutrition, immunization, birth defect prevention, and oral health. http://www.text4baby.org |
| The Agricultural Health Study | Research Initiative | CDC, SAMHSA | NIEHS, NCI | "The Agricultural Health Study (AHS) is a prospective study of cancer and other health outcomes (e.g. Parkinson’s disease, diabetes, thyroid disease, respiratory diseases, rheumatoid arthritis and other autoimmune disorders, and reproductive health) in a cohort of licensed pesticide applicators and their spouses from Iowa and North Carolina. The AHS began in 1993 with the goal of answering important questions about how agricultural, lifestyle and genetic factors affect the health of farming populations. The study is a collaborative effort involving investigators from National Cancer Institute, the National Institute of Environmental Health Sciences, the Environmental Protection Agency, and the National Institute for Occupational Safety and Health. More than 89,000 pesticide applicators and spouses in Iowa and North Carolina have participated in the study. Their participation has provided, and continues to provide, the data that researchers need to help the current and future generations of farmers and their families live healthier lives. Between 1993 and 1997, 52,394 licensed private pesticide applicators (mostly farmers) from Iowa and North Carolina enrolled, as did 32,345 of their spouses. The study also included 4,916 commercial pesticide applicators in Iowa in its first two phases. The average ages at enrollment were 47.1 years, 38.0 years, and 46.9 years for private applicators, commercial applicators and spouses. The study began by collecting baseline information from participants when they enrolled (1993-1997). Follow-up telephone interviews were conducted in the second (1999-2003), third phase (2005-2010), and fourth phases (2013-2015) of the study. At Phase 2, participants provided updated information on farming practices, lifestyle, and health and were asked to complete a dietary questionnaire and provide a sample of cheek cells as a source of DNA. The Phase 3 interview also updated information on farming practices, lifestyle, and health while Phase 4 focused on changes in health status. The cohort continues to be followed via linkages with cancer registries and vital statistics. Participants periodically participate in comprehensive sub-studies, including an investigation of genetic and environmental risk factors for asthma and other respiratory diseases and studies of Parkinson’s disease, neurobehavioral function and cognitive decline. Biological and environmental samples are being collected from a subset of the cohort to facilitate mechanistic studies that might explain links between pesticide and other exposures and increased risk for cancer and other conditions. " http://www.aghealth.nih.gov/ |
| The American Congress of Obstetricians and Gynecologists (ACOG) Committee for Healthcare for Underserved Women | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | The purpose of this committee is to identify and address barriers to care, and monitor access to specific women’s health care services. http://www.acog.org/About-ACOG/ACOG-Departments/Health-Care-for-Underserved-Women |
| The American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | This committee addresses gynecologic practice issues. |
| The American Congress of Obstetricians and Gynecologists (ACOG) reVITALize | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, HRSA | NICHD | The American College of Obstetricians and Gynecologists and the members of the Women’s Health Registry Alliance lead the reVITALize data definition standardization efforts to harmonize definitions for the data elements used in obstetrics and gynecology. The harmonization of these definitions is critical to assure that data sharing and aggregation can provide the kind of quality information we will need to provide the best care for women and newborns now and in the future. http://www.acog.org/About-ACOG/ACOG-Departments/Patient-Safety-and-Quality-Improvement/reVITALize |
| The Biomarkers of Nutrition for Development (BOND) program | Research Initiative | CDC | NICHD | The Biomarkers of Nutrition for Development (BOND) program is designed to harmonize the process for selection, use, and interpretation of biomarkers to assess exposure, status, and effect of nutrients. BOND has also involved close collaborations with CDC both in terms of the development of the evidence informed reviews and the implementation of the results domestically and internationally. In addition FDA has served as a member of the BOND steering committee and staff have participated in the development of BOND outputs. https://www.nichd.nih.gov/global_nutrition/programs/bond/Pages/index.aspx |
| The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative | Research Initiative | FDA | NINDS, NCCIH, NIA, NIBIB, NIDA, NIDCD, NIMH | The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is part of a new Presidential focus aimed at revolutionizing our understanding of the human brain. By accelerating the development and application of innovative technologies, researchers will be able to produce a revolutionary new dynamic picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space. Long desired by researchers seeking new ways to treat, cure, and even prevent brain disorders, this picture will fill major gaps in our current knowledge and provide unprecedented opportunities for exploring exactly how the brain enables the human body to record, process, utilize, store, and retrieve vast quantities of information, all at the speed of thought. http://braininitiative.nih.gov/ |
| The Critical Path Institute (C-Path) International Neonatal Consortia (INC) | Committee, Work group, Advisory group, or Task Force | FDA | NICHD | The International Neonatal Consortium (INC). INC is a coalition of industry, academia, patient representatives, the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), other governmental agencies, professional organizations, foundations and the Critical Path Institute (C-Path) that will focus on accelerating the development of safe and effective treatments for neonates. http://c-path.org/programs/inc/ |
| The Critical Path Institute (C-Path) Global Pediatrics Trials Consortium | Committee, Work group, Advisory group, or Task Force | FDA | NICHD | The Critical Path Institute (C-Path), a pioneering non-profit organization dedicated to accelerating the pace and reducing the costs of medical product development by facilitating unique partnerships among a wide range of stakeholders, has formed a new consortium, the Global Pediatric Clinical Trials Network Pre-Launch Consortium (“Pre-Launch Consortium”). According to Dr. Janet Woodcock, Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), “Health care providers must have high-quality, reliable data to inform treatment decisions for their pediatric patients. C-Path has leveraged its expertise and stakeholders to support the development of a first-of-its-kind pediatric clinical trial network. The Pre-Launch Consortium signals an important step toward efficient and sustainable pediatric data collection and development of better treatments for children. I strongly support this effort and look forward to working with this global consortium.” The mission of the Pre-Launch Consortium will be the formation of an independent non-profit entity that will operate a novel global pediatric clinical trials network (“Network”). The Pre-Launch Consortium will establish the Network, create its organizational and operating framework, and identify its leadership team. This work will involve collaborators from academia, government, scientific, and regulatory agencies, industry, foundations, child health advocacy groups, and other important stakeholders. http://c-path.org/critical-path-institute-establishes-the-global-pediatric-clinical-trials-network-pre-launch-consortium/ |
| The Effect of Various Drugs on the Retina | Other | FDA | NEI | Using powerful in vivo imaging technology, it is possible to view the retina at the cellular level. This collaboration seeks to monitor changes to the retina for drugs that are known to cross the blood/retina barrier to better understand possible toxicity. |
| The Environmental Determinants of Diabetes in the Young (TEDDY) | Research Initiative | CDC | NIDDK, NIAID, NICHD, NIEHS | This consortium is organizing international efforts to identify infectious agents, dietary factors, or other environmental factors that trigger type 1 diabetes in genetically susceptible people. The study enrolled over 8,000 newborns and is following them for 15 years to identify environmental triggers of type 1 diabetes. http://www.teddystudy.org |
| The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) | Research Initiative | CDC | NCI | EMBLEM provides a unique infrastructure to obtain valuable data and samples to study Burkitt’s lymphoma (BL) epidemiology. Study data will help characterize or investigate: 1. The association of malaria-resistance genes with endemic BL. 2. Host genetic polymorphisms associated with BL using genome-wide association methods. 3. The role of the Epstein-Barr virus (EBV) genetic variants in endemic BL. 4. The role of malaria immunology and phenotype of inflammation in BL. 5. The complexity of coinfection with different P. falciparum malaria genotypes in BL. 6. The interaction between helminthic parasites, HIV, malaria, and EBV in BL. 7. The immunohistochemistry and molecular pathology of BL. 8. The impact of malaria, helminthic parasites, and HIV on childhood BL. http://emblem.cancer.gov/ |
| The Federal Tuberculosis Task Force | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, IHS, OS | NIAID, NICHD | The Federal Tuberculosis (TB) Task Force is a coalition composed of the Federal agencies and organizations involved in U.S. TB control efforts. Established in 1991, the Task Force facilitates coordination of activities between Federal agencies. It was created by the Director of the Centers for Disease Control and Prevention (CDC) to address the outbreaks of multidrug-resistant (MDR) TB occurring during the 1985-1992 surge in TB cases. The TB Task Force is co-chaired by CDC and NIAID. http://www.cdc.gov/tb/about/taskforce.htm |
| The Healthy Brain Initiative | Public Education Campaign | ACL, CDC | NIA | A call to action and a guide to assist in implementing a coordinated approach to moving cognitive health into public health practice. http://www.cdc.gov/aging/healthybrain/index.htm |
| The Impact of Tobacco Use on Oral Health and the Oral Microbiome | Research Initiative | CDC, FDA | NCI | U.S. Food and Drug Administration Intramural Center of Tobacco Regulatory Science Award Program funded a project examining how tobacco affects oral health and the oral microbiome in the National Health and Nutrition Examination Survey (NHANES) study. |
| The Incidence of Breast and Other Cancers Among Female Flight Attendants | Research Initiative | CDC | NCI | A cohort study of approximately 10,000 Pan Am flight attendants to determine cancer incidence (primarily breast cancer) associated with cosmic radiation and circadian disruption from their work. |
| The Interagency Committee on Human Nutrition Research (ICHNR) | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIDDK | The Interagency Committee on Human Nutrition Research (ICHNR) provides a mechanism for communicating among the various Federal agencies to enhance the coordination of human nutrition research activities. http://www.niddk.nih.gov/about-niddk/offices-divisions/office-nutrition-research/Pages/default.aspx |
| The Intersection of Violence and HIV Risk in Women Working Group | Committee, Work group, Advisory group, or Task Force | ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OAR | This working group established to address the research issues on violence and HIV in women including research gaps, current knowledge and current interventions. The working group conducted meetings separately and together with the White House working group in which they provided information and recommendations to the White House Violence against Women and HIV Initiative. The activities of this working group were integrated into the National HIV/AIDS Strategy. http://www.whitehouse.gov/sites/default/files/docs/vaw-hiv_working_group_report_final_-_9-6--2013.pdf; http://www.whitehouse.gov/the-press-office/2012/03/30/presidential-memorandum-establishing-working-group-intersection-hivaids-; |
| The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NCI, NIBIB, OD/OSP | This subcommittee of the National Science and Technology Council''s Committee on Technology is responsible for coordinating the National Nanotechnology Initiative (NNI). The NNI was established in 2001 to coordinate federal research and development in nanotechnology by providing a vision of the long-term benefits and opportunities offered by nanotechnology and acting as a locus for communication, cooperation, and collaboration between federal agencies involved in nanotechnology research and development. In 2011, the NSET developed a strategic plan that encompasses a comprehensive nanotechnology R&D initiative built on shared goals, priorities, and strategies that complement agency-specific missions and activities. http://www.nano.gov/nset |
| The NIH Bone Marrow Stromal Cell Transplantation Center | Research Initiative | FDA | NIDCR, CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NINDS | The mission of the NIH Bone Marrow Stromal Cell (BMSC) Transplantation is to develop clinical grade bone marrow stromal cells for use in clinical trials that utilizes the ability of these cells to exert immunomodulatory and immunosuppressive effects that are beneficial for the treatment of a number of diseases and disorders, and to provide assistance to clinical investigators in the preparation of regulatory documents for institutional review boards and the U.S. Food and Drug Administration. http://sigs.nih.gov/bmsctc/Pages/default.aspx |
| The Public Health Service (PHS) Men Who Have Sex With Men (MSM) Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The Working Group is developing guidelines and strategies to improve HIV/STD programs for men who have sex with men (MSM). |
| The Public Health Service (PHS) Review Committee on the Use of Marijuana in Clinical Research | Committee, Work group, Advisory group, or Task Force | FDA, OS, SAMHSA | NIMH, NCCIH, NIDA, NINDS | Follow-up review of revised application for purchase of research-grade marijuana from NIDA for use in proposed treatment study of refractory post-traumatic stress disorder (PTSD) in military veterans. An additional protocol revision and re-review are planned. http://www.drugabuse.gov/marijuana-research-nida |
| The Science of Sex and Gender in Human Health | Training Initiative | FDA | OD/DPCPSI/ORWH | This is a Web-based course that offers a scientific understanding of the major physiological differences between the sexes; their influence on illness and health outcomes; and their implications for policy, medical research, and health care. http://sexandgendercourse.od.nih.gov/ |
| The U.S. Transfusion-Transmissible Infection Monitoring System (TTIMS) – Blood donation safety monitoring program | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The TTIMS project includes characterization of transfusion-transmissible infection (TTI) marker risks in at least half of the U.S. blood supply with monitoring of temporal, geographic, and demographic trends, and provides a framework for evaluating the effect of a new intervention (such as implementation of a new deferral policy) on TTI risks and blood donor risk factors. This program fills a significant gap in current public health blood donor surveillance efforts by monitoring the safety of the nation’s blood supply and can serve as a resource for additional investigations. |
| The United States Renal Data System (USRDS) | Resource Development | CMS, HRSA | NIDDK | The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about chronic kidney disease and end-stage renal disease (ESRD) in the U.S. The missions of the USRDS are: (1) To characterize the total renal patient population and describe the distribution of patients by socio-demographic variables across treatment modalities; (2) To report on the incidence, prevalence, mortality rates, and trends over time of renal disease by primary diagnosis, treatment modality and other variables; (3) To develop and analyze data on the effect of various modalities of treatment by disease and patient group categories; (4) To identify problems and opportunities for more focused special studies of renal research issues; (5) To conduct cost effectiveness studies and other economic studies of ESRD; and (6) To make the data available to investigators, and by supporting investigator-initiated projects, to conduct biomedical and economic analyses of ESRD patients. http://www.usrds.org |
| Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NCATS | A group of Therapeutics for Rare and Neglected Diseases (TRND) staff and U.S. Food and Drug Administration (FDA) staff from the Center for Drug Evaluation and Research (CDER) meet on a semi-monthly basis to discuss projects for the TRND program. The purpose of this working group is to discuss the scientific progress on each project toward the eventual goal of an Investigational New Drug Application for each project. Results of experiments are discussed, and TRND staff takes the feedback of FDA/CDER staff into consideration when developing future project plans. http://www.ncats.nih.gov/research/rare-diseases/trnd/trnd.html |
| Tobacco and Nicotine Research Interest Group (TANRIG) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, SAMHSA | NIDA, NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIEHS, NIMH, NINR, OD/DPCPSI/OBSSR | The Tobacco and Nicotine Research Interest Group (TANRIG) was formed in January 2003 with the goal of increasing collaboration, coordination, and communication of tobacco- and nicotine-related research among National Institutes of Health Institutes and Centers, as well as with other relevant U.S. Department of Health and Human Services agencies. http://sigs.nih.gov/tobacco/Pages/default.aspx |
| Tobacco Regulatory Science Program (TRSP) | Research Initiative | FDA | OD/DPCPSI/ODP, CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIDCR, NIEHS, OD/OER | Located in the National Institutes of Health (NIH) Office of Disease Prevention, the Tobacco Regulatory Science Program (TRSP) coordinates the trans-NIH collaborative effort with the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support its regulatory activities over tobacco products. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research. The NIH has the infrastructure for the solicitation, review, and management of research. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. Support from FDA was used to fund grants and to provide administrative support and oversight to manage Funding Opportunity Announcements (FOA), application review, policy implementation and oversight, and communicating and reporting to a variety of sources. https://prevention.nih.gov/tobacco-regulatory-science-program |
| Tox21 - Memorandum of Understanding on High Throughput Screening, Toxicity Pathway Profiling, and Biological Interpretation of Findings | Research Initiative | FDA | NIEHS, NCATS | This Memorandum of Understanding sets in place mechanisms to strengthen existing collaborations in the research, development, validation, and translation of new and innovative test methods that characterize key steps in toxicity pathways. Central is the exploration of high throughput screening assays and tests using phylogenetically lower animal species as well as high throughput whole genome analytical methods, to evaluate mechanisms of toxicity. Ultimately, the data generated by these new tools is to be provided to risk assessors to use in the protection of human health and the environment. Success is expected to result in test methods for toxicity testing that are more scientifically and economically efficient and models for risk assessment that are more biologically based. http://www.ncats.nih.gov/tox21 |
| Toxicology and Risk Assessment Conference (TRAC) | Committee, Work group, Advisory group, or Task Force | ATSDR | NIEHS | Toxicology and Risk Assessment Conference (TRAC) is an annual conference planned by multiple Federal Agencies to develop new policy and training modules for risk assessment. The broad base of federal partners includes: ATSDR; NIOSH; USAF 711th HPW/AFRL; USAFCEC; USAPHC; US NAMRU; USEPA-NCEA. In 2015, the planning committee developed a memorandum of understanding to secure agency involvement for providing scientific direction for the conference (i.e. technical input). http://www.cdc.gov/niosh/conferences/TRAC/ |
| Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NIAID | The presidential declaration issued at the 2009 EU-US summit called for the creation of “a transatlantic task force on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us.” The objectives of the Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) are to increase the mutual understanding of U.S. and EU activities and programs relevant to the antimicrobial resistance issues identified in the declaration to deepen the transatlantic dialogue, provide opportunities to learn from each other, and promote information exchange, coordination, and cooperation. http://www.cdc.gov/drugresistance/tatfar/ |
| Trans-NIH American Indian and Alaska Native Health Communications and Information Workgroup | Committee, Work group, Advisory group, or Task Force | ACL, IHS | NIAMS, CC, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/ORWH, OD/OCPL | Formed in 2005, the Trans-NIH AI/AN Health Communications and Information Work Group provides a forum for health education and communications staff from National Institutes of Health (NIH) Institutes, Centers, and Offices to share strategies and effective communication approaches to develop and disseminate health information to American Indian and Alaska Native communities. In partnership with the Indian Health Service (IHS) and the Administration on Aging/Administration for Community Living (AoA/ACL), the Work Group conducts outreach to 1,600 IHS Community Health Representatives (CHRs) and 600 AoA/ACL Title VI grantees nationwide through quarterly e-newsletters featuring NIH health information. The e-newsletter, which replaced quarterly hard-copy mailings, features a wide range of health topics and is distributed to IHS CHRs and AoA/ACL grantees that provide services to Native elders. The purpose of the project is to increase awareness among CHRs and Title VI grantees about the availability of free or low-cost, science-based health information for patients and the general public. http://www.niams.nih.gov/About_Us/Mission_and_Purpose/Community_Outreach/Multicultural_Outreach/AIAN_WG/default.asp |
| Trans-NIH Plan for HIV-Related Research | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS | OD/DPCPSI/OAR, CSR, FIC, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI, OD/DPCPSI/ORWH | Each scientific area of the strategic plan is developed by Coordinating Committees comprised of representatives from the NIH Institutes and Centers and scientific experts from other agencies, including CDC, HRSA, VA, USAID, DoD, and PEPFAR. These committees assist in developing the annual Trans-NIH Plan for HIV-Related Research to ensure that the AIDS research budget funds the highest priority HIV/AIDS research. The plan 1) frames the development of the NIH AIDS research budget; 2) determines the use of NIH AIDS-designated dollars; 3) tracks and monitors HIV/AIDS research expenditures; and 4) informs the public, the scientific community, Congress, and the AIDS-affected communities about the NIH HIV/AIDS research agenda. The Plan also shapes the NIH investment in HIV/AIDS research. http://www.oar.nih.gov/strategicplan/ |
| Trans-NIH Structural Birth Defects Working Group (SBDWG) | Committee, Work group, Advisory group, or Task Force | CDC | NICHD, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NIDCR, NIDDK, NIEHS, NINDS | The Trans-NIH SBDWG brings together extramural program officials from NIH components whose missions include research into structural birth defects, with the ultimate goal of facilitating advances in our understanding of the etiology, mechanisms, epidemiology, prevention, and treatment of structural birth defects. http://www.nichd.nih.gov/NIHstructuralbirthdefectsWG |
| Trans-NIH Topics for Twitter chats | Public Education Campaign | OS | NICHD, NCI, NIDA, NIMH | The NICHD plays an active role in social media, including leading Twitter chats on different topics within its mission. Often these topics also fall into the portfolios of other NIH Institutes and Centers, so the NICHD reaches out to those Institutes to request their participation, which provides a broader range of research-based information to chat participants. For example, the NICHD led a Twitter chat about the teen brain in collaboration with ABC News'' Chief Health and Medical Editor, Dr. Richard Besser, the National Institute of Mental Health, and the HHS Office of Adolescent Health. The chat was well attended, 44,400,000 impressions made; 1,800 tweets posted; and 439 users. In addition to NUMH, the National Institute on Drug Abuse and the National Institute on Alcoholism and Alcohol Abuse also participated in the chat. https://www.nichd.nih.gov/news/resources/links/Pages/index.aspx#twitter |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community | Research Initiative | ACL | NIA | The National Institute on Aging (NIA) is soliciting applications using the National Institutes of Health R01 and R21 award mechanisms for translational research that move evidence-based research findings toward the development of new interventions, programs, policies, practices, and tools that can be used by community-based organizations to help elderly individuals remain healthy and independent, and living in their own homes and communities. The goal of this initiative is to support translational research involving collaborations between academic research centers and community-based organizations with expertise serving the elderly, specifically encouraging connections with Area Agencies on Aging, organizations affiliated with the Corporation for National and Community Service, and other entities that will enhance our understanding of practical tools, techniques, programs, and policies that communities across the nation can use to more effectively respond to needs of their aging populations. http://grants.nih.gov/grants/guide/pa-files/PA-11-123.html |
| Transplant Cancer Match Study | Research Initiative | HRSA | NCI | A study linking databases of U.S. transplant recipients, donors, and wait list candidates to multiple U.S. cancer registries to evaluate the spectrum of cancer risk in transplant recipients. http://transplantmatch.cancer.gov/ |
| Traumatic Brain Injury Common Data Elements Standards - Interagency Steering Committee | Resource Development | CDC | NINDS, CIT | The Traumatic Brain Injury (TBI) Common Data Elements (CDE) Standards – Interagency Steering Committee provides oversight to a Federal scientific initiative to develop and utilize common data elements for TBI. http://www.commondataelements.ninds.nih.gov/TBI.aspx#6 |
| Treating for Two Interagency Working Group (Medications in Pregnancy) | Committee, Work group, Advisory group, or Task Force | CDC | NICHD | This workgroup supports of the objectives of the Treating for Two Initiative as described below: Women and healthcare providers don’t have enough information to answer questions about medications and pregnancy. Treating for Two is CDC’s prescription for this problem. Treating for Two aims to improve the health of women and babies by working to identify the safest treatment options for the management of common conditions before and during pregnancy. |
| Treating for Two: Safe Medication Use in Pregnancy Initiative | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA | OD/DPCPSI/ORWH, NICHD | The initiative provides expert input for the development of a conference on systematic, evidence-based review of specific medications used during pregnancy and adverse fetal outcomes. http://www.cdc.gov/pregnancy/meds/treatingfortwo/index.html |
| Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) | Research Initiative | CDC | NIDDK | Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) is a multi-center clinical research study examining the safety and efficacy of three treatment options for type 2 diabetes in the pediatric population. TODAY was initiated due to the increase in type 2 diabetes in children and adolescents, which itself is linked to the rise in obesity. http://todaystudy.org |
| Trends in Hormone Concentrations in U.S. Men and Relationship to Endocrine Disrupting Chemicals in the National Health and Nutrition Examination Survey (NHANES) Population | Research Initiative | CDC | NCI | An examination of serum hormone levels of men in the National Health and Nutrition Examination Survey (NHANES) population to determine whether levels have declined over time and whether they correlate with serum levels of endocrine disrupting chemicals. |
| Tribal Epidemiology Centers Program | Research Initiative | IHS | NIMHD | To develop Epidemiology Centers and public health infrastructure for American Indian/Alaska Native communities. http://www.ihs.gov/epi/index.cfm?module=epi_tec_tecs |
| Tribal Health Research Advisory Council (HRAC) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, IHS, OS, SAMHSA | NIMHD | To support the activities of the Council, including obtaining input from tribal leaders on health research priorities and needs, and dissemination of information. http://minorityhealth.hhs.gov/hrac/ |
| Tularemia Animal Model Qualification Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | This working group is collaborating on qualification of primate model of pneumonic tularemia under FDA''s Animal Model Qualification/Drug Development Tools Program. Animal model qualification is a regulatory decision and will be published on the FDA web site when final. Collaboration includes exchange of study data, study reports, and agreements on regulatory strategy for model qualification. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm284078.htm |
| U. S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NCI, NIEHS | The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee and Nanotechnology Environmental, and Health Implications (NEHI) Working Group provide leadership in establishing the national nanotechnology environmental, health, and safety research agenda and in communicating data and information related to environmental and health aspects of nanotechnology between National Nanotechnology Initiative (NNI) agencies and with the public. NNI activities support the development of new tools and methods required for the research that will enable risk analysis and assist in regulatory decision-making. NNI agencies engage and interact with regional, state, and local groups, educational institutions, industry-supported groups, and non-governmental organizations to enhance the impact and value of NNI efforts and to provide a collaborative approach. http://www.nano.gov/nehi |
| U.S. Preventive Services Task Force (USPSTF) | Resource Development | AHRQ | NCI, OD/DPCPSI/ODP | The U.S. Preventive Services Task Force (USPSTF) is an independent panel of non-Federal experts in prevention and evidence-based medicine and is composed of primary care providers. The USPSTF conducts scientific evidence reviews of a broad range of clinical preventive health care services (such as screening, counseling, and preventive medications) and develops recommendations for primary care clinicians and health systems that are published in the form of "Recommendation Statements." http://www.uspreventiveservicestaskforce.org/ |
| U.S.-Brazil Joint Commission Meeting on Science and Technology - Working Group on Public Health | Meeting/ Workshop | CDC, OS | NIAID, NCI | The Working Group on Public Health was established under the Joint Commission Meeting (JCM) to identify and address public health issues of mutual interest and priority. JCMS are collaborative agreements with foreign governments in fields of science and technology and are established by the U.S. Department of State. |
| U.S.-Uzbekistan Joint Committee Meeting (JCM) for Science & Technology Cooperation | Meeting/ Workshop | FDA | NIAID, NCI | This collaboration was in furtherance of the 2010 U.S.-Uzbekistan Science and Technology Agreement, signed by then Secretary of State Hillary Clinton and First Deputy Prime Minister Rustam Azimov. Approximately 30 U.S. scientists, university researchers, and representatives from both government and non-profit agencies attended, along with approximately 60 Uzbek scientists, researchers, and government officials. The aim of the Joint Committee Meeting (JCM) was to define two-year action plans for cooperation in three mutually-identified areas: agriculture, renewable energy, and evidence-based medicine. |
| Understanding and Identifying the Needs for Medical Devices | Committee, Work group, Advisory group, or Task Force | FDA | NCATS | The Institute of Medicine Rare Diseases and Orphan Products 2010 Report recommended that the FDA and NIH perform an assessment of unmet devices needs, and determine the impediments, and options for overcoming these impediments. The assessment will document examples of compelling unmet needs across sections of medical specialties culminating in a report and publication. Collaborating are the Office of rare Diseases Research at NCATS, and the Office of Orphan Product Development and other parts of the FDA. |
| Unified Medical Language System Metathesaurus (UMLS) | Resource Development | AHRQ, CDC, CMS, FDA | NLM | NLM''s Unified Medical Language System (UMLS®) facilitates the development of computer systems that behave as if they understand the meaning of the language of biomedicine and health. To that end, NLM produces and distributes the UMLS Knowledge Sources (databases) and associated software tools (programs) for use by system developers in building or enhancing electronic information systems that create, process, retrieve, integrate, and/or aggregate biomedical and health data and information, as well as in informatics research. By design, the UMLS Knowledge Sources are multi-purpose. |
| Urology Interagency Coordinating Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA | NCCIH, NCI, NIA, NICHD, NIDDK, NINDS | Public law 99-158 establishes a need for the Urology Interagency Coordinating Committee and emphasizes the importance of interagency coordinating meetings. Meetings focus on interagency collaboration to elicit ideas from meeting participants to enhance current research directions within the National Institutes of Health and form partnerships among agencies. |
| US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA | NIAID | The purpose of this committee is to provide advice and consultation to the Surgeon General on issues relating to the professional practice and personnel activities, civil service, and Commissioned Corps of the Medical Category. Provides advisory assistance to the Chief Professional Officer and to the Agency and/or Program Heads of the USPHS and to non-PHS programs that routinely use USPHS personnel. https://dcp.psc.gov/osg/physician/default.aspx |
| Value Set Authority Center (VSAC) | Resource Development | AHRQ, CDC, CMS, OS | NLM | The National Library of Medicine (NLM) provides an online repository of value sets (code sets from standardized medical vocabularies) that are used for clinical quality measurement in the CMS EHR Incentive Program (meaningful use). The Value Set Authority Center (VSAC) provides downloadable access to all official versions of vocabulary value sets contained in the 2014 Clinical Quality Measures (CQMs). Each value set consists of the numerical values (codes) and human-readable names (terms), drawn from standard vocabularies such as SNOMED CT® , RxNorm, LOINC and ICD-10-CM, which are used to define clinical concepts used in clinical quality measures (e.g., patients with diabetes, clinical visit). http://vsac.nlm.nih.gov |
| Violence Against Women Steering Committee (DHHS VAW) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/ORWH, NIA, NIAAA, NICHD, NIDA, NIMH, NLM, OD/DPCPSI, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR | The DHHS Violence Against Women Act (VAWA) steering committee is chaired by the Office on Women’s Health (OWH). The VAWA committee has the responsibility for coordinating the Department of Health and Human Services (DHHS) response to issues related to violence against women and their children, and also coordinates DHHS violence related activities with those of other Federal agencies. The members of the committee establish links with professional societies in the health and social service fields to increase attention to women’s health and violence issues. The members of the committee also serve as resource experts for the National Advisory Committee on VAW, which is chaired by the HHS Secretary and the DOJ Attorney General. http://womenshealth.gov/about-us/who-we-are/groups-committees/steering-committee.html |
| Viral Hepatitis Implementation Group | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA | NIDDK, NIDA | Building on the success of the nation’s first comprehensive cross-agency action plan, released in 2011, the U.S. Departments of Health and Human Services (HHS), Housing and Urban Development (HUD), Justice (DOJ), and Veterans Affairs (VA) released a 3-year update of the plan in April 2014. The updated Viral Hepatitis Action Plan builds on the foundation of and momentum generated by the original action plan and seeks to harness: new recommendations for health care providers regarding screening for hepatitis C; promising new developments in treatments for hepatitis C; mounting public awareness of and concern about hepatitis B and hepatitis C; and the expansion of access to viral hepatitis prevention, diagnosis, care, and treatment offered by the Affordable Care Act. http://www.hhs.gov/ash/initiatives/hepatitis/ |
| We Can! (Ways to Enhance Children’s Activity and Nutrition) | Public Education Campaign | CDC, HRSA | NHLBI, NCI, NICHD, NIDDK | Through the We Can! (Ways to Enhance Children’s Activity and Nutrition) program, the National Institutes of Health and other U.S. Department of Health and Human Services partner agencies disseminate strategies, tools, and resources to community organizations, the general public, healthcare providers, and other groups. Strategies focus on three behaviors: eating right, moving more, and reducing screen time to help prevent obesity in youth. Parents and caregivers of 8-13 year olds are the primary focus of the program''s outreach. http://www.nhlbi.nih.gov/health/public/heart/obesity/wecan/ |
| Webinar for Community Leaders on the Health Education Program Media-Smart Youth | Meeting/ Workshop | OS | NICHD | In FY15, NICHD led a webinar for community leaders on the health education program Media-Smart Youth, which was hosted by HHS’s Center for Faith-based and Neighborhood Partnerships, in the Office of the Secretary. Media-Smart Youth is one of several programs the Center has promoted through its Let’s Move Faith and Communities! initiative. |
| White House Conference on Aging | Committee, Work group, Advisory group, or Task Force | ACL, CDC, CMS | NIA | National Institutes on Aging (NIA) staff is involved in regular communications with the White House Conference organizers as well as other HHS colleagues to identify deliverables and speakers for the conference. HHS, The Office of the Assistant Secretary for Health (ASH), leads the "Healthy Aging" work group, in which the NIA is most involved. http://www.whitehouseconferenceonaging.gov/ |
| White House Interagency Committee on the Implementation of the US Strategy to Prevent and Respond to Gender-Based Violence Globally | Committee, Work group, Advisory group, or Task Force | ACF | NIDA, OD/DPCPSI/ORWH | Led by the Secretary of State and the Administration of the United States Agency for International Development, this working group was established by President Obama’s Executive Order 13623 - Preventing and Responding to Violence Against Women and Girls Globally. The working group’s charges were to address gender-based violence, which shall coordinate implementation of the Strategy by the executive departments and agencies that are members of the Working Group. http://www.presidency.ucsb.edu/ws/index.php?pid=101708 |
| White House Office of National Drug Control Policy (ONDCP) Electronic Health Records (EHRs) Interagency Working Group | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA | NIDA, NIAAA, NIMH | This interagency working group coordinates initiatives across the U.S. Department of Health and Human Services to improve efforts to leverage meaningful use of electronic health records, health information technology, and related research and implementation activities as a means to improve quality, safety, and efficiency for substance use disorder research and treatment. http://www.whitehouse.gov/ondcp |
| Work Group on Harmonizing Hemoglobinopathy Data Sets | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NLM, NCATS, NHLBI, NICHD, NIGMS, OD/OER | The mission of the Workgroup for Harmonizing Hemoglobinopathy Data Sets is to create a resource for federal programs and extramural communities to use in data systems which incorporate data elements in hemoglobinopathies. Specifically this entails establishing a Hemoglobinopathies Uniform Medical Language including: identifying specific goals and objectives for the kind of data that are required by these programs; case definitions for electronic data systems at all levels; consensus about conditions and data elements to be included; and differentiation between data needs for surveillance and for registries/biorepository. |
| Workgroup on Asian American, Native Hawaiian, and Pacific Islander Health Issues (WAANHPI) | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, OS, SAMHSA | NIMHD | This collaboration was created to support HHS public health activities on Asian Americans, Native Hawaiians, and Pacific Islanders including the development and updating the annual report to the White House Initiative on Asian Americans and Pacific Islanders (WHIAAPI). http://minorityhealth.hhs.gov/omh/content.aspx?id=8806&lvl=3&lvlid=63 |
| Workgroup on Research Related to Evidence Based Policy | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA, OS, SAMHSA | NIDA | This workgroup focuses on research issues surrounding evidence-based policy. Discussions generally include cross cutting questions-- e.g., What is evidence-based? What are key lessons that have been learned as evidence-based policy has been rolled out? In addition, this group provides updates on meetings and projects related to evidence-based policy. |
| Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | OD/DPCPSI/OAR, NICHD, NIMH | Working Groups of HIV experts from across the country, including physicians, pharmacists, researchers, and HIV treatment advocates responsible for writing, reviewing, and updating HIV/AIDS prevention and treatment guidelines. http://www.aidsinfo.nih.gov/Guidelines/?MenuItem=Guidelines&Search=On |
| Workshop on Research Directions in Genetically-Mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis | Meeting/ Workshop | FDA | NHGRI, CC, NEI, NIAID, NIDDK, NIGMS, NIMH, NINDS | Workshop held March 3-4 2015 to identify future research directions in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), jointly across multiple NIH ICs and FDA''s pharmacosurveillance group. Goals are to review current state of knowledge of surveillance, pathogenesis, and treatment of SJS/TEN; examine role of genomics and pharmacogenomics in etiology, treatment, and eradication of preventable causes of SJS/TEN; and identify gaps, unmet needs, and priorities for future research to eliminate genetically mediated SJS/TEN globally. |
| Workshop Planning on Cardiovascular Diseases in the Inmate and Released Prison Population | Meeting/ Workshop | SAMHSA | NHLBI, NCI, NIA, NIDA, NIDDK, NIMH, NIMHD | Assess existing information on the cardiovascular health of prison populations both while they are incarcerated and after their release, to identify gaps in knowledge and propose promising areas for research with an eye towards interventions to improve the cardiovascular health of this population. The working group will also consider the barriers and challenges of conducting research in these populations. |
| Yale Specialized Center of Research (SCOR) on Gender-Sensitive Treatment for Tobacco Dependence | Research Initiative | FDA | NIDA | The Yale-Specialized Center of Research (SCOR) is bringing together leading basic and clinical science experts to establish an interdisciplinary, translational, cross-species program of research aimed at identifying novel therapeutics to address the critical health disparity that female smokers face. http://medicine.yale.edu/psychiatry/scor/index.aspx |
| Zoster Working Group of the CDC Advisory Committee on Immunization Practices | Committee, Work group, Advisory group, or Task Force | CDC | NIAID | The Working Group discusses new zoster vaccines and makes recommendations to the Advisory Committee for Immunization Practices (ACIP) on how to use zoster vaccines. |
An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government
organization in the United States.
A .gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.